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Wound healing is a highly organized and dynamic process mediated by several 
regulatory mechanisms. Tight regulation of the cellular and biochemical events of wound 
healing aid the optimal restoration of tissue integrity. Fibrosis, a result of abnormal 
wound healing, occurs due to perturbations in regulatory mechanisms associated with 
pathological accrual of scar tissue. Keloid scars, an example of skin fibrosis, clinically 
manifest as raised, reddish nodules that can enlarge and become inactive or may grow 
and become distorted with claw-like extensions due to extensive collagen secretion. The 
fibroblasts have been implicated in this skin fibrosis condition as the primary function of 
these cells is production of collagen and extracellular matrix. Keloid-derived fibroblasts 
display an overactive phenotype. These fibroblasts up-regulate expressions of collagen I-
III, increase activities of glycolytic enzymes and elevate ATP levels over an extended 
period. This study analyses the skewed bioenergetics of keloid fibroblasts to relate it to 
the pathology of this skin disorder.  
Cultured human skin keloid fibroblasts (KF) showed bioenergetics similar to 
cancer cells in generating ATP mainly from glycolysis as demonstrated by increased 
lactate production and rate of glucose utilization. The basal oxygen consumption was 
lower in KF possibly due to their switch to aerobic glycolysis from mitochondrial 
oxidative phosphorylation (OXPHOS). However, when fortified with excess exogenous 
respiratory substrates, ATP production and mitochondrial membrane potential increased 
to a similar maximal level compared to normal fibroblasts (NF). The decreased basal 
OXPHOS likely adapts KF for survival as reduced ROS production was measured in 
these fibroblasts in comparison to NF.  
 xiii 
Although KF exhibit the Warburg phenomenon of aerobic glycolysis, these 
benign tumor cells retain ability to oxidize pyruvate unlike malignant cells. This is 
reflected in the activities and expression levels of pyruvate dehydrogenase (PDH) and 
pyruvate dehydrogenase kinase 1 (PDK1). PDK1 controls the activity of PDH by 
phosphorylating it.  
The overactive system observed in KF was attributed to their 
glycolytic/hexokinase phenotype. The distribution of mitochondrial-bound hexokinase 
(HKII) and cytosolic HK was near equal in NF but HKII activity was significantly higher 
in KF, explaining the greater inhibition by 3-bromopyruvate (3-BP), a specific inhibitor 
of HKII. Likewise, mRNA and protein levels of HKII were elevated in KF. The 
mitochondrial localization of HKII in KF involved the Akt pathway. HKII represents an 
ideal target for keloid therapy; treatment with 3-BP reduced cell viability and depleted 
intracellular ATP levels more significantly than NF. Targeting the altered bioenergetic 
phenotype of KF reduced the migration and extracellular matrix secretion reaffirming the 
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1.  GENERAL INTRODUCTION 
1.1 THE SKIN 
Skin is the largest organ of the integumentary system that serves as an important 
environmental interface providing a protective envelope for the living tissues of an 
animal. It is continuously targeted by an array of chemical and physical environmental 
pollutants (Athar, 2002), trauma and toxins (Altmeyer and Huffmann, 1995). Two 
different tissues constitute the adult skin (Figure 1.1): the keratinized stratified epidermis 
composed mainly of squamous epithelial cells, namely, keratinocytes and an underlying 
dermis composed of a thick layer of collagen-rich connective tissue that serves to protect 
tissues from stress and strain (Altmeyer and Huffmann, 1995).  
The epidermis is organized in four distinct cell layers or strata and is composed 
mainly of keratinocytes. The innermost basal layer consists of actively proliferating 
keratinocytes that migrate up the strata to the surface. As the keratinocytes traverse to the 
surface, they die and change in shape and composition due to isolation from blood source 
(Fuchs, 1990). This results in the corneocyte (horny) layer that serves as a protective 
barrier.  
The dermis plays major roles by supplying nutrients to the epidermis and 
providing support structurally (Altmeyer and Huffmann, 1995). This layer is composed 
predominantly of fibroblasts that produce collagen-rich connective tissue. It houses hair 
follicles and several mechanoreceptor endings that provide the sense of heat and touch. 
The deepest layer is composed mainly of adipocytes where fat pads serve to insulate the 
body.  





Figure 1.1 Anatomy of the skin. Modified from 
http://www.burnsurgery.org/Modules/BurnWound/images/?M=A 
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1.2  WOUND HEALING 
Wound healing is a highly dynamic biological process that serves to restore tissue 
integrity (Santoro and Gaudino, 2005). Normal healing is a finely organized and 
overlapping sequence of events (Figure 1.2) that can be categorized into four main 
phases: coagulation, inflammation, fibroplasia and remodeling (Cohen et al, 1992). The 
coagulation phase occurs at the onset of tissue injury. The presence of blood components 
at the site of injury mediates the contact of platelets to exposed collagen as well as other 
components of the extracellular matrix. This contact triggers the secretion of clotting 
factors, growth factors and cytokines such as transforming growth factor-β (TGF-β) and 
platelet derived growth factor (PDGF) by the platelets. The fibrin clot, temporarily 
formed by the aggregation of platelets with fibrin, serves as a shield protecting wound 
tissue as well as providing a provisional matrix through which cells can migrate during 
the healing process (Clark, 2001).  
Release of cytokines and essential growth factors by the platelets serves as a 
chemotactic signal for the recruitment of circulating inflammatory cells such as 
polymorphonuclear neutrophils (PMN), macrophages and leukocytes to the wound site 
(Martin, 1997).  This signals the onset of the inflammatory phase of wound repair. 
Essentially, 24h after initial wounding, the neutrophils are the main cells present. They 
act to remove foreign material, bacteria and impaired matrix components at the wound 
site (Hart, 2002). However, 48h after wounding, the macrophages become the main 
inflammatory cells at the wound site. The presence of wound macrophages serves as a 
marker signaling that the inflammatory phase is concluding and the onset of the 
proliferative (fibroplasia) phase is imminent (Diegelmann and Evans, 2004). During the 
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proliferative phase, dermal fibroblasts are recruited to the wound site by growth factors 
such as PDGF and TGF-β. There, they proliferate and begin to migrate into the 
provisional matrix of the wound clot where they produce collagen and lay down new 
extracellular matrix (Eckes et al, 1996).  
Occurring simultaneously is the process of reepithelialization that involves the 
keratinocytes. The normal epidermis comprises a basal layer of highly proliferating 
keratinocytes and a suprabasal compartment of keratinocytes at end-satge differentiation 
(Fuchs, 1990). The process of reepithelialization is an important phase as it covers the 
defect incurred upon wounding. Following injury, keratinocytes traverse across the 
surface and undergo mitosis to expand the population (Odland and Ross, 1968; 
Krawczyck, 1971). After the onset of migration, epidermal cells returning from the 
wound margin undergo proliferative burst (Garlick and Taichman, 1994; Matoltsy and 
Viziam, 1970) which is stimulated by the presence of epidermal growth factors (EGF) 
and TGF-β produced by activated wound macrophages and platelets (Hunt et al., 1984; 
Schultz et al., 1991; Yates et al., 1991). This increases the demand for oxygen and 
nutrients. Local factors in the wound microenvironment such as low pH, reduced oxygen 
tension and increased lactate initiate the release of factors to increase local blood supply 
(Knighton et al., 1983; LaVan and Hunt, 1990). Factors such as vascular endothelial 
growth factor (VEGF), fibroblast growth factor (FGF) and TGF-β stimulate angiogenesis 
to meet the increased demand for nutrients. Once the defect is covered, the keratinocytes 
undergo stratification and differentiation to create a renewed epidermis.  
In the remodeling phase, the wound site initially consists of granulation tissue that 
is replaced by scar tissue. The scar tissue provides continuity within the wound spaces, 
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however, several compositional and architectural differences exist compared to tissue 
native to the site (Sopher, 1972). Analysis of normal scar tissue indicates a weaker 
collagen structure where the maximum regained tensile strength of collagen in a wound is 
approximately 80% of normal skin (Diegelmann and Evans, 2004). The main cell 
involved in the production of extracellular matrix during the wound healing process is the 
fibroblast.  
1.3  ROLE OF FIBROBLASTS IN WOUND HEALING 
Fibroblasts are the main cells at the wound site (Table 1.1) as fibroplasia 
progresses (Diegelmann and Evans, 2004). These cells that migrate into the wound area 
arise from undifferentiated mesenchymal cells in the surrounding tissue. This migration is 
controlled by chemotactic cues (PDGF and TGF-β) and contact guidance mechanisms 
(Figure 1.3) such as the fibronectin matrix that fibroblasts attach to and traverse into the 
wound to begin producing collagen and other extracellular matrix materials (Ohta et al., 
1987). In the transition from the migratory phenotype to the profibrotic phenotype, 
fibroblasts undergo intracellular changes and its deposition of extracellular matrix 
deviates from great quantities of fibronectin (Grinnell et al., 1981; Kurkinen et al., 1980) 
to mainly collagen (Welch et al., 1990). Production of vast quantities of collagen by 
fibroblasts has been reported to be influenced by TGF-β (Ignotz and Massague, 1986; 
Roberts et al., 1986) and interleukin-4 (IL-4) (Postlethwaite et al., 1992). Although the 
remodeling phase extends for months after injury, the decrease in the rate of collagen 
synthesis occurs after about three weeks (Abatangelo et al, 1995). 
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Figure 1.2 Sequence of cellular and biochemical events during wound healing 






   
 7
Following tissue injury, the process of remodeling involves both synthesis and 
degradation of the elements of the extracellular matrix. For example, specific 
collagenases are present in fibroblasts, neutophils and macrophages that control collagen 
turnover. The control over the turnover of extracellular matrix is mediated by soluble 
factors such as interferon- γ (IFN-γ) (Duncan and Berman, 1985; Granstein et al., 1987) 
that activate signal transduction pathways that result in the expression of specific genes. 
These effectors modulate fibroblast proliferation, secretion of new extracellular matrix 
materials as well as control expression of specific proteinases such as matrix 
metalloproteinases (MMP) that lead to extracellular matrix degradation. Insoluble 
macromoleules of the extracellular matrix can also control collagen deposition. The 
abundant collagen matrix can repress fibroblast proliferation and fibroblast collagen 
synthesis (Clark et al., 1995; Grinnell, 1994). These processes are important in the 
remodeling of the extracellular matrix during wound healing. 
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Figure 1.3 Extracellular environment of fibroblast 
Schematic representation of interactions between the fibroblasts, 
extracellular matrix molecules and soluble factors as described by 
(Siméon et al, 1999) 
   
 9
Activity Role in wound healing 
Production of growth factors Stimulation of autocrine and paracrine 
signaling mechanisms 
Proliferation and migration Formation of granulation tissue 
Release of proteases Lysis of provisional fibronectin matrix and 
remodeling of the extracellular matrix 
Production of extracellular matrix 
components 
Formation of connective tissue 
Providing a dynamic linkage between 
actin bundles and the extracellular 
matrix 
Generate contractile forces for wound 
contraction 




Table 1.1  Summary table of the roles of fibroblasts in wound repair (Cohen et 
al, 1992) 
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1.4 THE EXTRACELLULAR MATRIX OF SKIN 
 The extracellular matrix is a highly organized structure composed of several 
complex elements each of which is made up of different components such as various 
types of collagen, glycoproteins, elastin, glycosaminoglycans and proteoglycans 
(Mignatti et al., 1996).  Elastin fibers permit elasticity of the skin and the ability of 
proteoglycans to absorb large amounts of water reiterates its importance in maintaining 
hydration. Glycoproteins, such as fibronectin and laminin are important as they mediate 
the attachment of cells to the matrix. Despite the presence of a large number of 
glycoproteins in the extracellular matrix, the various types of collagen play an integral 
role since they provide not only the structural scaffolds of the skin but also regulate many 
cellular functions (Eckes et al, 1996).   
Collagen is the main protein found in the connective tissue of animals. Although 
28 different types of collagen have been identified, about 90% of total collagen in our 
body consists mainly of collagen I, II, III and IV (Diegelmann and Evans, 2004). Normal 
dermal collagen on a per weight basis approaches the tensile strength of steel and is a 
strong and highly organized molecule (Diegelmann and Evans, 2004). Analysis of 
collagen gene expression and biosynthesis during the various phases of wound healing 
indicated initial deposition of collagen III and fibronectin, however, during the later 
stages, collagen I gradually replaces collagen III (Clore et al., 1979). Excessive 
accumulation of scar collagen due to dysregulation of the processes involved in wound 
healing is the basis of several fibrotic diseases such as hypertrophic scars and keloids. 
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1.5  FIBROSIS 
 Fibrosis is defined as the replacement of the normal structural elements of the 
tissue by indistinct, non-functional and pathological accrual of scar tissue (Diegelmann 
and Evans, 2004). It results in clinical problems such as liver cirrhosis and 
atherosclerosis. Raised scars, namely, keloids and hypertrophic scars represent skin 
fibrosis and are explained to be due to perturbations in the balance of synthesis and 
degradation of collagen. Several mechanisms exist that could illustrate the excessive 
accumulation of collagen (Diegelmann and Evans, 2004). These mechanisms are 
summarized below: 
1. Elevated synthesis of collagen 
In studies carried out in fibroblasts isolated from several patients with dermal fibrotic 
conditions, increased collagen production was evident (Gruber, 2003; Ohta et al., 1987). 
2. Reduced degradation of collagen polypeptides 
Increased mast cell density has been reported in fibrotic conditions (Kofford et al., 1997). 
These cells contain specialized enzymes required to process procollagen. In fibrotic 
pathogenesis, abnormal peptides resulting from such processing can possibly stimulate 
collagen synthesis leading to over accumulation of collagen (Desmouliere, 1995). 
3. Increase in local fibroblast population with a normal rate of collagen production 
During the replacement of granulation tissue with scar tissue, granulation tissue 
fibroblasts (myofibroblasts) containing α-smooth muscle (SM) actin undergo apoptosis 
and disappear. However, in conditions where excessive scaring and fibrosis is present, α-
SM actin containing fibroblasts persist (Ehrlich et al., 1994). 
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1.6  HYPERTROPHIC SCARS 
Hypertrophic scars are raised fibrous lesions that normally do not extend beyond 
the initial boundaries of the wound site. These scars arise due to excessive amassing of 
scar collagen and result from burns and other injuries involving the deep dermis. 
Although hypertrophic scars are often misdiagnosed as keloids, several significant 
differences exist between these two types of scars (Ladin, 1995; Montagna et al 1993) 
(Table 1.2).  
1.7 KELOIDS 
Keloids are a clinical example of fibrosis. The term keloid is derived from the 
Greek word “chelè”, meaning crab claw (Breasted, 1930). Keloids were mentioned for 
the first time in the 1700 BC by Eygptian surgeons (Breasted, 1930). In 1806, Baron 
Jean-Louis Alibert gave the first clinical description of keloids (Alibert, 1806). These 
scars contain biochemical and cellular markers that are characteristic of fibrosis (Kelly, 
1988; Rahban and Garner, 2003; Shaffer et al., 2002) and occur only in humans (Figure 
1.4). Keloids develop randomly and can arise because of several causes such as irritation, 
acne, insect bites and burns.  
Certain regions of the body are more prone to keloid formations. Scars occurring 
over the anterior chest, ears, upper back and shoulders are likely to undergo keloidal 
transformation (Cosman et al, 1961) (Figure 1.4). Keloids are normally asymptomatic 
and are often a cosmetic problem. However, in some individuals they can cause 
significant pain. These raised reddish nodules can enlarge and become inactive or may 
grow and become distorted with claw-like extensions (Kelly, 2004). 
 







Figure 1.4 Keloid scars. Figures were generously provided by Dr Phan TT 
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KELOID HYPERTROPHIC SCAR 
Tissue growth can extend beyond the 
original site of injury 
Excessive tissue growth remains in the 
confines of the wounded region 
No regression  Remains the same and may regress 
Minor injuries can result in the growth of 
large keloids 
Commonly commensurate to the size of 
the original wound  
Absence of myofibroblasts Contain α-SM actin expressing 
myofibroblasts  
Fibroblast density and proliferation rate at 
the wound site is increased 
Increased fibroblast density 
Collagenous fiber bundles are larger and 
more irregular.  
Collagen fibers lie haphazardly forming 
loose sheets; increased ratio of type I to III 
collagen 
Fine, randomly organized collagen fibrils 
that connect dermal collagen bundles that 
run parallel to the epithelial surface 
Blood vessels are partially or fully occluded 
in keloids 
Blood vessels are small 
Regrowth likely after surgical excision Surgical excision possible 
 
 
Table 1.2 Histological and clinical differences between keloid and hypertrophic 
scars 
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1.7.1  Epidemiology 
Keloids occur in individuals of all ages although the incidence of keloids in 
patients aged between 10 to 30 years is higher; with the mean age of keloid development 
in females being 22.3 years and for males being 22.8 years (Schierle et al., 1997). 
Although a slight predominance of keloid incidence in females compared to males exists’ 
a higher rate of earlobe piercing among females may provide an explanation for this 
observation (Kelly, 1988). The association between keloid formation and hormonal 
influences has been implicated due to increased keloid development in pregnant 
individuals and individuals undergoing puberty (Kelly, 1988). Demography plays a 
possible role in keloid incidence. Prevalence of keloids amongst the African, Hispanic 
and Asian populations (Tuan and Nichter, 1998) indicate keloid formation susceptibility 
may be related to skin pigmentation.  
1.7.2 Genetics 
 Since keloids are ubiquitous in certain populations and families, genetic factors 
are likely to influence keloid formation. A study on familial predisposition to keloids was 
conducted in two families with an autosomal dominant inheritance pattern of keloid 
formation (Marneros et al., 2004). In an African-American family, evidence of a keloid 
susceptibility locus was found on chromosome 7p11; and in a Japanese family, the 
linkage was on chromosome 2q23. These observations indicate that genetic factors may 
contribute to keloid susceptibility and therefore serves as a basis for the identification of 
responsible genes. 
Individuals suffering from Goeminne syndrome are characterized by multiple 
keloids amongst other disorders (Goeminne, 1968). This provides another evidence of 
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genetic susceptibility to keloid disease. However, no consistent pattern exists regarding 
the mode of genetic transmission and therefore more remains to be elucidated. 
1.7.3  Pathogenesis 
Intracellular mechanisms responsible for keloid formation remain elusive. To 
date, no reports indicate a single unifying hypothesis to explain the pathogenesis of 
keloid formation. Current studies indicate that interaction between fibroblasts and the 
extracellular matrix’ atypical extracellular matrix remodeling and possible abnormalities 
existing in keloid fibroblasts may contribute to keloid scar formation.   
1.7.3.1  Keloids and the extracellular matrix 
 In normal scar formation, rigid control over the synthesis and degradation of  the 
extracellular matrix is crucial. In keloids, there is evidence that this balance is altered due 
to either elevated synthesis or decreased degradation of the extracellular matrix elements.  
Histopathology of keloids suggests that these raised nodules contain increased amounts 
of extracellular matrix of connective tissue (Border and Noble, 1994). 
 Collagen is the principal extracellular matrix component in keloids. In the last 
phase of wound repair, remodeling of the extracellular matrix results in replacement of 
collagen III with collagen I, increase in proteoglycan production and degradation of 
fibronectin. Isolated keloid-derived fibroblasts (KF) produce up to 20 times more 
collagen than those fibroblasts isolated from normal skin in vitro (Cohen et al, 1990) and 
further analysis of the connective tissue indicate that the ratio of the collagens type I/III 
in keloids was significantly higher than normal skin (Abergel et al., 1985). Reports 
suggest that overproduction of collagen I with insignificant changes in collagen III 
expression may explain the altered ratio (Uitto et al., 1985). Besides collagen, expression 
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levels of other extracellular matrix elements such as fibronectin, proteoglycans and 
elastin were significantly higher in KF in vitro (Abergel et al., 1985; Babu et al., 1989; 
Friedman et al., 1993; Kischer and Hendrix, 1983).  
Abnormal collagen turnover in keloids due to increased activities of enzymes 
involved in collagen biosynthesis, such as prolyl hydroxylase, has been reported (Abergel 
et al., 1985) however, discrepancies in collagen degradation have also been observed. 
Degradation of nascent collagen polypeptides was below the range of normal controls 
(Abergel et al., 1985). Anomalous collagen deposition because of alterations in collagen 
degradation was reported in both hypertrophic and keloid scars (Craig, 1973).  
1.7.3.2  Keloid fibroblasts 
The primary responsibility of fibroblasts is production of collagen and 
extracellular matrix. Therefore, in attempting to elucidate keloid pathogenesis, 
characterized by increased accumulation of extracellular matrix materials, it is important 
to conduct an in vitro analysis of KF. During normal wound healing, simultaneous 
increase in collagen gene expression, synthesis and accumulation occurs. This happens 
for about 3 weeks after which the buildup ceases (Abatangelo et al., 1995).  
Examination of KF indicates prolonged periods of proliferation and increased rate 
of collagen synthesis (Diegelmann et al., 1979, Russel et al., 1989). Cultured KF respond 
atypically to hydrocortisone and TGF-β (Desmouliere et al., 1995). TGF-β and 
hydrocortisone inhibit growth and collagen biosynthesis, respectively, in normal skin 
fibroblasts. However, in KF, such inhibitory actions were absent. These results indicate 
that the conditions that are normally inhibitory to growth and collagen synthesis at the 
late stages of wound healing are redundant in KF.  
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During the transition from granulation tissue to scar, apoptosis regulates the 
cellular population within the wound site (Desmouliere et al., 1995). However, in KF, it 
was reported that Fas-mediated apoptosis is dysregulated (Chodon et al., 2000). Further 
analysis of keloid samples indicated large numbers of apoptotic cells at the epidermis and 
dermis, however, the number and distribution of apoptotic cells decreased more distal to 
the keloid lesion (Appleton et al., 1996). It was therefore suggested that continuous 
fibroblast proliferation at the dermal/keloid interface propagates the fibrosis observed in 
keloids. Recent reports demonstrate that KF contain mutations on p53 (Ladin et al., 1998; 
Saed et al., 1998), a gene known to modulate apoptosis. 
1.7.3.3  Microenvironment of the keloid scar 
Histological examination of keloids demonstrates a normal skin periphery, an 
inflammatory border, and a stable portion, which is hypo-vascular and hypoxic (Berry et 
al., 1985). Accumulation of lactate, a product of anaerobic glycolysis, has also been 
reported in keloid scar tissues in vivo (Hoopes et al., 1971). Hypoxia, therefore, may play 
a significant role in keloid pathogenesis. 
Hypertrophic burn scars were shown to be sites of relative hypoxia (Sloan et al., 
1978) and the oxygen tension in a wound is low days after the injury (Haroon et al., 
2000; Ninikoski and Hunt, 1972). Both keloid and hypertrophic scars exhibit features of 
microvascular occlusion from an excess of endothelial cells, which is reported to create a 
hypoxic environment that may further stimulate collagen synthesis (Kischer, 1992, 1993). 
The presence of hypoxia could possibly explain the induction of the expression of 
hypoxia inducible factor-1α (HIF-1α) mRNA and of HIF-1α subunit found in healing 
wounds (Albina et al., 2001). 
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1.8  Hypoxia  
 A critical cellular metabolic adaptation to decreased oxygen tension known as the 
Pasteur Effect involves increased conversion of glucose to lactate in hypoxic cells 
(Seagroves et al., 2001). Increased glycolysis requires transcriptional activation of genes 
encoding essential proteins such as glucose transporters and glycolytic enzymes, and this 
is mediated by a heterodimeric transcription factor, hypoxia inducible factor-1 (HIF-1) 
(Iyer et al., 1998; Seagroves et al., 2001). The regulation of HIF-1 levels by oxygen 
depends on HIF-1α as this subunit contains an oxygen-dependent domain. Within this 
domain, two proline residues (402 and 564) undergo hydroxylation by prolyl hydroxylase 
in the presence of oxygen. Hydroxylation targets HIF-1α for ubiquitination by the von 
Hippel-Landau protein and subsequent proteasomal degradation results. HIF-1β is 
constitutively expressed within a cell and is named the aryl hydrocarbon receptor nuclear 
translocator (ARNT). HIF-1α dimerizes with ARNT and binds to the core DNA sequence 
5'-RCGTG-3' (Knighton et al., 1983), leading to the transcriptional activation of several 
known target genes (Table 1.3). Hypoxia results in decreased ubiquitination and 
accumulation of HIF-1α (Sutter et al., 2000). 
VEGF, a well-known target of HIF-1, plays a significant role in keloidal 
pathogenesis (Wu et al., 2004). In KF, VEGF induces gene expression of plasminogen 
activator inhibitor-1 (PAI-1) in a time and dose-dependent manner by activating the 
ERK1/2 signaling pathways (Zhang et al., 2003). This indicates that hypoxia is involved 
in regulating PAI-1 gene expression in KF (Eitzman et al., 1996). PAI-1 plays an indirect 
role in pathologic and physiologic processes such as metastasis and wound healing by 
modulating the plasminogen system (Tuan et al., 1996). During wound healing, 
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proteolytic degradation of components by tissue-type and urokinase-type plasminogen 
activators (t-PA and u-PA respectively) contributes to the balance of extracellular matrix 
accumulation. Previous reports indicate elevated PAI-1 and low levels of u-PA in keloid 
fibroblasts (Niessen et al., 1999). The altered ratio of activator and inhibitor activities is a 
major contributing factor in abnormal extracellular matrix deposition, leading to the 
formation of keloids (Robles et al., 2007).  
1.9  Warburg effect   
 Proliferative cells preferentially use aerobic glycolysis rather than oxidative 
metabolism to generate ATP (Brand and Hermfisse, 1997), a phenomenon proposed as 
the primary defect in cancer (Warburg, 1956). Recent advances in anti-cancer therapy 
concentrates on targeting this elevated metabolic pathway. Clinically, keloids are benign 
tumors as they continue to grow beyond the periphery of the original wound margins. 
The increased rate of glycolysis even in the presence of oxygen is a common feature of 
many cancer cells and is termed the Warburg effect. This phenotype has been linked to 
the HIF-1, which affects angiogenesis, glucose transporter, and more importantly, 
glucose metabolism (Semenza, 1999) (Table 1.3). HIF-1α has been shown to activate the 
transcriptional regulation of genes encoding glycolytic enzymes (Semenza et al., 1994). 
The co-ordinated upregulation of all glycolytic enzymes on exposure to hypoxia has been 
demonstrated previously, whereas the activity of nonglycolytic enzymes remained 
unchanged (Robin et al., 1984). These observations were consistent with the conclusion 
that the rate of glycolysis was positively controlled by the glycolytic enzymes (Ainscow 
and Brand, 1999). 
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CELLULAR METABOLISM AND PROLIFERATION 
Adenylate Kinase 3   Aldolase A and C 
Enolase 1 (ENO1) Glucose Transporter 1 and 3 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Hexokinase I and II 
Pyruvate dehydrogenase kinase 1 
(PDK1) 
Transforming growth factor-β (TGF-β) 
Lactate Dehydrogenase A Phosphoglycerate Kinase 1 
Pyruvate Kinase M p21 
 
VASCULAR DEVELOPMENT OR REMODELING 
 
Nitric Oxide Synthase 2 Plasminogen Activator Inhibitor 1 
Vascular Endothelial Growth Factor 
(VEGF) 
VEGF Receptor FLT-1 
 
 
Table 1.3 HIF-1 induced expression of several target genes (Semenza, 2000) 
 
 
The accumulation of lactate in keloid tissues in vivo indicates that glycolysis is 
rampant (Hoopes et al., 1971). No reports have suggested the possible role of the 
Warburg effect on the metabolism of KF that could explain their overactive system. In 
vitro analysis of the bioenergetic signature of KF is feasible, as KF appear to retain their 
keloid characteristics during culture by their ability to synthesize collagens in vitro 
(Diegelmann et al., 1979). This provides us an avenue to study possible targets in these 
atypical fibroblasts in search of a possible cure that remains obscure to date. 
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1.10 Current treatment options 
To date there are no therapeutic options available that have 100% success rate 
(Robles et al., 2007). Surgical excision is largely unsuccessful due to the high recurrence 
rate of keloids after removal. Table 1.4 provides a summary of current treatments for 
keloids that have reached the stage of clinical trials (Robles et al., 2007). The caveat in 
analyzing the efficacy of these treatments is the limited follow up time, as many keloids 
tend to recur after more than a year. In addition, the small patient sample size may lead to 
overestimation of the effectiveness of these treatments. 
 





Inhibit collagen synthesis 
and fibroblast growth in 
vitro; reduce TGF-β 


















Block cell cycle, degrade 
RNA and DNA, induce 
ROS production 
3 months post 
treatment: 100% 
success 
IFN α-2b NA Antiproliferative and 
antifibrotic; increase 
colleganase activity 
57% recurrence  
 
Table 1.4 Summary of current treatment options available for keloids  
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2.  AIMS OF THE THESIS 
The emphasis of researching keloid fibroblasts (KF) from the standpoint of its 
altered signaling mechanisms has been studied vastly. Due to the paucity of knowledge 
on the metabolism of these atypical fibroblasts that likely gives rise to their overactive 
system, the initial aims of this thesis was to gain a deeper knowledge of the differences in 
the bioenergetic signature of KF in comparison to normal fibroblasts (NF) and as a 
benign tumor model. In doing so, these differences may form the basis of potential 
therapeutic strategy for this skin disease that has no effective treatment to date.  
 Chapter 3 described work that identified glycolysis as the main bioenergetic 
pathway contributing to the elevated ATP biosynthesis in KF. These observations 
indicate that KF exhbit a metabolic phenotype that deviates from that of NF which are 
more dependent on OXPHOS. However, several similarities to tumor cells were observed 
in KF. 
Chapter 4 described a likely difference between benign and highly metastatic 
tumors from the standpoint of their ability to oxidize pyruvate. Here, KF were used as a 
model for benign tumors and the pyruvate oxidation pathway was analyzed and compared 
to reported data on pyruvate metabolism in highly metastatic tumors. 
 Chapter 5 challenged the dogma of type II HK expression in only highly 
metastatic tumors. Here the intracellular HK distribution pattern of KF was examined and 
compared to NF. The expression of type II HK in benign tumors (KF) will be described. 
 Chapter 6 examined the role of hypoxia in contributing to the altered bioenergetic 
phenotype observed in KF. Stable transductants of KF expressing the dominant negative 
form of HIF-1α were assessed for changes in their glycolytic and fibrotic phenotype. In 
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addition, hypoxia was induced in NF through treatment with DFO a hypoxia-mimetic and 
changes to the metabolic phenotype of these cells were measured.  
 As results from chapter 5 suggested mitochondrial-bound HKII was elevated in 
the KF, this enzyme was studied as a potential therapeutic target in keloids by treatment 
with 3-BP a specific inhibitor of HKII. The effects of this drug on known pathogenic 
attributes of KF, namely increased cell migration, aberrant extracellular matrix deposition 
and elevated rate of glucose utilization amongst others, were analyzed in chapter 7.  
2.2  SPECIFIC AIMS 
2.2.1 To identify the main ATP synthesizing pathway (glycolysis or oxidative 
phosphorylation) in KF 
2.2.2 To study glycolytic and oxidative phosphorylation related proteins/enzymes 
expression  
2.2.3 To examine pyruvate metabolism in KF as a model of benign tumors 
2.2.4 To investigate the importance of hypoxia-inducible factor-1α on altered metabolism  
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3.  BIOENERGETICS OF KELOID FIBROBLASTS 
3.1  INTRODUCTION 
The repair of damage at the site of wound injury involves both epidermal skin 
cells and fibroblasts that deposit collagen and other extracellular matrix proteins to fill up 
the wound. Keloids are characterized by the excessive deposition of extracellular 
collagens by abnormal fibroblasts in response to cutaneous injury. It is known that  
Collagen I and III, and their respective mRNAs are up regulated in these highly 
proliferative cells (Naitoh et al., 2001), which suggest an overactive system. However, 
the underlying biochemical mechanisms of keloid pathogenesis remain unknown 
(Haverstock, 2001). Long after an initial tissue injury, keloid fibroblasts (KF) continue to 
proliferate resulting in an accumulation of non-functional scar tissue giving rise to raised 
nodules and the ATP levels therein remain high (Ueda et al., 1999). As most of the 
energy in the cell is produced in the mitochondrion, this organelle is implicated in keloid 
pathophysiology.  
3.1.1  CELLULAR BIOENERGETICS 
 The cellular bioenergetic signature involves the simultaneous collaboration of 
exergonic (nutrient oxidation) and endergonic processes (maintenance). Energy derived 
from nutrient breakdown is transferred through the intermediate synthesis of ‘high-
energy’ phosphate compounds such as ATP (Voet and Voet, 1995). Nutrient oxidation 
also gives rise to precursors required in the synthesis of essential biological molecules 
such as lipids, nucleotides and proteins. The two main ATP producing pathways in cells 
are glycolysis and oxidative phosphorylation, with the latter contributing 95% of the total 
ATP produced within a cell (Figure 3.1).  




Figure 3.1 Bioenergetics of a normal cell. 
Normal cellular bioenergetics is a coordinated series of reactions 
involving both glycolysis and oxidative phosphorylation. The latter stage 
produced the bulk of the ATP derived from the metabolism of glucose. 
Glycolysis, which occurs in the cytoplasm, produces just 5% of the total 
ATP.     
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3.1.2  GLYCOLYSIS 
  Glycolysis is the process of oxidation of glucose through a series of reactions 
localized in the cytoplasm. It serves two principal functions: generate high-energy 
intermediates, namely, ATP and NADH, and produce three and six-carbon intermediates 
that are required for nucleotide biosynthesis (Voet and Voet, 1995). The outcome of 
pyruvate, an end metabolite of glycolysis, was determined by the presence of oxygen that 
plays a significant role in deciding its fate.  
 Under hypoxic conditions (lack of oxygen), pyruvate is converted to lactate by 
lactate dehydrogenase (LDH). The primary function of this conversion is to maintain the 
glycolytic flux through the recycling of NAD+. The control of this metabolic flux is 
crucial and is adjusted in response to parameters within and outside the cell. The rate is 
regulated to serve its two main functions: ATP production and the provision of building 
blocks for synthesis of essential biomolecules. In glycolysis, the reactions catalyzed by 
enzymes hexokinase, phosphofructokinase, and pyruvate kinase are irreversible thus 
these enzymes are potential sites of control, and these three enzymes serve regulatory 
functions in glycolysis. Regulation of enzyme activity occurs via feedback control 
through allosteric effectors or by covalent modification. A slower form of control is 
transcriptional regulation that mediates the protein expression levels of the essential 
enzymes. The transcription factor, hypoxia inducible factor-1 alpha (HIF-1α) expressed 
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3.1.3  OXIDATIVE PHOSPHORYLATION (OXPHOS) 
 In normal cellular environment, glycolysis is coupled to aerobic respiration. In the 
presence of oxygen, pyruvate enters the mitochondria and is oxidized to carbon dioxide 
and water through the Krebs cycle and ultimately the electron transport chain. The 
electron transport chain typically produces 36 ATP which is generated at the FoF1ATP 
synthase (respiratory Complex V) by coupling the movement of the protons down the 
concentration gradient through this enzyme. These processes produce in total 36 ATP 
molecules per glucose molecule oxidized. This is 18 times compared to the amount of 
ATP synthesized under hypoxic conditions where glycolysis functions alone.  
 Yet, in highly malignant tumor cells, the less efficient form of ATP biosynthesis 
predominates despite the availability of oxygen. However, in these transformed cells, 
glycolysis occurs at an elevated rate in comparison to their normal tissues of origin. The 
basis of 18F-deoxyglucose positron-emission tomography (FDG-PET) used for clinical 
diagnosis of highly malignant tumors exploits the increased glucose utilization in these 
tumor cells (Figure 3.2).  
Clinically, keloids are benign tumors as they continue to grow beyond the 
periphery of the original wound margins. Therefore, analysis of the main bioenergetic 
pathways involved in the metabolism of KF provides insight into the mechanism 
involved in keloid pathogenesis. A schematic representation of the various substrates and 
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Figure 3.2 Principle of 18F-deoxyglucose Positron-emission tomography (FDG-
PET) scanning technique    
 
FDG-PET scanning technique is based on elevated uptake of glucose and 
high hexokinase activity in malignant tumor cells. Figure is taken from 
(Pedersen, 2007) 
 
Figure 3.3 An overview of the sites of action of respiratory substrates and 
inhibitors (in parentheses) used in this study 
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3.2  RESULTS 
 
3.2.1  OPTIMUM PERMEABILIZATION OF FIBROBLASTS 
Digitonin treatment solubilizes the cholesterol on the plasma membrane. This contributes 
to increased permeability of the cell plasma membrane. Hence, the entry of mitochondrial 
respiratory substrates into the cell can occur which increases the mitochondrial 
membrane potential. Permeablization by digitonin was optimized at a concentration 
where no damage to the mitochondrial membrane was evident. This was determined 
using JC-1, a mitochondrial dye that accumulates and aggregates in energized 
mitochondria (in the presence of respiratory susbrates). Both normal (NF) and keloid 
fibroblasts (KF) were optimally permeabilized with 60-80µg digitonin per 106 cells as 
shown by the maximal increase in the fluorescence of the J-aggregates following the 
entry of glutamate/malate and succinate. The energization of the MMP by these 
respiratory substrates was apparent and the increase in mitochondrial membrane potential 
was inhibited by rotenone and antimycin A, respectively (Figure 3.4). 65µg digitonin/106 
cells was chosen in subsequent experiments to be suitable for both NF and KF. 
3.2.2  ELEVATED RATE OF ATP BIOSYNTHESIS AND INTRACELLULAR 
          ATP IN KF 
KF were shown to biosynthesize ATP from exogenous ADP (1mM) more rapidly than 
NF; their respective specific activities, expressed in means ± SD nmol ATP/min/106 cells 
were 11.97 ± 3.7 and 3.27 ± 0.8 for N = 5, giving a ratio of 3.7 for KF:NF (Figure 3.5A). 
Likewise, intracellular ATP was higher in KF with respective values (expressed in means 
± SD nmol ATP/106 cells) of 8.97 ± 1.2 and 4.67 ± 0.9 (Figure 3.5B). Both sets of data 
showed significant difference between NF and KF with p < 0.01. 
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Figure 3.4 Optimization of digitonin concentration for effective permeabilization 
in normal skin fibroblasts analyzed using JC-1  
 
Cells were permeabilized as described in section 9.2.3 and optimal 
permeabilization was achieved between 60 and 80µg digitonin/106 cells. 
65µg digitonin/106 was chosen for subsequent experiments involving cell 
permeabilization.  







Figure 3.5 ATP producing capacity of KF and NF 
 
(A) The rate of ATP biosynthesis was measured in digitonin-
permeabilized samples of NF and KF to which an exogenous source of 
ADP (1mM) was provided. N = 5; **p < 0.01.  
 
(B) Intracellular ATP levels measured in lysates prepared from five 
different samples of NF and KF where **p < 0.01. The amount of ATP 
was quantified as described in section 9.2.5.1  
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3.2.3  KF EXHIBIT GREATER DEPENDENCE ON GLYCOLYSIS FOR ATP 
          GENERATION 
The biosynthesis of ATP in KF was inhibited to a higher degree by iodoacetate and 
oxamate, inhibitors of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and lactate 
dehydrogenase (LDH), respectively, compared with NF, which implied that their ATP 
production relied more on the glycolytic pathway (Table 3.1). On the other hand, the 
degree of inhibition by thenoyltrifluoroacetate (TTFA), an inhibitor of respiratory 
complex II, carbonyl cyanide p-trifluoro-methoxyphenylhydrazone (FCCP), an 
uncoupler, and oligomycin, an inhibitor of FoATPase was more pronounced in NF, 
suggesting that they depend more on oxidative phosphorylation (OXPHOS) for their ATP 
production. In view of this finding, OXPHOS was studied by measuring the amount of 
ATP produced from the oxidation of respiratory substrates such as glutamate/malate, and 
succinate in digitonin-permeabilized cells. 
3.2.4  INTACT OXPHOS IN KELOID FIBROBLASTS 
3.2.4.1  ATP biosynthesis 
Consistent with the data on ATP biosynthesis above, KF again showed higher basal 
capacity of about 3.6 times compared with NF measured in the absence of exogenous 
substrates (Table 3.2). Addition of respiratory substrates increased significantly the rate 
of ATP production in both NF and KF to an approximately similar maximum value. The 
increase represents the amount of ATP derived from their oxidation via OXPHOS. The 
magnitude of increase was greater in NF compared with KF supporting the earlier 
conclusion that contribution by OXPHOS was greater in NF when TTFA, FCCP, or 
oligomycin was added (Table 3.1) 
 















Iodoacetate (10Mm) Glycolysis 
(GAPDH) 
9.25 ± 1.96  35.6 ± 3.8  
# 
Oxamate (10mM) Glycolysis 
(LDH) 
8.89 ± 2.3 19.7 ± 2.8 
# 
TTFA (250µM) OXPHOS 
(Complex II) 
36.3 ± 3.1 14.8 ± 1.5 
** 
FCCP (10µM) OXPHOS 
(uncoupler) 
53.3 ± 4.3  24.5 ± 4.1 
 **
 
Oligomycin (10µg/ml) OXPHOS 
(Fo F1 ATPase) 
34.04 ± 3.1 16.2 ± 0.6 
** 
 
Table 3.1 Action of inhibitors of glycolysis and OXPHOS on ATP biosynthesis 
in NF and KF 
 
ATP biosynthesis was measured in NF and KF that were exposed to 
various inhibitors of OXPHOS and glycolysis. Data were expressed as 
mean % inhibition ± SD for N = 3, as compared to controls. KF showed 
greater dependence on glycolysis for cellular ATP synthesis indicated by 
larger degrees of inhibition by specific glycolytic inhibitors. ATP 
biosynthesis in NF however, were more significantly affected by 
inhibitors targeting OXPHOS 
 
 **p<0.01, # p<0.005 were obtained by comparing values between 



























3.7 ± 0.3 
  

























Table 3.2 Biosynthesis of ATP in digitonin-permeabilized fibroblasts from 
respiratory substrates 
 
The rate of ATP biosynthesis in the presence of mitochondrial 
respiratory substrates was measured in permeabilized fibroblasts. 
Although KF showed elevated rate of ATP biosynthesis, introduction of 
exogenous mitochondrial respiratory substrates increased the rates in 
both NF and KF to approximately similar amounts.  Values are 
expressed as nmol ATP/min/106 cells for N = 3 where *, **  p < 0.005  
compared to NF control and # p < 0.01 compared to KF control 
 
 
3.2.4.2  Mitochondrial membrane potential 
Measurement of MMP with complex I and II substrates showed intact activities of these 
two respiratory complexes in both NF and KF (Figure 3.6). This indicates that the 
electron transport chain is functional in these fibroblasts and decreased dependence on 
OXPHOS in KF is not due to decreased activities of the complexes I and II.  





Figure 3.6 Analyses of complex I and II activities  
  
Complex I and II activities were assessed by measuring the formation of J-
aggregates in the presence of their respective respiratory substrates. Both 
types of fibroblasts showed comparable degree of energization by 
glutamate/malate and succinate indicating intact complex I and II 
activities in KF and NF 
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3.2.5  ELEVATED RATE OF GLUCOSE UTILIZATION  
When cells metabolize D-[2-3H] glucose, the tritium label is lost as 3H2O at the 
phosphoglucose isomerase reaction (Rose and O'Connell, 1961). The rate of glucose 
utilization measured by the amount of tritiated water formed from D-[2-3H] glucose was 
linear for the first 3 h and was significantly higher in the KF compared with NF. Figure 
3.7 shows two representative scans of glucose utilization measured in KF and NF. 
3.2.6  INCREASED ACTIVITIES OF SOME GLYCOLYTIC ENZYMES 
The specific activities of HK, GAPDH and LDH, expressed as means ± SD nmol reduced 
nicotinamide adenine dinucleotide (NADH) or reduced nicotinamide adenine 
dinucleotide phosphate (NADPH)/min/mg protein were 1.8 ± 0.51, 343.1 ± 28.3 and 
554.3 ± 12.1, respectively, for five samples of NF. The corresponding values for KF, 
which were significantly different (with p < 0.05) were 130, 63, and 35% higher. 
Measurement of pyruvate kinase (PK) activities of KF and NF showed no significant 
difference where p = 0.12 for N = 4 (data not shown).  





Figure 3.7 Rate of glucose utilization  
 
Tritiated water formed from radiolabeled glucose was separated by Dowex-1-borate column chromatography and measured by liquid 
scintillation counting. The rate of glucose utilization was significantly higher in KF compared with NF as shown by two representative 
plots
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3.2.7  HIGHER RATE OF GLUCOSE CONSUMPTION AND LACTATE  
          PRODUCTION  
The uptake of glucose from the culture medium was not different in KF and NF for the 
first 2 days of culture when the cells were ~50% confluent. For the subsequent 3 days, 
KF consumed more glucose as reflected by a greater decrease of glucose in the medium 
(Figure 3.8); this was accompanied by a higher accumulation of lactate compared with 
NF. The cell number and protein contents per well were essentially similar in NF 
compared with KF during the 5 days of culture. 
 
Figure 3.8 Glucose uptake and lactate accumulation measured in medium 
Glucose and lactate in the culture medium were measured by the glucose 
oxidase and LDH assays, respectively. From day 3 to 5 when the cells 
became confluent, KF consumed significantly more glucose compared 
with NF, concomitant with a greater production of lactate by KF. *p<0.01 
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3.2.8  DECREASED RATE OF OXYGEN CONSUMPTION  
Basal electron transport chain activity in NF and KF were compared in three different 
samples by measuring oxygen consumption by a fluorescence-based assay, as described 
in section 9.2.10. Significantly lower basal rate of oxygen consumption was evident in 
KF when compared to NF (Figure 3.9) corroborating previous findings of decreased 
reliance on OXPHOS for ATP production in KF (Table 3.1). 
 
Figure 3.9 Oxygen consumption rates of NF and KF  
A fluorescence-based measurement of oxygen uptake in three samples of 
NF and KF showed a significantly lower rate of oxygen consumption in 
KF where *p < 0.05 
 
3.2.9  LOWER RATE OF PRODUCTION OF REACTIVE OXYGEN SPECIES 
AND HYDROGEN PEROXIDE  
Production of reactive oxygen species (ROS) measured by the 2’,7’-dichlorofluorescein-
diacetate assay was significantly higher in three batches of NF compared with KF (Figure 
3.10A). Known antioxidants, ascorbate, and Trolox (a vitamin E analog) were able to 
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reduce the ROS production. The generation of H2O2 was higher in NF and the antioxidant 
effect of Trolox was also apparent (Figure 3.10B). 
 
 
Figure 3.10 Production of ROS and H2O2  
 
The rates of production of (A) ROS and (B) H2O2 were significantly higher in NF 
compared with KF. The antioxidants, Trolox and/or ascorbate, at a final concentration of 
50 µM reduced the production of ROS and H2O2.  
 
Values are means ± SD for N=3; **p<0.01 when compared with basal ROS generation 
and #p<0.005 for comparison of basal H2O2 production between NF and KF 
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3.2.10  SIMILAR ANTIOXIDANT LEVELS IN KF AND NF  
To ensure that the reduced levels of ROS and H2O2 in KF were not due to increased 
intracellular antioxidants, glutathione concentration and total antioxidant power of KF 
and NF were compared. No significant difference was evident on the levels of glutathione 
in both KF and NF (Figure 3.11A). The total antioxidant power was also similar (Figure 
3.11B).  
 
Figure 3.11 Comparison of antioxidant levels   
 
(A) Total intracellular glutathione (GSH) concentration was analyzed by 
using monochlorobimane (MCB), a dye that reacts with GSH and 
expressed as µM GSH/µg protein in cell lysate. The non-fluorescent MCB 
reacts with GSH catalysed by glutathione-S-transferase (GST) to give rise 
to fluorescent MCB-glutathoine conjugate. Intracellularly, GSH functions 
as a scavenger of toxic compounds especially those associated with 
oxidative stress. GSH levels were measured in three different samples of 
NF and KF as described in section 9.2.12.1. Both NF and KF showed 
similar ceontratation of intracellular GSH 
 
(B) The total antioxidant power of NF and KF was measured based on the 
ability of antioxidants to reduce copper (II) ions (Cu2+)   to copper (I) ions 
(Cu+). Cu+ forms a complex with a chromogenic reagent, bathocuproine 
disulfonate. This complex absorbs at 490nm. The total antioxidant capcity 
was expressed in terms of µM uric acid equivalents based on the method 
described in section 9.2.12.2 from uric acid standards of 62.5µM to 
500µM  
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3.3  DISCUSSION 
Keloid scars are characterized by excessive collagen deposition during the wound 
healing process. ATP is required for this uncontrolled production of extracellular matrix. 
Although cellular ATP is normally synthesized in the mitochondria by OXPHOS, the 
increased lactate in keloid tissue (Hoopes et al., 1971) suggests that glycolysis may 
provide the main energy source. To examine the separate contribution of mitochondrial 
and extra-mitochondrial compartments to the biosynthesis of ATP, it is necessary to 
examine OXPHOS activity in mitochondria to delineate any cytoplasmic contribution 
from glycolysis. Isolation of mitochondria from fibroblasts is a technical challenge 
because of the scarcity of this organelle, which represents only 2.4% of the volume of 
human skin fibroblasts compared with 28% of the cell volume in hepatocytes (Mourant et 
al., 1998). On the other hand, to measure ATP synthesis by mitochondria in whole cells, 
it is necessary to permeabilize the plasma membrane to facilitate the entry of respiratory 
substrates without compromising the integrity of the mitochondrial membranes. Digitonin 
permeabilization has previously been monitored by ATP synthesis (Manfredi et al., 2002; 
Ouhabi et al., 1998) or by oxygen uptake (Kunz et al., 1995; Villani et al., 1998).  
Our method of measuring the mitochondrial membrane potential with 5,5’,6,6’-
tetrachloro 1,1, 3,3’ tetraethylbenzimidazolcarbocyanine iodide (JC-1) to monitor 
digitonin titration is rapid and sensitive and the assay also provides an assessment of the 
activity (or lack of activity) of the mitochondrial respiratory complexes (Figure 3.4). 
Using this procedure, complex I and II activities in both NF and KF were observed when 
their respective substrates were introduced (Figure 3.6). 
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Under normal basal conditions, KF appeared to preferentially use the alternative 
pathway of glycolysis instead of OXPHOS for their ATP biosynthesis. This conclusion 
was supported by the observation of increased accumulation of lactate in the culture 
medium (Figure 3.8). The higher activities of glycolytic enzymes (HK, GAPDH and 
LDH) contributed to the greater rate of glucose utilization by KF compared with NF 
(Figure 3.7). Biochemical data on ATP biosynthesis using specific inhibitors of 
glycolysis and OXPHOS have alluded to glycolysis as the preferred pathway in KF, 
because ATP generation was inhibited largely by iodoacetate, and oxamate. In contrast, 
inhibition by TTFA (a respiratory inhibitor), FCCP (an uncoupler), and oligomycin (an 
inhibitor of Fo ATP synthase) was more pronounced in NF. 
Proliferative cells preferentially use aerobic glycolysis rather than oxidative 
metabolism to generate ATP (Brand and Hermfisse, 1997), a phenomenon proposed as 
the primary defect in cancer (Warburg, 1956). Keloids are described as benign tumors 
(Linares et al., 1993). Although our data showed that KF appeared to rely mainly on 
glycolysis for their energy supply under basal conditions, these cells are also capable of 
generating ATP from added respiratory substrates via OXPHOS. It is tempting to propose 
that this dual capability with a greater reliance on glycolysis confers on KF the capacity 
to proliferate and survive in spite of (or because of) its hypoxic environment. This 
advantage was translated into a higher rate of biosynthesis of ATP with its accumulation 
in the cell (Figure 3.5A and 3.5B). In addition, a switch to glycolysis may enable the KF 
to minimize their production of ROS, which are generated normally from mitochondrial 
oxidation. Although mitochondria isolated from human skin fibroblasts have been shown 
to produce ROS, including superoxide and nitric oxide (Chen et al., 1996; Cobbold, 
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2001), we found that the rate of ROS production was lower in KF compared with NF 
(Figure 3.10) correlating with decreased oxygen consumption in the KF (Figure 3.9). 
Antioxidant levels of NF and KF were comparable (Figure 3.11). 
The aerobic glycolysis described above in KF is a common feature of many 
cancer cells and this Warburg effect has been linked to the HIF-1, which affects 
angiogenesis, glucose transporter, and glucose metabolism (Semenza, 1999). The HIF-1α 
subunit has been reported in healing wounds (Albina et al., 2001) and demonstrated to be 
expressed at higher levels in keloid tissues compared with the adjacent skin (Wu et al., 
2004; Zhang et al., 2003). HIF-1α has been shown to activate the transcriptional 
regulation of genes encoding glycolytic enzymes (Semenza et al., 1994). The co-
ordinated upregulation of all glycolytic enzymes on exposure to hypoxia has previously 
been demonstrated, whereas the activity of nonglycolytic enzymes remained unchanged 
(Robin et al., 1984). These observations were consistent with the conclusion that the rate 
of glycolysis was positively controlled by the glycolytic enzymes (Ainscow and Brand, 
1999), a relationship that was also apparent in our study of a higher rate of glycolysis 
with higher activities of HK, GAPDH and LDH in KF. 
In conclusion, KF under basal conditions are characterized by a higher rate of 
ATP biosynthesis, with glycolysis as their primary energy source. This enhanced 
glycolytic flux provides a mechanistic basis to treat keloid scar formation. Thus, KF in 
culture could provide a human cell model to study the effects of drug candidates on their 
bioenergetics including their response to hypoxia, conceivably via the activation of the 
HIF pathway. Enhanced glycolysis and attenuated OXPHOS as observed in KF seem to 
be a salient feature of many cancer cells (Moreno-Sanchez et al., 2007) and the 
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dependency on glycolysis appeared to more pronounced with the progression of 
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4.  INSIGHTS INTO TUMORIGENESIS FROM THE METABOLISM OF 
KELOID FIBROBLASTS 
4.1  INTRODUCTION 
In highly metastatic human cancers, aerobic glycolysis is evident which likely 
confers a substantial adaptive advantage to these invasive cells (Czernin and Phelps, 
2002; Hawkins and Phelps, 1988). The possible reasons for elevated glycolysis are 
defects in mitochondrial respiration i.e. OXPHOS, increased expression and activities of 
glycolytic enzymes, oncogene signaling (p53 mutations) and the hypoxic 
microenvironment in tumors due to the lack of oxygen (Gillies and Gatenby, 2007). KF 
exhibit similar glycolytic characteristics as tumor cells with functional OXPHOS. 
Therefore, this chapter examines pyruvate oxidation, which links glycolysis to the 
mitochondrial TCA cycle. Tumor cells that exhibit the “Warburg effect” exhibit a 
markedly reduced ability to utilize pyruvate as a substrate, as seen in mitochondria 
isolated from hepatomas and Ehrlich ascites cells that show > 50%  drop in their capacity 
to transport electrons from pyruvate to oxygen than the control rat liver (Eboli et al., 
1977).   
The pyruvate dehydrogenase (PDH) complex whose activity is controlled by PDH 
kinase (PDK) catalyzes the oxidative decarboxylation of pyruvate (product of aerobic 
glycolysis). The ability to oxidize pyruvate decreases with an increase in the metastatic 
potential of tumor cells [Figure 4.1, (Eboli, 1985)]. Instead, tumor cells convert pyruvate 
to lactate, a product of anaerobic glycolysis, even in the presence of oxygen. The 
pathway associated with pyruvate oxidation is summarized in Figure 4.2. 
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Figure 4.1 Representation of varying PDH activity in rat liver and Morris 
hepatomas  
 
Bars represent total PDH and the shaded space represents the active form. 
Figure taken from (Eboli, 1985) 
 
 
Figure 4.2  Pyruvate oxidation in cells  
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4.1.1  Pyruvate dehydrogenase (PDH) 
 
PDH is an enzyme complex composed of multiple subunits of three main 
enzymes, E1, E2 and E3, and is located in the mitochondrial matrix. The inner core of the 
mammalian PDH complex is an icosahedral structure consisting of 60 copies of E2. E1, a 
tetramer composed of subunits α2β2, is located at the outermost region of the complex. E3, 
a homodimer, and multiple copes of an E3 binding protein that links E3 to E2 is also found 
in the complex (Voet and Voet, 1995). The following table summarizes the components 
of the PDH complex (Table 4.1). 
PDH plays an important role in linking glycolysis and the TCA cycle and 
therefore is carefully controlled (Matthews et al., 1997). PDH has both allosteric and 
covalent modifications as control mechanisms. The mechanism of covalent modification 
is described due to its implication in tumorigenesis. Control of PDH activity by covalent 
modification involves phosphorylation and dephosphorylation of specific serine residues 
on the α-subunit of E1. Phosphorylation of the α-subunit of E1 inhibits PDH complex 
activity (Linn et al., 1969). Therefore, the percentage of active PDH reflects the 
percentage of unphosphorylated α-subunits of E1. This in turn reflects the activity of 
pyruvate dehydrogenase kinase (PDK), the enzyme that catalyzes the ATP-dependent 
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Enzyme Abbreviation Prosthetic group 
Pyruvate dehydrogenase E1 Thiamine pyrophosphate 
Dihydrolipoyl Transacetylase E2 Lipoamide 
Dihydrolipoyl Dehydrogenase E3 Flavin adenine nucleotide 
 
Table 4.1  Components of the PDH complex  
 
Summary table of enzymes and the corresponding prosthetic groups that 
form the PDH complex  
 
4.1.2  Pyruvate dehydrogenase kinase (PDK) 
Four isoforms of PDK have been identified in humans and rodents. PDK1, PDK2, 
PDK3 and PDK4 are the terms designated to each isoform. This enzyme is made up of 
two different subunits, α and β. The α-subunit contains kinase activity and is regulated by 
proteolytic cleavage (Sugden and Holness, 2003). The β-subunit plays a regulatory 
function. Short-term regulators of PDK activity include inhibitors such as pyruvate and 
ADP and activators like acetyl-CoA and NADH (Kerbey et al., 1976).  
 Recent studies have shown that PDK1 expression is induced by HIF-1 and in turn 
phosphorylation and inactivation of the PDH complex occurs (Kim et al., 2006; 
Papandreou et al., 2006). In a lymphoma model, its tumorigenic potential increased 
through expression of key proteins, PDK1 among them, and a simulatenous increase in 
glycolysis and angiogenesis is observed (Kim et al., 2007).  The inactivation of the PDH 
complex switches off the oxidation of pyruvate through the TCA cycle and the 
mitochondrial electron transport chain. Therefore, it is likely that in tumor cells, even in 
the presence of oxygen, pyruvate is converted to lactate by lactate dehydrogenase (LDH). 
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4.1.3  Lactate dehydrogenase (LDH) 
 LDH reversibly catalyzes the conversion of pyruvate to lactate with a concomitant 
reduction of NAD+ to NADH and vice versa (Voet and Voet, 1995). Five isozymes have 
been described, all of which are tetramers. In humans, the enzyme complex is composed 
of two subunits (M and H) which are coded for by different genes. LDH-A codes for the 
M subunit and LDH-B for the H subunit. The M subunit converts pyruvate to lactate 
under anaerobic conditions in normal cells. The other subunit, H, kinetically favors the 
conversion of lactate to pyruvate and is found at high levels in aerobic tissues such as the 
heart. Table 4.2 summarizes the five isoforms of LDH and their respective subunit 
compositions. 
LDH ISOFORM H SUBUNIT M SUBUNIT 
LDH-1 4 - 
LDH-2 3 1 
LDH-3 2 2 
LDH-4 1 3 
LDH-5 - 4 
 
 Table 4.2  Isoforms of LDH and subunit composition 
In tumor cells, elevated levels of glycolytic enzymes and changes in isozyme 
types are commonly observed (Greiner et al., 1994). LDH-A (codes for the M subunit) is 
a target gene of HIF-1 and is found elevated in several cancers (Chung et al., 1995; 
Huang and Jungmann, 1995; Matrisian et al., 1985; Short et al., 1994). The fast kinetics 
of LDH-A catalyzed conversion of pyruvate to lactate ensures rapid and constant supply 
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of ATP as well as regenerates NAD+ to allow continuation of the glycolytic flux, thus, 
may be essential for tumor proliferation. 
In this study, the ability of KF to oxidize pyruvate was analysed by measuring 
ATP biosynthesis and mitochondrial membrane potential. In addition, the expressions of 
key proteins, namely, PDH E1-α, PDK1 and LDH-A were compared in KF and NF. This 
may shed light on possible differences that could contribute to the glycolytic/benign 
phenotype of the KF in contrast to the glycolytic/malignant phenotype of metastatic 
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4.2  RESULTS 
4.2.1  COMPARABLE EXPRESSION OF PDK1  
Pyruvate dehydrogenase kinase (PDK) is a kinase enzyme that acts to inactivate pyruvate 
dehydrogenase by phosphorylating it in the presence of ATP. Comparison of protein 
expression levels of PDK1, an isoform of PDK, showed no significant difference between 
KF and NF where p-value was 0.279 (Figure 4.3). 
 
 
Figure 4.3  Comparison of PDK1 expression  
 
Expression of PDK1 remained unchanged in KF. Band intensities were 
quantified by using the ImageJ software and expressed as relative to β- 
tubulin; p = 0.279 
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4.2.2  PDH E1-α SUBUNIT EXPRESSION UNAFFECTED IN KF 
The protein expression levels of the E1-α subunit of PDH in four samples of KF and NF, 
normalized to β-tubulin (Figure 4.4) showed no significant difference them (p = 0.471). 
 
 
Figure 4.4  Protein expression levels of PDH E1-α subunit by Western blot 
analysis 
 
No significant difference in PDH E1-α expression was detected in four 
different samples of KF and NF. Band intensities were quantified by using 
the ImageJ software and expressed as relative to β- tubulin; p = 0.4 
 
 
4.2.3  PYRUVATE METABOLISM IN TUMORS 
4.2.3.1  KF show intact pyruvate oxidation 
Energization of MMP by pyruvate (and succinate) measured by the JC-1 probe was 
equally good in digitonin-permeabilized digitonin-permeabilized NF and KF suggesting 
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that their mitochondrial oxidation of pyruvate was comparable (Figure 4.5). Similarly, 
ATP biosynthesis in the presence of 5mM each of pyruvate and malate was comparable 
in both types of fibroblasts; 33.8 ± 1.5 nmol/min/million cells for NF and 32.8 ± 2.3 




Figure 4.5  Analysis of pyruvate oxidation in permeabilized NF and KF  
 
Both KF and NF were equally energized by 10mM pyruvate as seen by 
similar degree of formation of J-aggregates upon addition of pyruvate. 
This suggests that pyruvate oxidation in these cells were comparable
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4.2.3.2  Integral PDH activity  
The “active” fraction of PDH, expressed as a percentage of total PDH activity was 
similar in NF and KF (Figure 4.6). The total activity expressed in nmol NADH/min/mg 
protein were 3.64 ± 0.14 for KF and 3.78 ± 0.19 for NF for N= 7 was also not 
significantly different.  
 
Figure 4.6  Measurement of PDH activity (active and total)   
 
Cell homogenates of seven batches of KF and NF were analyzed to 
determine “active” and “total” PDH activity. When expressed as 
percentage of “active” to “total” PDH activity, the values were similar for 




4.2.3.3  Increased PDK1 in highly metastatic tumors 
HCT116 and E1 are colon cancer cells with varying potential to metastasize, with the 
latter having a higher metastatic potential. Western blot analysis of protein expression 
levels of PDK-1 and PDH E1-α subunit in these cells indicate increased PDK-1 
expression in the highly metastatic form (E1) (Figure 4.7). However, a down regulation 
   
 57






Figure 4.7  PDK1 and PDH E1-α subunit protein expressions in human colon 
cancer with varying metastatic potential 
 
The more metastatic line, E1, has reduced PDH E1-α expression but 
increased PDK1 levels. Band intensities were quantified using the ImageJ 
software and expressed as relative to β- tubulin 
 
 
4.2.4  ELEVATED EXPRESSION OF LDH-A IN KF  
The expression of LDH-A commonly found elevated in majority of tumors was analyzed 
in KF and compared to normal skin fibroblasts.  Expression of LDH-A was significantly 
higher in four different samples of KF compared to NF (Figure 4.8) corroborating with 
previous findings of elevated LDH activity in KF. 





Figure 4.8  Protein expression of LDH-A  
 
LDH-A expression levels in whole cell lysates of four different NF and 
KF were compared by western blot analysis. Significantly higher amount 
of LDH-A was observed in KF. Intensity of bands was quantified using 
the ImageJ software and expressed as relative to β-tubulin where N=4; 
*p<0.05 compared to NF 
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4.3  DISCUSSION 
 
 In most malignant, rapidly growing tumor cells, the down-regulation of 
mitochondrial enzymes has been frequently observed (Pedersen, 1978; Schreiber et al., 
1970). It has been suggested that tumors which exhibit pronounced ‘Warburg effect’ do 
have functional mitochondria with ATP synthesizing ability but the decrease in 
mitochondrial content per cell may account for the lower net oxygen consumption 
capacity (Pedersen, 2007). In our analysis, intact activities of complexes I and II on the 
mitochondrial electron transport chain of KF indicate integral mitochondrial capacity to 
utilize respiratory substrates for ATP biosynthesis or energisation of the mitochondrial 
membrane potential despite low basal activity of the mitochondria as indicated by 
reduced oxygen consumption and decreased ROS generation. This led us to study 
pyruvate oxidation which links glycolysis and oxidative phosphorylation in cells.  
Our study showed that pyruvate oxidation in KF and NF was similar; digitonin-
permeabilized KF and NF were energized equally effectively by pyruvate as NF (Figure 
4.5). This demonstrated the entry and oxidation of pyruvate in the mitochondria to elicit 
the MMP measured with the JC-1 probe. The oxidative metabolism of pyruvate produced 
ATP indicating an intact and functional pyruvate oxidative pathway. “Active” and “total” 
pyruvate dehydrogenase (PDH) enzymatic activities in cell lysates were similar in NF 
and KF (Figure 4.6) corroborating with similar expression levels of pyruvate 
dehydrogenase kinase 1 (PDK1) and the PDH E1-α subunit (Figure 4.3 and 4.4).  
Earlier work on mitochondria isolated from Ehrlich ascites tumor cells showed 
reduced capacity of as much as 50% or more in pyruvate oxidation (Eboli, 1985; Eboli et 
al., 1977; Eboli and Pasquini, 1994). Interestingly, the PDH complex activity in three 
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Morris hepatoma cell lines showed an inverse relationship between PDH complex 
activities with their degree of malignancy (Figure 4.1). It was concluded that the PDH 
complex activity might be linked to neoplastic transformation and possibly the 
progression of tumor. In other words, PDH activity was reduced in tumors with great 
reduction in highly malignant tumors (Eboli, 1985). Our analysis of PDK1 and PDH 
expression levels in tumors of varying metastatic potential supported this analysis (Figure 
4.7). The highly metastatic human colorectal cancer cell line, E1, showed increased 
PDK1 expression compared to its less metastatic counterpart, HCT116, although PDH 
E1-α subunit was only slightly decreased. The PDK/PDH pathway is also repressed 
significantly in non-small cell lung carcinomas (Koukourakis et al., 2005) and inhibition 
of PDH complex activity contributes to malignancy in human head and neck squamous 
cell carcinoma (McFate et al., 2008). 
 Studies have shown that HIF-1 induces PDK1 which in turn phosphorylates and 
inactivates PDH (Kim et al., 2006; Papandreou et al., 2006). The net result is the 
shunting of pyruvate to lactate; the latter contributes to the breakdown of extracellular 
matrix to facilitate cell mobility in malignant cells. Although suppression of 
mitochondrial pyruvate oxidation was not apparent in KF, previous results indicate an 
accumulation of lactate possibly due to the more rapid rate of glycolysis. The increased 
conversion of pyruvate, the end- product of glycolysis, to lactate by LDH may explain the 
reduced basal mitochondrial respiration in KF. Coupled with increased LDH activity in 
KF, expression of LDH-A was also observed to be upregulated (Figure 4.8) LDH-A is a 
target of HIF-1α and preferentially converts pyruvate to lactate (Voet and Voet, 1995). 
Therefore, one might hypothesize that less pyruvate may be available to enter the 
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mitochondrial Krebs cycle resulting in reduced basal oxidative phosphorylation activity 
observed in KF. Furthermore, lactate is reportedly able to regulate HIF-1α expression 
where in the presence of lactate, accumulation of HIF-1α occurs even under normoxic 
conditions (Lu et al., 2002). 
  In conclusion, although KF exhibit the glycolytic phenotype of cancer cells, their 
oxidative capacity to metabolize pyruvate in the mitochondria is retained and it is 
comparable to that of NF. The manifestation of normal mitochondrial oxidation of 
pyruvate together with a functional PDH/PDK1 pathway distinguishes these benign 
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5.  EXPRESSION OF HK II IN KELOID FIBROBLASTS 
5.1  INTRODUCTION 
HK catalyzes the first step of glycolysis: 
Glucose + ATP  Glucose-6-phosphate (G-6-P) + ADP 
The four isozymes of HK, I, II, III and IV, vary in terms of affinity for their substrates 
and product inhibition by G-6-P (Voet and Voet, 1995). Selective expression of isozymic 
forms of HK differing in catalytic and regulatory properties, as well as subcellular 
localization is an important factor in determining the pattern of glucose metabolism in 
mammalian tissues or cells (Wilson, 2003). Both type I and II HK contain an N-terminal 
sequence critical for binding to the mitochondria (Wilson, 2003). 
Mitochondrial localization of HK was first noted in the brain (Crane and Sols, 
1954), with the brain mitochondria expressing the highest amounts of HK (Wilson and 
Felgner, 1977) compared to other tissues of the body. The predominant isozyme type I 
(HKI), binds reversibly to the outer mitochondrial membrane (OMM) (Wilson, 1984) and 
the total HK activity in vivo may be controlled by the relative distribution between 
cytosolic and mitochondrial forms, with the latter being more active. This mitochondrial 
localization of HK is critical for brain function as the brain utilizes glucose as its main 
energy source under most conditions. HK on the brain mitchondria serves primarily a 
catabolic function where it coordinates glycolysis (G-6-P formation) with the terminal 
stages of OXPHOS occurring in the mitochondria by using intramitochondrial ATP as 
substrate (Wilson, 2003). Thus, the overall rate of glucose metabolism corresponds with 
cellular energy demand and excessive production of lactate is avioded (BeltrandelRio and 
Wilson, 1991).  
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A hallmark of many cancers, particularly the more aggressive, is the capacity to 
metabolize glucose at an elevated rate (Mathupala et al., 2006). HK isozymes from 
tumors exhibiting the high glycolytic phenotype have been cloned and sequences 
correspond to HK type II (HKII), being the major isozyme overexpressed by more than 
100-fold (Thelen and Wilson, 1991; Mathupala et al., 1997). Although HKI is also 
present in some highly glycolytic tumors, it is at low levels relative to HKII (Arora et al., 
1990; Bustamante et al., 1981; Kurokawa et al., 1982; Parry and Pedersen, 1983; Rempel 
et al., 1994; Shinohara et al., 1991). Localization of HKII on the OMM through its 
interaction with VDAC1 has been reported in highly metastatic hepatic carcinomas 
(Linden et al., 1982; Nakashima et al., 1988) and may serve anti-apoptotic functions 
(Figure 5.1). When the VDAC binding site is not occupied by HKII, the VDAC-adenine 
nucleotide translocator (ANT) complex mediates access of external Bax (pro apoptotic 
protein) to cytochrome c and ANT stays in a conformation that allows it to easily change 
structure to cause permeability transition (Vyssokikh and Brdiczka, 2004). The binding 
of HKII hinders Bax binding and employing the ANT as a specific anti-porter. It has also 
been reported that Bax and HKII compete for the same binding site (Figure 5.1) 
(Pastorino et al., 2002). 
Studies have shown that the Akt/Protein kinase B (PKB) pathway can control the 
mitochondrial localization of HKII. This growth factor pathway has been shown to 
inhibit apoptosis (Gottlob et al., 2001) possibly through the localization of HK onto the  
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Figure 5.1 Functions of VDAC and its binding partners in apoptosis 
(A) HKII and Bax compete for similar binding sites on VDAC resulting in 
opposing effects on apoptosis. Bax, a pro-apoptotic protein, binds to 
VDAC on the OMM and initiates the formation of the permeability pore 
that mediates the release of cytochrome c into the cytosol. This triggers 
apoptosis in cells 
 
(B) HKII competes with Bax for similar binding sites on VDAC. The 
absence of growth factor, Akt, results in the activation of GSK-3β. This 
kinase phosphorylates VDAC and prevents the binding of HKII to the 
channel, allowing Bax to bind an initiate cytochrome c release. The 
presence of Akt results in the phosphorylation and inactivation of GSK-
3β. HKII is then able to bind to VDAC on the OMM and inhibit the 
formation of the permeability pore thus preventing apoptosis. This 
strategic position also enables this enzyme which catalyses the 
phosphorylation of glucose (the first committed step in glycolysis) access 
to ATP exported out of the mitochondria via the ANT. 
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mitochondrial membrane (Majewski et al., 2004). It was reported that downstream 
effectors of this pathway, phosphotidyl inositol-3-kinase (PI3-kinase) and glycogen 
synthase kinase-3β (GSK-3β) are essential in mediating the intracellular distribution of 
the mitochondria-bound HKII. GSK-3β phosphorylates VDAC and prevents its binding 
to HKII on the OMM (Pastorino et al., 2002). The activity of GSK-3β is controlled by 
PI3-kinase (activated by Akt/PKB pathway) whereby phosphorylation by the kinase 
inactivates GSK-3β. Therefore, localization of HKII onto the OMM occurs.   
It seems highly likely that the “Warburg effect” seen in tumor cells and in KF 
could be due to alterations in HK, in particular HKII. High aerobic glycolytic rate 
observed in Ehrlich tumors was attributed to HK localization on the mitochondria 
(Bustamante et al., 1981). In the highly glycolytic hepatomas, no detectable glucokinase 
(HKIV) is seen despite high amounts in the normal liver (tissue of origin), therefore, 
transformation of a liver hepatocyte to highly glycolytic hepatomas requires the silencing 
of HKIV of high Km (for glucose) while HKII of low Km is overexpressed (Parry and 
Pedersen, 1983). Therefore two factors that play important roles in mediating the high 
glycolytic phenotype in tumor cells are the amplification and upregulation of the gene 
that encodes HKII resulting in increased protein expression and HKII binding to VDAC 
on the OMM (Pedersen, 2007). These factors may contribute to the similar phenotype 
observed in KF. In this chapter HK distribution and isozyme expression patterns in KF, a 
benign tumor, and the role played by HK in mediating the effects of elevated glycolysis 
and increased lactic acid secretion in KF will be investigated.  





Figure 5.2  Mitochondrial localization of HKII 
 
HKII interaction with VDAC on the outer membrane has preferred access 
to ATP synthesized on the inner membrane by the ATP synthasome, a 
complex between the ATP synthase and transporters for ADP/ATP and 
phosphate (Pi) by ANT and phosphate ion carrier (PIC) respectively. 
Figure is modified from (Pedersen, 2007) 
ANT 
HKII 
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5.2  RESULTS 
5.2.1  INCREASED MITOCHONDRIAL LOCALIZATION OF HK IN KF 
The distribution of HK in KF was more than two times higher in the mitochondria 
compared to the soluble fraction (70% vs 30%) while NF showed near equal cellular 
distribution (Figure 5.3). Assays of succinate dehydrogenase (SDH) and glucose-6-
phosphate dehydrogenase (G6PDH) showed little to no difference in their compartmental 
distribution in both fibroblasts (Figure 5.3 inset). 
 
Figure 5.3 Distribution of HK in mitochondrial and cytosolic compartments of 
NF and KF 
 
Hexokinase activity was measured in the mitochondrial (bound) and 
soluble fractions of normal and keloid fibroblasts. The ratio of the activity 
of mitochondrial-bound HK relative to its cytosolic counterpart is 70:30 
for KF while that of NF is 50:50. The marker enzymes, SDH and G6PDH 
showed similar compartmental profiles for both NF and KF (inset). Data 
on marker enzymes (inset) attests to the relative purity of the two fractions 
isolated by differential centrifugation  
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5.2.2  ELEVATED GENE EXPRESSION OF HKII  
Analysis of mRNA expression by quantitative real-time PCR (RT-PCR) showed 
significant upregulation in HKII in KF; the data were obtained from six different samples 
each of NF and KF and were normalized against 18S rRNA (Figure 5.4). The other 
mitochondrial isoform of HK, HKI was not analyzed in this study as this isoform is 
commonly found in most mammalian tissues. For example, more than 70% of total 
intracellular HK activity in skeletal muscle is accounted for by HKI (Ritov and Kelly, 
2001).  
 
Figure 5.4 Gene expression of HKII by RT-PCR  
 
The relative HKII mRNA expression levels were quantified by real-time 
PCR. A significant up-regulation in the expression of this mitochondrial 
isoform was seen in KF compared to NF. 18S rRNA was used as an 
internal control and the values were presented as the mean ratio of 
HKII:18S rRNA ± SE for N=6; #p<0.005 
 
5.2.3  HKII AND β-F1ATPASE EXPRESSION IN NF AND KF  
Protein expression levels of HKII, a mitochondria-bound isoform of HK which is one of 
glycolysis associated target genes of HIF-1α and β-F1ATPase a subunit of the 
mitochondrial ATP synthesizing complex, were analyzed in KF and NF. A reciprocal 
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relationship was identified between the HKII and β-F1ATPase expression. In KF, which 
express elevated HKII, lower β-F1ATPase was evident. In NF, the reverse pattern was 
observed where the cells expressed significantly lower HKII, but higher β-F1ATPase 
relative to KF (Figure 5.5). Similarly, measurement of activities of these enzymes 
showed a similar relationship (Table 5.1). These sets of data showed a reciprocal 
relationship between HK and ATPase. 
 
Figure 5.5 Comparison of HKII and β-F1ATPase expression in NF and KF   
 
Western blot analysis of HKII and β-F1ATPase in whole cell lysates of 
four different samples NF and KF showed reciprocal relationship. In NF 
where β-F1ATPase expression was higher, HKII was lower. In KF, 
however, the reverse was observed.  Band intensities were quantified by 
using the ImageJ software and expressed as relative to β- tubulin 
where*p<0.05
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Enzyme Normal fibroblasts Keloid fibroblasts 
HK 4.99 ± 0.82                <          15.57± 4.64* 
ATPase              10140 ± 1990             >          4870 ± 882* 
  
Table 5.1 Activities of mitochondrial HK and ATPase  
 
Mitochondrial HK activity in five different batches of KF was 
significantly higher than NF where * p < 0.05 compared to NF. Values are 
expressed as nmol NADPH formed/min/mg. Mitochondrial ATPase 
activity in three different batches of KF was lower than NF which 
correlate with its protein expression. The data corroborates with the 
reciprocal relationship observed in the western blot analysis of their 
protein expression (Figure 5.5). Values are expressed as nmol NADH 
formed/min/mg where * p < 0.05 
 
5.2.4  HIGHER EXPRESSION OF HKII IN THE MITOCHONDRIAL 
FRACTION OF KF 
HKII protein expression level in KF was analyzed and compared to that of NF. 
Densitometric measurements of the bands, normalized to β-tubulin showed a significant 
difference between four batches of NF and KF (Figure 5.5). The mitochondrial fractions 
of KF were subjected to electrophoresis and membranes were probed for HKII protein 
expression and compared to NF. Analysis of HKII expression in the mitochondrial 
fractions showed a higher expression of this mitochondrial bound isoform of HK in KF 
(Figure 5.6). Expression of VDAC, the HKII binding partner on the OMM, remained 
comparable between KF and NF. 
 




Figure 5.6 Protein expression levels of HKII and VDAC1  
 
Significantly, higher HKII expression was detected in the mitochondrial 
fraction of KF whereas VDAC1 expression in whole cell lysates of NF 
and KF were comparable. Intensity of bands was quantified using the 
ImageJ software and expressed as relative to Complex I for the 
mitochondrial fractions where N=3; #p<0.005 compared to normal 
fibroblasts. VDAC expression measured in whole cell lysates, intensity of 
bands were expressed as relative to Complex I 
 
5.2.5  SIGNIFICANT CO-LOCALIZATION OF HKII AND VDAC  
 
Double immunofluorecence staining of KF with HKII and VDAC antibodies showed 
their extensive co-localization in KF as indicated by the orange fluorescence observed in 
the RGB merge (Fig 5.7A(iii) and B(iii)). This shows that HKII likely binds to the 
mitochondria by interacting with VDAC in these fibroblasts (Figure 5.7).  
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Figure 5.7 Dual-color immunofluorescent staining of HK II and VDAC in KF  
 
Immunofluorescent staining of HK II (green) and VDAC (red) was carried 
out in two samples of KF (A) KF22 and (B) KF23 (processed from the 
earlobe of 2 female subjects of comparable age, see Table 9.1). Two 
representative results from four independent experiments are shown. 
Extensive co-localization of HKII and VDAC was observed indicating 
interaction between both proteins in KF. 
A (i) and B (i): KF were probed with goat polyclonal anti-HKII antibody 
followed by detection with Alexa Fluor®488 conjugated rabbit anti-goat 
IgG. 
A (ii) and B (ii) Monoclonal anti-VDAC antibody followed by and Alexa 
Fluor®594 conjugated goat anti-mouse secondary antibodies were added to 
identify VDAC localization. 
A( iii) and B (iii): Images are a RGB merge of images represented in (i) 
and (ii). 
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5.2.6  DIFFERENTIAL EFFECTS OF 3-BROMOPYRUVATE (3-BP) 
 
3-BP is a specific inhibitor for HKII activity (Moreno-Sanchez et al., 2007). NF and KF 
were exposed to various concentrations of 3-bromopyruvate (3-BP) for 2h following 
which cell viability and intracellular ATP levels were measured. 
5.2.6.1  Cell viability 
A greater decrease in cell viability was evident in KF exposed to 30 and 50µM 3-BP for 
2h compared to NF. 100µM 3-BP appeared to be toxic to both (Figure 5.8). The higher 
susceptibility of KF to the toxicity of 3-BP at low concentrations is possibly due to 
increased expression of lactic acid transporters in these atypical cells. This confers 
preferential entry of 3-BP shown previously to be transported by these transporters into 
benign tumor cells. Furthermore, 3-BP specifically targets and inhibits the HKII activity 
in other cells.  
5.2.6.2   Intracellular ATP 
A significant fall in intracellular ATP levels in KF exposed to 30 and 50µM 3-BP for 2h 
was observed compared to NF (Figure 5.9). The maximal decrease of 90% was observed 
at 100µM of 3-BP for both NF and KF. The degree of reduction in intracellular ATP was 
of a higher magnitude compared to the decline in cell viability measured at 30 and 50µM 
3-BP (Figures 5.8 and 5.9). 
 




Figure 5.8 Effect of 3-BP on cell viability   
 
Cell viability of KF measured by the MTT assay was significantly more 
compromised compared to NF following exposure to 30 and 50µM 3-BP 
for 2h. Values are expressed as means (% of control) ± SE for N=8; 
*p<0.05 and **p<0.01 when compared to NF 
 
 
Figure 5.9 Effect of 3-BP on cellular ATP levels  
 
Intracellular ATP in KF and NF, measured 2h after exposure to 3-BP was 
significantly decreased by 30-100µM 3-BP. However at the lower 
concentrations of 30 and 50µM, the reduction was more significant on KF. 
Both fibroblasts were affected to a similar extent at 100µM 3-BP. Values 
are expressed as means (% of control) ± SD for N=8; #p<0.005 when 
compared to NF 
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5.2.7  COMPARING EFFECTS OF 3-BP ON TOTAL HK ACTIVITY  
The inhibitory action of 3-BP on the total HK activity measured in whole-cell lysates was 
significantly higher in KF for all concentrations from 30 to100µM compared to NF 
(Figure 5.10). It is likely that this differential effect is due to the action of 3-BP on HKII, 






Figure 5.10 Inhibition of total HK activity  
 
The HK activity measured in whole cell lysates of KF was more susceptible to 3-BP 
inhibition at all concentrations from 30-100µM. The values are expressed as % inhibition 
compared to control where N=7; *p<0.05, **p<0.01 compared to NF 
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5.2.8  EFFECT OF DIFFERENT SUBSTRATES ON 3-BP TOXICITY  
To examine the effects of 3-BP, fibroblasts were grown in 5mM glucose or 5mM 
pyruvate instead of the normal 25 mM glucose used in the standard culture medium. 
Viability of KF grown in 5mM glucose was compromised by 30µM and 50µM 3-BP in 
contrast to those cultured in an equimolar concentration of pyruvate (Figure 5.11A). 
Similarly, the minimal effect of 3-BP on the viability of KF cultured in pyruvate was also 
reflected in a negligible change in intracellular ATP up to 100µM 3-BP. In contrast, KF 
grown in glucose medium showed a pronounced dose-dependent decrease in cellular 














Figure 5.11 Differential effect of 3-BP on KF grown in glucose or pyruvate  
Seven batches of KF were grown in 5 mM each of glucose or pyruvate and 
the effects of 3-BP on these fibroblasts were compared: 
  
(A) Cell viability – KF grown in glucose were more compromised by 30 
and 50µM 3-BP compared to the negligible effect on NF grown in 
equimolar pyruvate 
  
(B) Intracellular ATP – Cellular ATP was not significantly affected by 15 
to 100µM 3-BP in KF grown on pyruvate which corroborates with the 
data above on cell viability (Figure 5.11A). In contrast, intracellular ATP 
was significantly compromised by 30 to 100µM 3-BP in KF grown in 
glucose. * p < 0.05; **p < 0.01; # p <0.005 
 
5.2.9  INCREASED EXPRESSION OF p-GSK 3β IN KF 
Phosphorylated GSK 3β (p-GSK 3β) is an inactive form of the kinase that mediates the 
localization of HKII onto the OMM. When active, GSK 3β phosphorylates VDAC, thus 
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preventing the placement of the HK isoform onto the OMM. The possible role of the Akt 
pathway in mediating the increased mitochondrial localization of HKII observed in KF 
(Figure 5.5) was investigated by analyzing the expression of p-GSK 3β. Significantly 
higher level of the p-GSK 3β was observed in three samples of KF compared to NF 
(Figure 5.12). This suggests that the Akt pathway may be responsible for the 
mitochondrial localization of HKII in KF where its strategic position of HK allows for 
elevated rate of glucose utilization. 
 
Figure 5.12 Increased amount of p-GSK 3β in KF 
 
Equivalent amounts (25µg) of protein derived from whole cell lysates of 
three different NF and KF were subjected to electrophoresis followed by 
blotting onto a nitrocellulose membrane. The membrane was probed with 
mouse monoclonal antibodies specific for the phoshorylated form of GSK 
3β. All three samples of KF expressed significantly higher amounts of p-
GSK 3β compared to NF where #p < 0.005. Unfortunately no suitable 
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5.3  DISCUSSION 
 The glycolytic phenotype of KF has been demonstrated in our previous findings 
to be attributed to an increased rate of glycolysis and an upregulation of three glycolytic 
enzymes of which HK exhibited the highest increase. HK catalyses the first step in 
glycolysis and among the HK isoforms, the mitochondrial isoform, HKII seems to 
predominate in fast growing hepatoma cells with activity of 1-3 orders of magnitude 
higher in hepatoma compared to normal and regenerating liver (Arora and Pedersen, 
1988; Bustamante and Pedersen, 1977). In this study, analysis of HK distribution pattern 
in KF and NF indicate increased mitochondrial localization of HK in KF (Figure 5.3) of 
which HKII is the likely isoform (Figure 5.6). This was consistent with increased levels 
of mRNA and protein expression of HKII in KF (Figure 5.4 and 5.5). HKII, together with 
other glycolytic enzymes, are known to be upregulated by the HIF-1 transcription factor 
(Semenza et al., 1994).  
 HKII binds to the OMM through its interaction with porin, also known as voltage-
dependent anion channel (VDAC), the protein that forms channels through which 
metabolites traverse the OMM (Vyssokikh and Brdiczka, 2004). Double 
immunofluorescent staining of these two proteins, HKII and VDAC, in KF showed 
effective co-localization (Figure 5.7) substantiating our previous findings of HKII 
expression in these atypical fibroblasts. Mitochondrial HKII preferentially utilizes ATP 
generated by OXPHOS which was conceived to bestow a metabolic advantage on tumor 
cells (Arora and Pedersen, 1988; Bustamante and Pedersen, 1977; Golshani-Hebroni and 
Bessman, 1997; Gots and Bessman, 1974; Gots et al., 1972); this might be the case in 
KF.  
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The decreased dependence of KF on OXPHOS for ATP was also investigated. 
Previous results indicated intact activities of complex I and II, however, the rate of 
oxygen consumption was reduced in KF. In lieu of this, the expression of a subunit of the 
mitochondrial ATP synthesizing complex, β-F1ATPase, was analyzed. In the presence of 
oxygen, Fo F1ATPase phosphorylates ADP to ATP, thus, playing the main role in energy 
production in the mitochondria. The mitochondria in a normal cell account for about 95% 
of total ATP production (Voet and Voet, 1995). In tumor cells, however, this pathway is 
impaired. Besides decreased pyruvate metabolism (discussed in Chapter 4), repression of 
β-F1ATPase expression in tumor cells has been reported (Cuezva et al., 2007).  
Four different samples of KF showed decreased expression and activity of this 
enzyme when compared to NF (Figure 5.5 and Table 5.1) possibly explaining reduced 
ATP synthesis by OXPHOS in KF. Evidently, HKII and β-F1ATPase show a reciprocal 
relationship where increased expression of HKII occurs simultaneously with decreased β-
F1ATPase expression (Figure 5.5). Normal and tumor biopsies of patients analyzed for 
expression levels of mitochondrial proteins indicate changes in β-F1ATPase expression 
occur concurrently with that of glycolytic markers of the cell. (Cuezva et al., 2004; 
Cuezva et al., 2002; Isidoro et al., 2005; Isidoro et al., 2004). This led to the formulation 
of the Bioenergetic Cellular Index (BEC). The BEC defines the bioenergetic signature of 
cancer cells by taking into account the bioenergetic competence of the mitochondria and 
the overall mitochondrial potential of the cell (Cuezva et al., 2007). This bioenergetic 
signature significantly correlates with the survival of colon (Cuezva et al., 2002), lung 
(Cuezva et al., 2004) and breast (Isidoro et al., 2005) cancer patients. 
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Since the discovery of HKII in highly metastatic hepatomas, many attempts have 
been made to target this isoform in these cells. Particularly successful was 3-
bromopyruvate (3-BP) which eradicated hepatoma produced in experimental animals 
(Geschwind et al., 2002; Ko et al., 2001; Vali et al., 2007). In our study, 3-BP showed a 
differential inhibitory action at 30µM and 50µM 3-BP on cell growth and ATP 
production between NF and KF (Figure 5.8 and 5.9). A more significant inhibition of HK 
activity in KF was observed at all concentrations of 3-BP when compared to NF (Figure 
5.10) suggesting the dominance of the HKII isoform in KF.  
Pyruvate, which bypasses glycolysis, was able to produce ATP in KF. This 
suggests their functional OXPHOS capability. This study showed that ATP biosynthesis 
from pyruvate was not affected by 3-BP as this molecule acts upstream at the HK step 
(Figure 5.11B). Therefore, with an intact and functional pyruvate oxidative pathway, the 
KF produced sufficient energy from OXPHOS to survive the toxic action of 3-BP in 
contrast to those cells grown in glucose medium (Figure 5.11A).  
The observation of HKII expression in keloids, a benign form of tumor, is novel 
as this enzyme has only been reported in highly metastatic tumors. These tumors exhibit 
increased rates of glucose utilization by virtue of HKII localization on the mitochondrial 
membrane. Signaling pathways have been implicated in HKII localization on the 
mitochondria. One such pathway is via Akt/PKB signalling (Gottlob et al., 2001; 
Pastorino et al., 2002). Activation of this pathway results in phosphorylation and 
inactivation of glycogen synthase kinase-3β (GSK-3β). This enzyme controls 
mitochondrial localization of HKII where inactivation of GSK-3β results in the optimal 
localization of HKII on the OMM. The Akt/PKB pathway has been implicated in keloid 
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scar formation (Asano et al., 2004; Lim et al., 2003; Zhang et al., 2006b) and attempts to 
block this pathway have provided potential therapeutic options for keloids (Zhang et al., 
2006a). In Figure 5.12, KF showed increased expression of the phosphorylated form of 
GSK-3β. Based on this observation, it is likely that the Akt/PKB pathway is responsible 
for the mitochondrial localization of this HK isoform through inactivation of GSK-3β. 
This optimal localization of HK could explain the increased glycolytic rate exhibited by 
the KF.  
Therefore it is likely that the increased toxicity of 3-BP to KF can be attributed to 
its action on HKII resulting in inhibition of glycolysis, the more significant energy 
producing pathway in KF. This, however, remains to be investigated along with the effect 
of this molecule on the pathological attributes of KF, namely, excessive extracellular 
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6.  ROLE OF HYPOXIA IN KELOID PATHOGENESIS 
6.1  INTRODUCTION 
The hypoxia inducible factor-1 (HIF-1) is a heterodimeric transcription factor 
consisting of HIF-1α and HIF-1β subunits. Low oxygen tension activates the expression 
of HIF-1α (Wang et al., 1995) and this is especially critical in cells exposed to a hypoxic 
microenvironment. HIF-1α induces the expression of genes essential for glycolysis 
therefore, despite the inefficiency of glycolysis hypoxic cells, are able to produce ATP by 
increasing the rates of glucose utilization and elevating the glycolytic flux (Seagroves et 
al., 2001).  
In the tumor microenvironment, HIF-1α is critical for tumor cell survival and 
proliferation as it induces the expression of genes essential for elevated glycolysis, a 
hallmark of tumor cells (Robey et al., 2005; Semenza, 2000, 2002; Semenza et al., 2001, 
Table 1.3). Although the half life of HIF-1α is less than 5min following reoxygenation in 
post hypoxic cultured cells (Wang et al., 1995), highly metastatic tumor cells even under 
aerobic conditions are characterized by increased glucose uptake and elevated lactate 
production (Semenza, 2007). This represents the Warburg effect, a phenomenon 
generally associated with malignant transformation of solid tumors (Warburg, 1956) 
through activation of HIF-1. 
Within the keloid nodules, large numbers of partially or completely occluded 
microvessels are present (Kischer et al., 1982). This was believed to contribute to the 
hypoxic microenvironment observed in keloid scars (Sloan et al., 1978). Keloid has been 
shown to express a constitutively higher level of HIF-1α protein compared with the 
adjacent skin (Wu et al., 2004; Zhang et al., 2003). Our earlier studies on the 
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bioenergetics of KF indicated a higher rate of ATP biosynthesis and elevated activities of 
some glycolytic enzymes compared to NF. Increased glucose uptake and greater 
accumulation of lactate alluded to the glycolytic phenotype of KF.  
In hepatomas, amplified glycolysis was attributed to the higher mitochondrial 
localization of HK. Bypassing this initial glucose phosphorylation step reduced the rate 
of lactic acid secretion (Bustamante et al., 1981).  The isoform (later identified as HKII) 
(reviewed in Pedersen, 2007) was also a target gene of HIF-1α. In this study elevated 
expression of this HK isoform, both at the mRNA and protein levels was observed in KF.   
Therefore, we hypothesized that hypoxia-induced upregulation of genes 
associated with glycolysis is, at least, in part responsible for the glycolytic phenotype 
observed in KF; this may be responsible for the uncontrolled cell proliferation and 
aberrant ECM secretion observed in these atypical fibroblasts. To address the 
mechanisms underlying the hypoxia-induced regulation of glycolysis in an in vitro 
system, NF were exposed to desferrioxamine (DFO), an iron chelator that mimics 
intracellular hypoxia (An et al., 1998; Hasegawa et al., 1999; Wang and Semenza, 1993). 
This system was used to analyze the effects of hypoxia on the metabolism of these 
normal cells. In addition, transduction of a dominant negative form of HIF-1α (HIF-
1αDN) into KF was conducted to assess the contribution of this transcription factor to the 
glycolytic and fibrotic phenotype of the atypical KF. Using this experimental paradigm, 
we analyzed the role played by hypoxia and HIF-1α on the increased glycolysis and 
aberrant ECM deposition that are characteristics of keloid pathogenesis. 
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6.2  RESULTS 
6.2.1  HIF-1α EXPRESSION IN NUCLEAR EXTRACTS OF KF 
KF showed a strong expression of HIF-1α in its nuclear fraction and the apparent absence 
of this transcription factor in NF was evident (Figure 6.1). This was not so apparent when 
measured in the cell lysate (data not shown). Cyclin A was used as a loading control in 
this experiment. 
 
Figure 6.1 Protein expression of HIF-1α  
 
Expression of HIF1-α in nuclear extracts of four different batches of KF 
and NF was analyzed by western blot. HIF1-α expression was evident in 
KF but no bands were detected in NF. Cyclin A expression was also 
probed and used as loading control 
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6.2.2  HK ESSENTIAL FOR ELEVATED GLYCOLYSIS IN KF 
The importance of HK-mediated glucose phosphorylation, the first committed step of 
glycolysis, was studied in KF grown in either 5mM glucose or 5mM galactose. The latter 
substrate is able to bypass the reaction catalyzed by HK and enter glycolysis as shown in 
Figure 6.2. The lactic acid secretion of these KF grown in different media (5mM glucose 
or 5mM galactose) was measured as an indication of the rate of glycolysis. KF grown in 
glucose medium secreted significantly more lactic acid than those grown in galactose on 
days 3 and 5 when aliquots of the media were measured (Table 6.1). This provides an 
indication of the important role of HK in KF. Therefore, in this chapter, the role of 
hypoxia in mediating the changes in protein expression of this enzyme, mainly the HKII 
isoform, was assessed. 
 
Figure 6.2 Entry of galactose into glycolysis 
Galactose bypasses the initial phosphorylation step of gluose and enters 
glycolysis through the combined actions of galactokinase (GK), galactose-
1-phosphate uridyl transferase and phosphoglucomutase (PGM). In this 
study, galactose was used to determine the importance of HK to glycolysis 
in KF 
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 Lactate, µM 
Day 1 3 5 
5mM Glucose 64.6 ± 2.6 1215 ± 86.5 * 2465 ± 83.3 ** 
5mM Galactose 63.7 ± 1.8 1142 ± 6.23 2219 ± 94 
 
Table 6.1 Lactic acid secretion by KF grown in glucose or galactose  
Aliquots of media were removed from KF grown in 5mM glucose or 5mM 
galactose at days 1, 3 and 5 and lactic acid was measured using the LDH 
assay. Amount of lactic acid in the medium of KF grown in glucose 
compared to galactose was significantly higher indicating the initial 
glucose phosphorylation step catalyzed by HK could contribute to the 
elevated glycolysis observed in KF. Values are expressed as µM lactic 




6.2.3  EFFECTS OF HYPOXIA ON BIOENERGETICS OF NF 
Histological examination of keloids demonstrates a normal skin periphery, an 
inflammatory border and a stable portion that is hypo-vascular and hypoxic (Berry et al., 
1985). To analyze if hypoxia is an integral factor that mediates the possible 
transformation of NF to adopt a similar glycolytic phenotype as KF, NF were subjected 
to hypoxia through the treatment with a hypoxia mimetic, desferrioxamine (DFO) for 6h 
at 200µM. Preliminary data showed that these represent optimal time and concentration 
of DFO for maximal HIF-1α expression. 
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6.2.3.1  Mitochondrial membrane potential  
Normoxic (control) and hypoxic (DFO-treated) NF were permeabilized and the rate of 
formation of J-aggregates upon introduction of mitochondrial respiratory substrates, 
glutamate/malate and succinate was measured. Under hypoxic condition, NF showed 
similar capacity to oxidize these respiratory substrates (Figure 6.3); thus, no impairment 
in the mitochondrial complex I and II activity was evident. 
 
Figure 6.3 Assessment of complex I and II activities in NF under hypoxia  
 
Both control (normoxic) and DFO-treated NF (hypoxic) were 
permeabilized by 65µg digitonin/106 cells (P65 NF) and activities of 
complex I and II were analyzed by measuring the formation of J-
aggregates. In the presence of mitochondrial respiratory substrates, both 
control and DFO-treated NF showed comparable degree of energization 
by glutamate/malate and succinate suggesting intact complex I and II 
activities under normoxia and hypoxia. Addition of respiratory inhibitors 
of complex I and II, rotenone and TTFA respectively, reduced the levels 
of J-aggregates (maximally increased by the respective substrates) 
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6.2.3.2  Glycolytic enzyme activities 
The specific activities of key glycolytic enzymes that were increased in KF were 
analyzed and compared between normoxic and hypoxic NF. Activities of HK, GAPDH, 
and LDH, expressed as means ± SD nmol NADH or NADPH/min/mg were 3.92 ± 1.4, 
2257 ± 161 and 586 ± 72, respectively, for five samples of hypoxic NF. The 
corresponding values of normoxic NF were 1.8 ± 0.16, 508 ± 78 and 176 ± 40, and were 
significantly lower (with p < 0.05) indicating that hypoxia could have possibly 
contributed to the glycolytic phenotype observed by inducing the expression and 
activities of key glycolytic enzymes.  
6.2.3.3  Expression of HKII and β-F1ATPase 
HKII and β-F1ATPase protein expression levels was analyzed in two samples of normal 
fibroblasts (NF102 and NF110) which were subjected to hypoxia by 6h exposure to 
200µM DFO. An increased expression of HKII and a decrease in β-F1ATPase expression 
was evident in hypoxic NF compared to normoxic NF (Figure 6.4). This similar protein 
expression pattern of increased HKII and reduced β-F1ATPase was previously observed 
in KF when compared to NF (Figure 5.5). The reduced dependence on OXPHOS for ATP 
generation in KF is likely due to the hypoxic condition these atypical fibroblasts are 
subjected to in the keloid microenvironment as decreased β-F1ATPase and increase in 








Figure 6.4 Expression of HKII and β-F1ATPase in hypoxic NF 
 
NF102 and NF110 were treated with 200µM DFO for 6h to induce 
hypoxia. Cell lysates were subjected to 10% SDS-PAGE followed by 
electroblotting onto a nitrocellulose membrane. The membrane was 
probed with antibodies specific to HKII and β-F1ATPase. In comparison 
to the normoxic controls, hypoxic NF (NF102 and 110) showed increase 
in HKII protein expression. In the hypoxic cells, decrease in β-F1ATPase 
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6.2.4  EFFECTS OF DOMINANT NEGATIVE HIF-1α ON KELOID 
PHENOTYPE 
The hypoxic core of keloid scars likely intiates HIF-1 mediated adaptation 
responses such as anaerobic metabolism in KF. It was observed that KF, in this study and 
others, express HIF-1α at higher levels compared to NF (Figure 6.1; Zhang et al., 2003 
and 2004).  Therefore, in this study, we established dominant negative HIF-1α 
transductant from one sample of KF (KF25) and examined the changes in glucose 
utilization rates, HKII protein expression, cell migration and ECM secretion. 
Figure 6.5 shows the structures of HIF-1α and dominant negative HIF-1α cDNAs. 
A deletion mutant of HIF-1α comprises only of the HIF-1α N-terminus (amino acids 30 
to 389) containing the DNA binding and dimerization (with HIF-1β) domains. The C-
terminus containing the transactivation domain was deleted. Thus, this mutant can 
sequester HIF-1β, by competing with endogenous HIF-1α, and bind to DNA, but cannot 
transactivate DNA and induce gene transcription. The V5-tagged form of human 
dominant negative form of HIF-1α was introduced into KF25. Stable transductants 
expressing the dominant negative form of HIF-1α (HIF-1αDN) were assessed for 
parameters previously known to play roles in keloid pathogenesis (i.e. elevated migration 
rate, increased extracellular matrix secretion) and compared to controls, which were 
transduced with empty (control), and green fluorescent protein fused (EGFP) vectors. 
HKII protein expression level and rate of glucose utilization analyzed in this study were 
also measured.  
 
 





Figure 6.5            Structures of HIF-1α and the dominant negative form 
 
A deletion mutant of HIF-1α (amino acids 30 to 389) lacking transactivation and oxygen-dependent degradation 
domains was generated from full-length HIF-1α (amino acids 1-826). This deletion mutant functions in a dominant 
negative manner through its inhibition of formation of functional HIF-1 
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6.2.4.1  Protein expression levels of HKII   
The mitochondria-bound isoform of HK was found to be elevated in KF (Figure 5.5). 
This isoform, a target gene of HIF-1 was measured in HIF-1αDN. In comparison to the 
controls, HIF-1αDN showed a decrease of 17% in HKII protein levels (Figure 6.6B). The 
vascular endothelial growth factor (VEGF) protein expression was also analyzed. This 
angiogenic protein is also a target of HIF-1 and is expressed at increased levels in KF 
(Wu et al., 2004).  The expression level of this protein was also reduced minimally in the 
HIF-1αDN compared to the EGFP or control vector transduced KF25 (Figure 6.6A). 
Therefore, it is likely that either HIF-1α alone is not responsible for elevated HKII 
protein levels in KF or low transduction efficiency may not significantly alter the hypoxic 
phenotype observed in KF.   
 
17% decrease 
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Figure 6.6 HKII and VEGF protein expressions in KF 25 control and HIF-1αDN 
 
Expression levels of key proteins, VEGF and HKII, known targets of HIF-
1 were analyzed in HIF-1αDN transductants and compared to control 
transductants (control and EGFP). VEGF expression was reportedly 
increased in KF (Wu et al., 2004), therefore, was used as a measure of 
transduction efficiency.   
 
(A) Analysis of VEGF showed minimal decrease (17%) in protein 
expression level in the HIF-1αDN KF compared to control and EGFP 
transductants.  
 
(B) Western blot analysis of HKII expression in HIF-1αDN showed 
similar decrease for this protein compared to control transductants. Band 
intensities were quantified by using the ImageJ software and expressed as 
relative to β- tubulin. 
 
6.2.4.2  Rate of glucose utilization 
KF exhibit elevated rate of glucose utilization that was attributed to its increased 
activities of glycolytic enzymes (Chapter 3). The role of HIF-1α in contributing to this 
phenotype demonstrated by KF was assessed by measuring the rate of glucose utilization 
in HIF-1αDN. However, the rate of glucose utilization was found to be comparable to the 
controls (Figure 6.7) suggesting that HIF-1α alone was not responsible for the elevated 
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Figure 6.7 Glucose utilization measured in HIF-1αDN 
 
Control and HIF-1αDN showed comparable rates of glucose utilization 
with a decrease of only 11%. Rates were calculated for the first 3h during 
which glucose uptake was linear and normalized to protein content per 
well 
 
6.2.3.3  Cell migration 
 
One factor that distinguishes keloids from hypertrophic scars is the ability of keloid scars 
to extend beyond the initial wound margin. The migration profile of HIF-1αDN was 
assessed by measuring the relative number of cells that traverse from the upper chamber 
to the lower chamber through crystal violet staining of the lower chamber. The migration 
rate of HIF-1αDN was close to 14% slower than the controls (Figure 6.8). This minimal 
decrease was not sufficient to conclusively suggest the contribution of HIF-1α to the 










Figure 6.8  Migration rate of HIF-1αDN compared to control 
 
Rate of migration of HIF-1αDN was measured using the transwell 
migration assay.  
25 x 103 cells were grown on the upper chamber in DMEM with 0.5% 
FBS. The lower chamber consisted of DMEM with 10% FBS functioning 
as a chemoattractant. After 48h, cells in the lower chamber were stained 
with crystal violet and absorbance read at 595nm. A slower migration rate 
was evident in HIF-1αDN when compared to control 
 
6.2.3.4  Extracellular matrix (ECM) secretion 
Keloid scars are clinically represented as raised nodules due to accumulation of ECM 
materials, namely, fibronectin and collagen. We hypothesized that the elevated glycolysis 
may contribute to the aberrant ECM deposition by providing sufficient ATP supply for 
the process of ECM synthesis and deposition. Herein, the role of HIF-1α in increased 
production of ECM materials by atypical keloid fibroblasts was investigated. The amount 
of fibronectin and collagen was measured in medium (DMEM) in which HIF-1αDN were 
14% decrease 
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cultured. Similar amounts of collagen and fibronectin were deposited in the media of the 
control and HIF-1αDN measured by western blot analysis (Figure 6.9).  
Therefore, based on the results obtained, it is likely that the HIF-1 pathway alone may not 
be responsible for the glycolytic and fibrotic phenotype observed in KF. The HIF-1 
pathway may function coordinated with other pathways e.g. Akt/PKB to result in the 
atypical phenotype exhibited by these KF.  This will be discussed in further detail. 
 
Figure 6.9 Measurement of ECM production in HIF-1αDN 
 
Fibronectin and collagen production by HIF-1αDN was measured by 
western blot. Transduced cells were seeded in 6-well plates and grown for 
1 week in DMEM until confluent. 10µl aliquots of medium taken from 
control and HIF-1αDN showed similar amounts of collagen and 
fibronectin indicating that possibly the HIF-1 pathway alone was not 
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6.3  DISCUSSION 
Based on studies which showed that hypoxia-induced expression of HIF1-α is 
responsible for elevated aerobic glucose consumption and lactate production in tumor 
cells (Gillies and Gatenby, 2007; Robey et al., 2005; Robin et al., 1984) and our previous 
results of KF exhibiting similar glycolytic phenotype as tumor cells (described in chapter 
3), the primary aim of this study was to investigate the importance of hypoxia in relation 
to the altered bioenergetic phenotype of KF. This hypothesis was analyzed using a two-
pronged approach. Firstly, NF were subjected to hypoxia via DFO treatment and 
alterations to bioenergetic phenotype of the hypoxic cells were assessed. Secondly, the 
dominant negative form of HIF-1α was introduced into KF and changes in the glycolytic 
and fibrotic phenotype, if any, were analyzed.    
The hypoxic core of tumors promotes HIF-1α stability and activity. Detectable 
levels of this transcription factor have been reported in benign and primary malignant 
tumors and elevated amounts are found in highly metastatic tumors (Zhong et al., 1999; 
Harris, 2002). Keloid tissues, a form of benign tumor, have been reported to express 
increased amounts of HIF-1α compared to normal skin (Zhang et al., 2003). In this study, 
we observed HIF-1α expression in KF, indicated by its presence in the nuclear fractions 
of these cells, but the transcription factor was apparently absent in all four samples of NF 
analyzed (Figure 6.1). Therefore, the presence of HIF1-α may explain the elevated 
glycolysis observed in KF as several genes that code for enzymes associated with the 
glycolytic pathway are targets of this transcription factor (Semenza et al., 1994). Of these 
enzymes, expression of HKII has commonly been associated with highly metastatic 
tumors (Mathupala et al., 1995; Nakashima et al., 1988; Shinohara et al., 1991).  
   
 99 
HKII gene amplification and high mRNA levels is observed in tumors with its 
promoter sequence being promiscuous to activators such as mutated p53, insulin, cAMP 
and hypoxic conditions (Mathupala et al., 1997; Mathupala et al., 1995, 2001; Rempel et 
al., 1996). There was significantly higher level of HKII detected in the mitochondrial 
fraction of KF (Figure 5.6). This enzyme, commonly elevated in highly malignant 
tumors, is observed for the first time in benign tumors (keloids) and may play an 
important role in the elevated glycolytic phenotype observed in KF. To analyze the role 
of HK, KF were grown in galactose, a substrate that bypasses HK in glycolysis. These 
cells showed significant reduction in lactic acid secretion (indicative of rate of glycolysis) 
compared to the fibroblasts grown in glucose (Table 6.1). This signifies that the first 
essential step of glucose phosphorylation catalyzed by HK was responsible for the 
increased rate of glycolysis observed in KF. Hence, we investigated whether induction of 
hypoxia would affect the expression of HKII and other glycolytic enzymes in fibroblasts 
derived form normal skin (NF). NF were subjected to hypoxia via treatment with 
hypoxia-mimetic, desferrioxamine (DFO). The mechanism of action of DFO in inducing 
hypoxia is represented in Figure 6.10. Treatment of human lung cell line A549 with DFO 
and transition metals induced expression of HKII mRNA and enzyme activity but did not 
affect levels of HKI, the other mitochondrial isoform of HK (Riddle et al., 2000).  
Following DFO treatment, NF showed increased expression of HKII and a 
simultaneous decrease in β-F1ATPase (Figure 6.4). This reciprocal relationship was 
observed in KF (Figure 5.5) even under normoxic conditions. Therefore it is likely that 
the hypoxic microenvironment in the keloid scar caused the changes in protein expression 
patterns of both HKII and β-F1ATPase. Although complex I and II activities remained 
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intact in these cells (Figure 6.3), reduction in β-F1ATPase observed in KF and in hypoxic 
NF could explain the decreased contribution of OXPHOS towards ATP biosynthesis in 
these atypical fibroblasts. Previous reports have suggested that HIF-1 optimizes 
efficiency of respiration by regulating the subunits of cytochrome oxidase (COX), 
another essential component of the mitochondrial electron transport chain (Complex IV) 
(Fukuda et al., 2007). HIF-1 expression, under reduced oxygen levels, activated 
transcription of genes encoding COX4-2 and LON, a protease required for the 
degradation of COX4-1, in mammalian cells. Therefore, it is likely that HIF-1 may also 
regulate β-F1ATPase expression as an adaptive response to lower oxygen levels to 
decrease OXPHOS and maximize ATP production via glycolysis. Further studies are 
required to investigate this adaptive significance of metabolic responses to hypoxia in KF 
and other tumor cells.      
Induction of hypoxia also resulted in elevation of glycolytic enzymes activities in 
hypoxic NF. Increased activities of these glycolytic enzymes were previously observed in 
KF compared to NF. Hence, it is likely that hypoxia plays a vital role in keloidal 
pathogenesis arising from the induction of HIF-1α and resulting in the glycolytic 
phenotype detected in KF. This phenotype allows KF to produce ATP despite the low 
oxygen tension and by elevating the glycolytic flux, meet the energy demands of the 
cells. The reciprocal decrease in β-F1 ATPase explains the decreased basal ATP 
production by OXPHOS. Reduced OXPHOS decreases ROS (natural products of 
mitochondrial respiration) production (Brand and Hermfisse, 1997) and is possibly 
another parameter aiding the survival of these atypical fibroblasts by conferring 
protection against oxidative stress (Figure 3.10).  
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To further assess the importance of HIF-1α contribution to the glycolytic and 
fibrotic phenotype of KF, we established dominant-negative HIF-1α transductants from a 
keloid fibroblast line, KF25 (HIF-1αDN). Figure 6.5 shows the structures of HIF-1α and 
dominant-negative HIF-1α cDNAs. This deletion mutant of HIF-1α comprises only of the 
HIF-1α N-terminus (amino acids 30 to 389). The C-terminus containing the 
transactivation domain and an oxygen-dependent degradation domain (ODD) was 
deleted. Thus, it functions in a dominant negative manner by inhibiting functional HIF-1 
formation.  
HIF-1α induces expression of several glycolysis-associated genes as an adaptive 
response to hypoxia. This is believed to result in the glycolytic phenotype exhibited by 
several tumors and possibly also in KF. We observed that HKII, a target gene of HIF-1α, 
was increased in KF both at the mRNA and protein levels. In this study, DFO-treated NF, 
also increased HKII expression (Figure 6.4). Therefore, HKII expression in HIF-1αDN 
was measured and compared to controls. However, HKII expression remained relatively 
unchanged in the HIF-1αDN transductants as in control (Figure 6.6B). Therefore, we 
were not able to conclude the involvement of HIF-1α in increasing the mitochondrial 
localized isoform of HK in KF. One pitfall was that the transduction efficiency could not 
be assessed irrefutably. Analysis of vascular endothelial growth factor (VEGF) 
expression levels, a well-known target gene of HIF-1α whose expression levels are 
reportedly elevated in KF (Gira et al., 2004; Steinbrech et al., 1999), also remained 
unaffected in the HIF-1αDN compared to control (Figure 6.6A).     
Further analysis of glucose utilization rates, cell migration and ECM secretion of 
HIF-1αDN indicated that these parameters were all comparable to control (Figures 6.7, 
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6.8 and 6.9, respectively). Hence, in this study, there is no conclusive evidence to suggest 
that hypoxia is integral in contributing to the glycolytic phenotype in KF. Although 
induction of hypoxia in NF did increase HKII expression (Figure 6.4) and activities of 
several glycolytic enzymes, these observations could be the adaptive response of the cells 
to hypoxia. Primary rat astrocytes also induce expression of glycolytic enzymes such as 
HKII upon exposure to hypoxia (Mitsu et al., 1999) suggesting that it may be unfair to 
draw a conclusion on the importance of hypoxia on KF based on the experiments done on 
hypoxic NF. However, it would be interesting to further evaluate the significance of 
hypoxia on β-F1-ATPase expression.  
 It is unclear whether hypoxia was responsible for elevated HKII mRNA and 
protein expression observed in KF even under normoxic conditions. There have been 
reports that other factors such as mutated p53 together with HIF-1α may promote HKII 
expression (Pedersen et al., 2002). It is, however, essential to identify whether HKII 
plays an important role in contributing to the elevated glycolysis in KF and ultimately its 
role in abnormal extracellular matrix secretion commonly associated with these atypical 
fibroblasts. The difficulties encountered with transfection of these primary cultures, limits 
the ability to carry out knock down experiments. However, the use of 3-BP, a specific 
inhibitor of HKII, may provide us with insights to HKII contribution to abnormalities 








Figure 6.10 Oxygen-dependent regulation of HIF-1α stabilization 
 
(A) HIF-1α is hydroxylated at specific proline and asparagine residues by HIF-prolyl hydroxylase (PHD) and asparaginyl 
hydroxylases (FIH-1), respectively, in the presence of oxygen (O2), 2-oxoglutarate (2-OG) and iron (II) (Fe2+) as co-factors. 
Hydroxylated HIF-1α then binds to the E3 ubiquitin ligase VHL complex that ligates a ubiquitin tail to the protein marking it for 
proteasomal degradation 
 
(B) Fe2+ is found at the active site of PHD where it is loosely bound to histidine and aspartic acid residues at the site. Iron chelator, 
desferrioxamine (DFO) is able to stabilize HIF-1α probably by binding to Fe2+, thus reducing its availability for the PHD enzyme
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7.  THERAPEUTIC TARGETING OF HKII IN KELOIDS WITH 3-BP 
7.1  INTRODUCTION 
Tumor cells deviate from the normal cellular phenotype. Their differences fall 
under two general catogeries: molecular biological phenotypes and bioenergetic 
phenotypes (Pedersen, 2007). In pursuit to identify an effective anti-cancer agent, 
targeting either phenotype is plausible.  
7.1.1  Therapeutic targeting of elevated glycolysis 
The shift from OXPHOS to glycolysis in tumor cells in response to hypoxia and 
oncogenic changes has been termed “metabolic remodeling” (Gatenby and Gillies, 2004).  
In tumor cells, ATP production from glycolysis can be as high as 60% compared to < 5% 
in normal cells. The greater dependence of tumor cells on glycolysis requires an increase 
in their rate of glucose uptake and usage. This biochemical hallmark of tumor cells has 
led to the search of inhibitors of glycolysis as anticancer drugs (Pelicano et al., 2006). 
Targeted therapeutics involved in specifically inhibiting elevated glycolysis may disrupt 
tumourigenesis by controlling abnormal cell proliferation, facilitating cell death and 
impeding angiogenesis (Pan and Mak, 2007). 
The close relationship between cell death pathways and bioenergetic machinery of 
the cell can be exploited. Necrosis occurs when cellular ATP levels drop precipitously 
(Eguchi et al., 1997; Leist et al., 1997; Richter et al., 1996). Therefore, an anticancer 
agent that preferentially enters tumor cells and destroys glycolysis will decrease cellular 
ATP levels and in so doing induces necrosis (Pedersen, 2007). One such agent is 3-
bromopyruvate (3-BP) which by virtue of its structure, enters via the lactate transporter 
and inhibits HKII, the first enzyme in the glycolytic pathway. 
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7.1.2  3-Bromopyruvate 
3-BP, a lactic acid analog, is a potent inhibitor of HKII (Moreno-Sanchez et al., 
2007). It enters tumor cells through the lactic acid transporters, which are upregulated in 
tumor cells. Preferential entry of 3-BP into tumor cells specifically depleted ATP and 
induced cell death in cancer cells (Geschwind et al., 2002; Ko et al., 2001). Intraarterial 
infusion of [14C] 3-BP into VX2 rabbit liver tumor models showed tumor uptake of 
radiolabeled 3-BP of 1.8% of injected dose per gram of tumor tissue, while uptake in 
other tissues was minimal (Vali et al., 2008). This favorable biodistribution profile was 
accompanied by decreased 18F-deoxyglucose (FDG) uptake in tumors. No effect was 
observed in normal tissues. Complete eradication of advanced liver cancers has also been 
reported in animals treated with 3-BP (Geschwind et al., 2004; Ko et al., 2004; Vali et 
al., 2007).   
Keloid fibroblasts (KF) exhibit similar glycolytic characteristics as tumor cells. 
Elevated glycolysis in tumor cells has been attributed to the mitochondria bound HKII. In 
the previous chapter, analyses of KF indicated an upregulation of HKII gene expression 
and its higher mitochondrial localization was demonstrated in KF compared to NF. 
Inhibition of this integral enzyme may provide a therapeutic strategy for keloids, 
characterized by excessive collagen secretion by atypical fibroblasts. Keloid fibroblasts 
showed higher susceptibility to toxicity at low concentrations 30 to 50µM of 3-BP and 
intracellular ATP levels were severely depleted.  
In this chapter, the effects of 3-BP on HKII activity in KF was assessed by 
measuring cell viability, rate of glucose utilization, cell migration and extracellular 
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matrix deposition of these abnormal KF in an attempt to examine its therapeutic potential 
for this human skin disease that has no effective cure to date.  
7.2  RESULTS 
7.2.1  LOSS OF PLASMA MEMBRANE INTEGRITY 
Cell viability was assessed by staining with calcien-AM and ethidium homodimer-1. 
Cytoplasmic staining by calcien-AM (green) indicates intact plasma membrane which 
was evident in untreated NF (Figure 7.1 A (i)) and KF (Figure 7.1 B (i)) as well as NF 
exposed to 3-BP up to 50µM (Figure 7.1 A (ii) and (iii)). Ethidium homodimer staining 
of the nucleus (red) indicates compromised integrity of the plasma membrane. In KF 
exposed to 30 and 50µM 3-BP, staining of the nucleus was clearly seen (Figure 7.1 B (ii) 
and (iii)). Plasma membrane lysis was only seen in NF exposed to high concentrations of 
3-BP (1mM) (data not shown). 
 




Figure 7.1 Analysis of plasma membrane integrity using calcien-AM and 
                        ethidium homodimer-1 (EH-1) staining  
 
Plasma membrane integrity is indicated by EH-1 exclusion. (A) NF and 
(B) KF were treated and analyzed as described in section 9.2.20. KF 
showed increased compromise in plasma membrane integrity, indicated by 
increased staining of the nucleus (red) by EH-1, at 30 and 50µM 3-BP 
compared to NF. Calcien-AM is cleaved by esterases in intact viable cells 
and emit green fluorescence. In comparison to NF, dimished green 
fluorescence is noted upon KF treatment with 3-BP at these critical 
concentrations  
 
7.2.2  MMP  DISSIPATES IN THE PRESENCE OF 3-BP 
 
Dissipation of MMP in cells is an indication of cell death. A decrease in the ratio of the 
red to the green fluorescence indicates a decrease in MMP (Reers et al, 1999). 
Quantitative analysis of MMP indicated a greater decrease in KF exposed to 50 and 
100µM 3-BP compared to NF (Figure 7.2). MMP was also analyzed qualitatively using 
confocal microscopy. In untreated KF and NF, there was formation of J-aggregates which 
exhibit a red fluorescence (Figures 7.3A and 7.3D) showing the presence of a MMP. The 
green fluorescence corresponding to the uptake of the JC-1 monomers was also seen 
(data not shown). There was a decrease in the red fluorescence in KF treated with 50µM 
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3-BP for 2 h, but this was not apparent in NF (Figures 7.3B and 7.3E). At a higher 
concentration of 100 µM, 3-BP was toxic to KF; no fluorescence was detected and there 
was appearance of bleb-like particles detected in the differential-contrast image (Figure 
7.3C). A decrease in red fluorescence was apparent in NF similarly treated but these cells 
retained their elongated morphology (Figure 7.3F). 
 
 
Figure 7.2 Effect of 3-BP on MMP 
 
A specific mitochondrial probe, JC-1 was used to examine the effect of 3-
BP on the mitochondrial membrane potential (MMP) based on the change 
in the ratio of the red fluorescence of the J-aggregates compared to the 
green fluorescence of the JC-1 monomers. At both 50µM and 100µM, 3-
BP decreased the MMP of NF and KF but the magnitude of decrease was 
significantly greater for KF than NF.  
 
The values are expressed as % of the corresponding controls ± SD for N= 














Figure 7.3 Confocal analysis of MMP in KF and NF treated with 3-BP 
 
The change in MMP was viewed by confocal microscopy which showed a 
decrease in the red fluorescence in KF treated with 50 µM 3-BP (B) 
compared to the corresponding control (A), while at 100 µM, no red or 
green fluorescence was detected except for the appearance of bleb-like 
particles (C). On the other hand, NF did not show a compromise in its red 
fluorescence at 50µM 3-BP (E) compared to its control (D) and they 
appeared to retain their elongated morphology with decreased red 
fluorescence at 100µM 3-BP (F), suggesting their greater resistance to the 
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7.2.3  LOWERED RATE OF GLUCOSE UTILIZATION IN KF BY 3-BP 
Glucose utilization was measured by the rate of formation of tritiated water from 
radiolabelled glucose by the phosphoglucose-isomerase reaction in fibroblasts pretreated 
with 3-BP for two hours prior to measurements. In KF, there was a significant decrease in 
the rate of glucose utilization following exposure to 30µM and 50µM 3-BP. However, a 
significant decrease in NF was only detected at 50µM 3-BP (Figure 7.4). The higher rate 
of glycolysis in untreated KF compared to the NF observed previously was again 
observed.  
 
Figure 7.4 Effect of 3-BP on rate of glucose utilization 
 
KF and NF were exposed to 3-BP for 2 h following which the rate of glucose utilization 
was measured. Significant reduction in glucose utilization rates of treated KF was seen.  
 
Values are expressed as mean pmol of glucose utilized/h/mg protein ± SD for N= 5; *p < 
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7.2.4  DECREASE IN CELL  PROLIFERATION OF KF IN THE PRESENCE OF 
3-BP 
Proliferating cell nuclear antigen (PCNA) is an antigen that is expressed in the nuclei of 
cells during the DNA synthesis phase of the cell cycle. It is often used as a marker for 
proliferation. Four samples of KF were treated with 30µM 3-BP for 2h following which 
PCNA expression was compared with the corresponding untreated controls. A significant 
decrease in PCNA expression was observed in KF treated with 30µM 3-BP (Figure 7.5). 
This indicates that 3-BP decreased the proliferation of KF in vitro. 
 
Figure 7.5 Expression of PCNA in KF exposed to 30µM 3-BP 
 
Four samples of KF were exposed to 30µM 3-BP for 2h following which 
PCNA expression was studied using Western blot analysis of the whole 
cell lysates. KF treated with 3-BP showed reduced expression of PCNA. 
Band intensities were normalized to loading controls and expressed as 
relative intensity where #p<0.005  
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7.2.5  3-BP DECREASES MIGRATION RATE OF KF 
Migration efficiency is measured using the scratch wound assay and the transwell 
migration system. For the scratch wound assay, KF were treated for two hours with 30 
and 50µM 3-BP after which scratch wounds were inflicted and “patching up” of the 
wound was monitored for 24h. The KF that were treated with 3-BP showed decreased 
“patching up” compared to an almost complete wound healing in the controls (Figure 
7.6A). In the transwell migration assay, similar decreased migration patterns were 
observed in KF treated with 3-BP (Figure 7.6B). Cells were pre-treated with similar 
concentrations of 3-BP for 2h after which cells were trypisinized and resuspended in low 
serum medium (0.5% FBS). As a chemoattractant, DMEM supplemented with 10% FBS 
was placed at the lower chamber. KF were allowed to migrate for 48h after which the 




















Figure 7.6 Migration of KF pretreated with 3-BP 
 
(A) Scratch wound assay was used to analyze the rate of migration of keloid 
fibroblasts (KF111). Cells were grown to near confluency overnight. The next 
day, a scratch wound was inflicted and the cells were subsequently exposed to 30 
and 50µM 3-BP for 2h. Following exposure, cells were washed and normal cell 
media was replaced. The wound healing was measured 24h after initial wounding. 
Treated cells showed reduced migration when exposed to 30 and 50µM 3-BP. 
Complete sealing of the wound was observed in the untreated control. 
(B) A significant decrease in cell migration was evident in KF exposed to 30 and 
50µM 3-BP where N = 4 and *p<0.05 and #p<0.005 compared to their 
corresponding controls. The transwell migration assay was used to compare the 
rate of migration in KF ± 3-BP (for 48h). 
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7.2.6  DECREASED SECRETION OF COLLAGEN I-III AND FIBRONECTIN 
Extracellular matrix molecules such as fibronectin and collagen are secreted by 
fibroblasts during the wound healing process to remodel the wounded tissue. Elevated 
rate of secretion of these extracellular matrix molecules is one of the causes of keloid 
pathogenesis. Four samples of keloid fibroblasts were treated with 30 and 50µM 3-BP for 
2h following which serum-free medium (DMEM alone) was added. After 1 week, 1ml 
aliquot of the medium was analyzed for fibronectin and collagen I, II and III. All four 




Figure 7.7  Effect of 3-BP on secretion of components of the extracellular matrix  
 
Secretion of fibronectin and collagen I, II and III by KF was analyzed after 
treatment with 3-BP. Four samples for KF were pre-treated for 2h with 30 
and 50µM 3-BP and subsequently replenished with serum-free media. 
After 1 week, one ml of each of the media was analyzed for fibronectin 
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7.3 DISCUSSION 
The consistent findings of altered bioenergetics attributed to the Warburg effect in 
a wide spectrum of cancers (Semenza et al., 2001; Warburg, 1956) provides an avenue 
for possible therapeutic intervention. Keloids are often described as benign tumors 
(Linares et al., 1993). There is no effective therapy to date (Berman et al., 2007). This 
fibrotic disorder ranges from small nodules to large, extensive scarring. The 
overproduction and accumulation of collagen and other extracellular matrix elements by 
abnormal keloid fibroblasts allude to the fibrosis (Abergel et al., 1987; Ohta et al., 1987). 
Surgical excision of keloids is often redundant as the scar recurs. Therefore, it is essential 
to develop and test new therapeutic strategies to effectively eliminate keloid fibroblasts 
and overcome the chances of recurrence. The elevated rate of glycolysis provides such a 
mechanistic approach.  
In this study, we targeted the first committed step of glycolysis - the 
phosphorylation of glucose catalyzed by HK, in particular, HKII. The mitochondrial 
localization of HKII provides an adaptive advantage to tumor cells as it confers the 
ability to increase the rate of glucose phosphorylation by virtue of its position on the 
outer mitochondrial membrane (Pedersen, 1978). This specific isoform is elevated in KF, 
hence, we hypothesized that specific inhibition of HKII would inhibit the elevated 
glycolysis in KF.  
Treatment of KF 30 and 50µM 3-BP compromised plasma membrane integrity 
more significantly than NF (Figure 7.1). This corroborates with previous findings of 
increased compromise in cell viability and ATP levels in KF similarly treated (Figure 5.7 
and 5.8). Another indication of reduced cell viability is the dissipation of mitochondrial 
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membrane potential (MMP). KF exposed to 30 and 50µM 3-BP showed lowered MMP 
measured both quantitatively and qualitatively using JC-1 (Figures 7.2 and 7.3). 3-BP 
reduced the rate of glucose utilization in KF, more significantly than NF (Figure 7.4). 
Exposure of KF to 30µM 3-BP decreased the in vitro expression of PCNA (Figure 7.5) 
and decreased cell proliferation (Figure 7.6A). Keloids often spread beyond the initial 
wound margins (Linares et al., 1993). Analysis of the migration rates of KF upon 
treatment with 30 and 50µM 3-BP showed reduced migratory potential (Figure 7.6B). In 
vitro analysis of production of extracellular matrix components indicated decreased 
secretion of collagen I-III and fibronectin by KF exposed to 3-BP (Figure 7.7).  
The inhibitory action of 3-BP on glycolysis is likely caused by its inhibition of 
HKII. Elevated HKII expression in KF reflects the necessity of increased glycolysis to 
maintain high ATP levels in these overactive fibroblasts. The prominent ATP level in 
keloid scars is possibly essential for the increased production of elements of the 
extracellular matrix. In this study, it is likely that targeted inhibition of elevated 
glycolysis in KF through the action of 3-BP on HKII, could reduce keloidal pathogenesis 
by decreasing cell proliferation, migration and secretion of extracellular matrix by these 
anomalous fibroblasts. Therefore, 3-BP may provide an effective therapeutic alternative 
in keloid scar treatment. The question now is to examine if this narrow window of 30-
50µM 3-BP is achievable in vivo for this small molecule to be considered a potential drug 
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8. CONCLUSION 
8.1  GENERAL CONCLUSIONS 
The complex network of signaling pathways involved in wound healing have 
been extensively documented. The mediation of all the events of the healing process from 
the moment of injury until the final repair of the tissue is by growth factors or cytokines. 
Evidence over the years has suggested that alterations in specific signaling pathways have 
resulted in abnormal wound healing. The normally ordered process spirals into one of 
excessive deposition and accumulation of scar tissue, giving rise to fibrosis. Keloids are 
an example of a fibrotic skin disorder, arising from uncontrolled fibroblastic deposition 
of collagen. Often described as a benign tumor, this disease is unique to humans. Several 
reports implicate the contribution of aberrant growth factor and cytokine activities to 
keloid pathogenesis. These include TGF-α and TGF-β, PDGF and Interleukin-6 (IL-6) 
(Border and Noble, 1994). Several downstream effectors such as Smad 2 and 3, Stat 3 
and the PI3 kinase pathway have been widely studied for their role in keloid formation. 
The clear indication from athese studies suggests an overactive system in the KF. It is 
likely that such a system is dynamic metabolically as well.  
 It was reported that long after an initial tissue injury, KF continue to proliferate 
resulting in an accumulation of non-functional scar tissue giving rise to raised nodules 
and the ATP levels therein remain high (Ueda et al., 2004). Such proliferative cells 
preferentially use glycolysis rather that oxidative metabolism to generate ATP (Brand 
and Hermiffese, 1997). Increased lactate in keloid scar tissue suggested glycolysis as the 
main energy source (Hoopes et al., 1971). This phenomenon of increased glycolysis has 
been proposed as a primary defect in cancer (Warburg, 1956). A landmark finding in 
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tumor biology was the discovery of the transcription factor, hypoxia-inducible factor-1 
(Semenza et al., 1994). This heterodimeric factor (-1α and -1β) is responsible for the shift 
of the tumor cells towards the glycolytic phenotype and attenuating OXPHOS. It does so 
by increasing expression of glycolytic enzymes and repressing pyruvate oxidation 
through expression of PDK1 (Kim et al., 200; Papandreou et al., 2006). Although studies 
have shown that keloids constitutively express higher level of HIF-1α protein compared 
with the adjacent skin (Zhang et al., 2003; Wu et al., 2004), a parallel between this 
transcription factor and the metabolism of keloids was not drawn. 
 The results in this study present evidence of the glycolytic phenotype exhibited by 
KF with several similarities to tumor cells. This led us to examine the use of 3-BP to 
target glycolysis as a potential treatment of keloid scars. In summary, the main significant 
findings are presented herein. 
8.1.1  Metabolically active KF are dependent on glycolysis 
KF under basal conditions are characterized by a higher rate of ATP biosynthesis. 
These atypical fibroblasts exhibit a greater dependence on glycolysis for their elevated 
cellular energy demands through amplifying expression and activities of key glycolytic 
enzymes and increasing the rate of glucose utilization. Although attenuation of OXPHOS 
was observed in KF as indicated by lowered rates of ROS generation and decreased basal 
oxygen consumption, functional electron transport chain activity was detected in these  
fibroblasts. When fortified with an exogenous source of mitochondrial respiratory 
substrate, such as succinate or glutamate and malate, KF were able to increase the MMP 
and synthesize ATP at rates comparable to NF. Therefore, KF depend on glycolysis for 
ATP biosynthesis and compensate for this less efficient pathway by increasing the 
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activities of glycolysis-associated enzymes and glycolytic flux. These abnormal 
fibroblasts, however, retain their OXPHOS ability. 
8.1.2  Intact pyruvate oxidation 
Despite enhanced glycolysis and attenuated OXPHOS observed in KF, pyruvate 
oxidation (linking glycolysis and OXPHOS) is functional in KF. Permeabilized KF 
effectively produced ATP from exogenous pyruvate at rates comparable to NF. The 
energization of MMP by pyruvate indicates functional electron transport activity. The JC-
1 assay used to analyze MMP, showed similar maximal increase in MMP (increase in 
fluorescence of red aggregates) between KF and NF upon the addition of pyruvate. This 
indicates that pyruvate undergoes oxidative metabolismin the mitochondria of KF as in 
NF. This would not be possible if pyruvate oxidation was compromised as it has been 
reported in highly metastatic tumors e.g. Morris hepatomas. Pyruvate oxidation was 
reported to diminish with increasing metastatic potential of the tumor (Eboli, 1985). 
Recent evidence suggests that in tumors the control of pyruvate oxidation is mediated by 
control of expression of a key protein namely PDK via HIF-1α (Sugden, 2003; Kim et 
al., 2007). 
PDK controls the activity of PDH by phosphorylating its catalytic subunit, PDH 
E1-α. Recent reports suggested that the expression of PDK1 is controlled by HIF-1α and 
dysregulated c-myc which in turn regulates pyruvate oxidation in tumors (Kim et al., 
2007). In KF, protein expression levels of PDK1 remained comparable to NF. The 
analysis of the PDH E1-α subunit showed similar expression in both KF and NF. To 
substantiate the unaltered pyruvate oxidation observed in KF, active and total PDH 
activities were measured. Both KF and NF showed similar activities of both active and 
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total PDH indicating uncompromised pyruvate oxidative pathway in KF. This suggests 
that one possible difference between benign and highly malignant tumors could be the 
pyruvate metabolic pathway.  
8.1.3  Upregulated expression of HKII in KF 
Expression of HKII was observed in KF. This isoform, described commonly in 
highly metastatic hepatomas, was found to be upregulated in KF both at the mRNA and 
protein levels. This led us to conclude that HKII may be responsible for the increased 
glycolytic phenotype exhibited by KF. KF grown in media contaning only galactose 
produced lactic acid, a by-product of anaerobic glycolysis, at a significantly slower rate 
compared to KF grown in glucose. This indicates that the HK-catalyzed glucose 
phosphorylation is an essential part of the elevated glycolysis observed in KF. This 
observation may be the result of the localization of HK on the mitochondrial membrane. 
KF show increased mitochondrial HK activity compared to NF and the mitochondrial 
fractions isolated from KF analyzed showed significantly higher amounts of HKII 
compared to NF. The binding of HKII to VDAC examined by immunofluorescence was 
evident in KF. Several reports indicate that the localization of HKII on the OMM is 
advantageous for tumor cells as it prevents apoptosis by inhibiting formation of the 
membrane permeability transition pore (MPTP) and aids glycolysis (Mathupala et al., 
2006).       
The control of HKII expression in KF remained to be elucidated. The HKII 
promoter is induced by several factors, namely, mutated p53 and HIF-1α (Mathupala et 
al., 1997). In this study, the possible role of hypoxia in inducing HKII/glycolytic 
phenotype in KF was investigated. 
   
 121 
8.1.4  Hypoxia and the overactive phenotype of KF 
To analyze the contribution of hypoxia to keloid pathogenesis, a two-pronged 
approach was taken. Firstly, NF were subjected to hypoxia by exposing them to 
desferrioxamine (DFO) a hypoxia-mimetic. Secondly, stable transductants of KF 
expressing the dominant negative form of HIF-1α were studied for changes to the 
glycolytic and fibrotic nature of these anomalous fibroblasts.  
Activities of key glycolytic enzymes, LDH, GAPDH and HK were increased in 
NF exposed to DFO and intact electron transport chain activity. The protein expression of 
HKII increased in these hypoxic NF in comparison to normoxic NF. This glycolytic 
phenotype was evident in KF. Interestingly, hypoxia also seemed to play a role in 
regulating the expression of β-F1ATPase a key enzyme of OXPHOS. This enzyme 
couples oxidation mediated by the electron transport chain (Complex I-IV) to 
phosphorylation which is catalyzed by FoF1ATPase (Complex V). This is the ATP 
synthesizing pathway of the mitochondria. The expression and activity of this protein was 
observed to be repressed in KF compared to NF. In hypoxia-induced NF, a similar 
repression was identified when compared to normoxic NF. Although reports have linked 
β-F1ATPase repression with poor prognosis of many forms of cancer (Cuezva et al., 
2002 ; 2007 ; Isidoro et al., 2005), this is the first time it has been suggested that hypoxia 
may play a role in mediating the expression of this integral protein of OXPHOS, 
therefore altering the bioenergetic phenotype of hypoxic cells.    
Reports have demonstrated that dominant negative HIF-1α (HIF-1αDN) 
introduced into pancreatic tumor cells reduced tumorigenicity by impeding glucose 
metabolism (Chen et al., 2003). The HIF-1αDN transductants created from the KF25 line 
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showed comparable rates of glycolysis, cell migration and ECM secretion as the control 
transductants. HKII expression also remained uncompromised. Therefore, we were not 
able to determine conclusively that hypoxia through HIF-1α expression is responsible for 
the altered bioenergetic phenotype observed in KF by elevating HKII expression. It is 
likely that HIF-1α acts in sync with other pathways to mediate the glycolytic and fibrotic 
phenotype observed in KF. There is some evidence, from this study, to suggest that the 
Akt kinase activity in KF is elevated. Increased levels of the phosphorylated form of 
glycogen synthase kinase 3β (GSK-3β) was observed in KF compared to NF. The 
phosphorylation of GSK-3β is mediated by Akt (Pap and Cooper, 1998) and has several 
implications. It has been reported that the targeted phosphorylation by Akt inactivates 
GSK-3β and this modulates cell cycle progression at the G1 phase (Diehl et al., 1998). In 
addition, the mitochondrial localization of HKII is reportedly controlled by GSK-3β. 
GSK-3β (active, dephosphorylated) controls HKII-VDAC association on the OMM, by 
mediating the phosphorylation of VDAC (Gottlob et al., 2001). p-GSK-3β (inactive, 
phosphorylated) in KF is unlikely to impede HKII localization on the OMM as it is not 
able to phosphorylate VDAC, therefore, increased levels of this HK isoform was 
observed in the mitochondrial fraction of the KF. 
8.1.5  3-bromopyruvate, possible therapy for keloids    
3-BP, a halogenated analogue of pyruvate, is a strong alkylating agent that targets the free 
SH groups of cysteine residues in proteins (Chen et al., 2007). Studies have indicated the 
effectiveness of this drug in anticancer therapy where it induced severe depletion of 
cellular ATP and caused massive cell death in hypoxic cancer cells (Xu et al., 2005b). 
This drug targets the elevated levels of HKII in tumor cells by inhibiting the activity of 
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this enzyme (Moreno-Sanchez et al., 2007). 3-BP was identified as a possible remedial 
agent for keloids. The specific inhibition of HKII by 3-BP was able to reduce 
significantly the abnormalities of KF e.g. in vitro, this drug decreased the elevated 
glycolytic phenotype in keloid-derived fibroblasts and in doing so effectively reduced the 
enhanced migration and secretion of ECM (fibronectin and collagen), which are features 
displayed by these abnormal fibroblasts that contribute to the pathogenesis of keloids.  
In conclusion, KF were found to exhibit an altered bioenergetic signature with a 
greater dependence on glycolysis. We propose the targeting of this elevated pathway to 
develop a potential therapeutic strategy to combat the fibrotic condition that has no cure 
to date. The potential target is HKII, whose expression was found to be increased in the 
mitochondrial fraction of KF. Although, the underlying mechanism responsible for 
induction of HKII expression in KF was not conclusively determined, increased levels of 
the phosphorylated form of GSK-3β in KF suggests the possible involvement of the 
Akt/PI3 kinase pathway in increasing the mitochondrial localization of HKII. Targeting 
the HKII enzyme with 3-BP, a potent inhibitor of HKII, was found to effectively repress 
the pathogenic characteristics of KF through significant reductions in glucose utilization, 
cell migration and ECM secretion. Hence, we propose the development of this drug as a 
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8.2  SPECIFIC CONCLUSIONS  
 Glycolysis is the preferred ATP synthesizing pathway in KF and occurs at an 
elevated rate compared to NF as indicated by increased rate of lactate 
accumulation and glucose utilization. This possibly provides ATP for increased 
migration and enhanced rate of ECM production and secretion, characteristiced of 
KF. 
 Basal oxygen consumption is reduced despite functional electron transport chain 
and pyruvate oxidation in KF. Further studies on involvement of p53 may address 
this question.  
 Up-regulate HKII expression both at mRNA and protein levels and increased 
mitochondrial localization of this isoform were demonstrated in KF. This could be 
attributed to the Akt signaling pathway as KF contain higher level of the 
phosphorylated form of GSK 3β; GSK 3β is a downstream subsrate of Akt. 
 The targeted inhibition of elevated glycolysis in KF with 3-bromopyruvate 
(specific inhibitor of HKII), significantly reduced cell viability, depleted 
intracellular ATP levels compared to NF. This drug decreased cell proliferation, 
cell migration and ECM secretion of the KF, affirming the potential of 3-BP as a 
possible therapy for keloids. However, more studies on animal models are 
required. 
8.3  FUTURE PERSPECTIVES 
The role of hypoxia in contributing to keloid pathogenesis was not conclusively 
evaluated in this study. Initial data suggested that hypoxic NF adopted some bioenergetic 
features of KF by elevating activities and expression of glycolytic enzymes especially 
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HKII and repressing β-F1 ATPase. It would be worthwhile to study the rates of glucose 
utilization and lactic acid accumulation in hypoxic NF to further substantiate the 
involvement of hypoxia in keloid formation. However, it remains to be elucidated if 
hypoxia alone is responsible for this fibrotic disorder.  Although several reports have 
implicated the contribution of HIF-1α to the glycolytic phenotype of tumor cells, recent 
findings have suggested the involvement of p53 in their altered bioenergetics (Ma et al., 
2007 and Matoba et al., 2006).  
Besides its role in regulating apoptosis, p53 is reported to modulate the balance 
between utilization of respiratory and glycolytic pathways (Ma et al., 2007). In isogenic 
HCT116 human colon cancer cells, the relative fraction of ATP derived from glycolysis 
was inversely proportional to p53 gene dosage (Matoba et al., 2006). In p53-deficient 
HCT116, decrease in aerobic respiration is evident and there is a compensatory rise in 
glycolysis. In other words, p53 inactivation promotes glycolysis. Furthermore, mutated 
p53 was also found to induce expression of HKII (Pedersen, 2002), the isoform of HK 
that is upregulated in KF. Recent reports demonstrate that there are p53 gene mutations in 
keloids (Saed et al., 1998). Therefore, it would be interesting to assess the possible role 
of p53 in keloid pathogenesis.  
Another transcription factor connected to altering the bioenergetics of tumor cells 
is c-myc. The expression of this transcription factor is tightly regulated in normal cells 
and is expressed in actively proliferating cells. However, in tumor cells c-myc becomes 
dysregulated. Interestingly, c-myc is able to transactivate similar glycolysis-associated 
genes (glycolytic enzymes and glucose transporter-1) and HIF-1 (Gardner et al., 2002). 
Keloids, in comparison to normal skin, exhibit elevated expression of c-myc when 
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analyzed by microarray and RT-PCR (Chen et al., 2004). It is likely that c-myc may 
contribute to the glycolytic phenotype observed in KF; however, that remains to be 
investigated.   
In our efforts to understand this disease, our results have suggested the potential 
of HKII as a therapeutic target. Yet, conclusive studies of the role it plays in keloid 
pathogenesis needs to be extended. The notoriety of primary cultures to effective 
transfection makes it almost impossible to carry out targeted knock down of this gene. 
However, it may prove fruitful to carry out knock-in of HKII experiments using 
immortalized cultures of fibroblastic origin, such as, NIH-3T3 cells. These cells could be 
analyzed for elevated glucose utilization rate and increased extracellular matrix 
deposition. It would also be interesting to further assess if the reciprocal relationship 
identified in this study between HKII and β-F1ATPase is a phenomenon in other tumors. 
The therapeutic benefits of 3-BP for keloids remains to be tested on animal 
models. Keloids, being a uniquely human disease, may pose a challenge. However, recent 
papers have reported the use an in vivo model to test the efficacy of a drug in question. In 
Park G, et al. 2008, KF were implanted into the dorsal region of BALB/c nude mice and 
nodules were found to develop to twice the size of those implanted with NF. This similar 
model was also used in other studies (Fujiwara et al 2005). In this study, in vitro 
assessment of 3-BP as a form of therapy for keloids appeared promising. It reduced cell 
migration, secretion of extracellular matrix components and compromised cell viability 
of the KF. Therefore, it is essential to assess if 3-BP is able to effectively treat keloid 
scars in vivo in man. 
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9.  MATERIALS AND METHODS 
9.1  MATERIALS 
Cell culture- Trypsin and penicillin-streptomycin mixture were purchased from 
GibcoBRL, Invitrogen (Carlsbad, CA). Fetal bovine serum (FBS) was purchased from 
Hyclone, Thermo Scientific (Waltham, MA).  
5,5’,6,6’-tetrachloro 1,1, 3,3’ tetraethylbenzimidazolcarbocyanine iodide, the Amplex 
Red hydrogen peroxide/peroxidase assay kit, monochlorobimane and Calcein-AM and 
ethidium homodimer-1 were from Molecular Probes Inc. (Eugene, OR). P1,P5-
Di(adenosine-5’) pentaphosphate pentalithium salt, glucose-6-phosphate dehydrogenase 
(204U/ml) and Dowex 1 x 8 (Cl- form, 200-400 mesh) were obtained from Fluka Chemie 
(Buchs, Switzerland). Nonidet P-40 was purchased from Calbiochem (San Diego, CA, 
USA). Sodium pyruvate was from GibcoBRL Life Technologies (Grand Island, NY, 
USA). The following were purchased from Sigma Aldrich Co. Ltd (St Louis, MO): ADP, 
ATP, 2’,7’-dichlorofluorescein diacetate; carbonyl cyanide p-trifluoro-
methoxyphenylhydrazone; glucose oxidase (151 kU/mg), L-glutamic acid, homovanillic 
acid, horseradish peroxidase type VI, (298U/mg), iodoacetate, LDH (5.3 kU/ml), L-malic 
acid, NAD+, NADP+, oligomycin (containing 59, 18, and 14% of oligomycin A, B, and 
C), oxamate, pyruvate, rotenone, antimycin A, thenoyltrifluoroacetate (TTFA), 
glutathione-S-transferase from equine liver (31U/mg), glutathione, bathocuproine 
disulfonate, uric acid, 6-hydroxy-2,5,7,8-tetramethyl chromane-2-carboxylic acid 
(Trolox), FL-ASC Bioluminescent cell assay kit, phenylmethylsulfonyl fluoride (PMSF), 
protease inhibitor cocktail consisting of [4-(2-Aminoethyl)benzenesulfonyl fluoride 
hydrochloride], aprotinin, bestatin hydrochloride, [N-(trans-Epoxysuccinyl)-L-leucine 4-
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guanidinobutylamide], leupeptin hemisulfate salt and pepstatin A; 3-bromopyruvate, 
thiamine pyrophosphate, p-iodonitrotetrazolium violet (INT), phenazine methosulfate, 
coenzyme A, dichloroacetate, thiazolyl blue tetrazolium bromide (MTT), 
decylubiquinone, crystal violet, 2, 6-dichlorophenolindophenol (DCPIP),  Tween-20 was 
from Sinopharm Chemical Reagent Co. Ltd (Shanghai, CHN). D-[2-3H] glucose (16 
Ci/mmol) was purchased from GE Healthcare UK Limited (Buckinghamshire, UK). Di-
sodium succinate hexahydrate was purchased from Merck & Co. (Whitehouse Station, 
NJ). BD Oxygen Biosensor system was purchased from BD Biosciences (Bedford, MA).   
Antibodies for western blot analysis - anti-HIF1-α, anti-β-tubulin and anti-fibronectin 
was from BD Transduction laboratories (San Jose, CA, USA); anti-cyclin A, anti-HKII 
polyclonal antibody and anti-PCNA were from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA); anti-PDK-1 polyclonal antibody, anti-LDH-A were from Abcam (Cambridge, 
UK); anti-porin-1 was from Calbiochem (San Diego, CA, USA); anti-OxPhos Complex I 
20kDa subunit and anti-PDH E1α were from Invitrogen Corporation (Carlsbad, CA); 
mouse monoclonal antibodies for collagen I, II and III were from Monosan (Sanbio, The 
Netherlands); mouse monoclonal anti-VEGF was from NeoMarkers (Lab Vision, 
Fremont, CA); mouse monoclonal anti-V5 was from Active Motif (Carlsbad, CA); anti-
phosphorylated GSK-3β was from Cell Signaling Technology, Inc. (Danvers, MA).  All 
secondary antibodies were conjugated with horseradish peroxidase and purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA) 
Secondary antibodies for immunofluorescence analysis - Alexa Fluor® 488 rabbit anti-
goat and Alexa Fluor® 594 goat anti-mouse fluorochrome tagged secondary antibodies 
were from Molecular Probes (Carlsbad, CA, USA).  
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9.2  METHODS 
9.2.1  COLLECTION AND PROCESSING OF SKIN SAMPLES 
Excised normal skin and keloid skin specimens (Table 9.1) were collected from plastic 
surgical procedures as reported in (Mukhopadhyay et al., 2007) under the guidelines 
approved by the National University Institutional Review Board. Signed informed 
consent had been obtained before operative excision. For babies, informed consent was 
obtained from the parents. All clinical investigations were conducted according to the 
Declaration of Helsinki Principles. A portion of the excised specimen was sent for 
histological confirmation of keloid identity and other portions were used for primary cell 
culture to isolate fibroblasts. 
9.2.2  PRIMARY FIBROBLAST CELL CULTURE 
Remnant dermis was minced and incubated in a solution of collagenase type-I (0.5 
mg/ml) and trypsin (0.2mg/ml) for 6 hours at 37°C. Cells were cultured in DMEM 
medium supplemented with 10% FBS and 100U/ml of penicillin-streptomycin mixture at 
37°C in 5% CO2. 
9.2.3  TITRATION OF DIGITONIN PERMEABILIZATION OF FIBROBLASTS 
Digitonin permeabilization was carried out on skin fibroblasts from passages 3 to 7. 
Briefly, cells were trypsinized and resuspended in 1ml of buffer (150mM KCl, 25mM 
Tris, 2mM EDTA, 0.1% bovine serum albumin (BSA), 10mM KH2PO4, 0.1mM MgCl2; 
pH7.4) following which cells were counted and 1 x 106 aliquots of cells were treated with 
different amounts of digitonin (0-100µg) for 1min after which digitonin action was 
stopped with the addition of 0.3% BSA.  
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9.2.4  MEASUREMENT OF MITOCHONDRIAL MEMBRANE POTENTIAL  
           (JC-1 ASSAY) 
9.2.4.1  Continuous monitoring 
The titration of digitonin was monitored by measuring the mitochondrial membrane 
potential using 5,5’,6,6’-tetrachloro1,1, 3,3’tetraethylbenzimidazolcarbocyanine iodide 
(JC-1). Briefly, 2ml of medium A (20mM Hepes, 250mM sucrose and 10mM MgCl2; pH 
7.1) supplemented with 12.5mM KH2PO4 and containing, 1mM ADP and 0.2µM JC-1 
was pre-warmed to 37°C. The reaction was started upon addition of 0.25 x 106 
permeabilized fibroblasts and the rate of formation of the J-aggregates was measured 
upon sequential addition of 5mM each of glutamate/malate, 10mM pyruvate or 10mM 
succinate. Specific inhibitors of respiratory complexes I to III, namely rotenone, 
antimycin A or theonyltrifluoroacetate (TTFA), were used to validate that the oxidation 
of these substrates occurred via the mitochondrial electron transport system. This assay 
also provides a means of assessing the activity (or lack of activity) of these respiratory 
complexes. 
9.2.4.2  Ratiometric assay 
Cells were harvested by trypsinization followed by centrifugation at 1,000g for 5min; 
they were counted by trypan blue exclusion. 1 x 106 cells were added to 1ml of assay 
buffer made up of 20mM Hepes, 250mM sucrose, 10mM MgCl2, 12.5mM KH2PO4 
adjusted to pH 7.1 and 0.2µM JC-1. 50 or 100µM 3-bromopyruvate (3-BP) was then 
introduced. 200µl of the above reaction mixture was added per well (4 replicates for each 
keloid (KF) and normal fibroblast (NF) sample) and fluorescence measurements were 
made at Ex/Em 485nm/535nm for green monomers and 485nm/595nm for red aggregates 
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of JC-1. The readings were taken at 15 min intervals for 2 h in a fluorescence microplate 
reader (Gemini XS, Molecular Devices). The results are expressed as a ratio of red to 
green fluorescence.  
9.2.4.3  Confocal microscopy 
Cells were grown overnight on coverslips in six-well plates. The next day, cells were pre-
treated with 0, 50 or 100µM 3-BP for 2 h after which cells were exposed to 2µM JC-1 (in 
PBS) for 30min. The samples were washed with PBS and the cells on coverslips were 
analyzed by confocal microscopy (IX81, Olympus). 
9.2.5  MEASUREMENT OF RATE OF ATP BIOSYNTHESIS 
9.2.5.1  Assay conditions.  
ATP generation from the exogenous addition of ADP and oxidation of respiratory 
substrates such as glutamate/malate and succinate was measured in digitonin 
permeabilized skin fibroblasts. Briefly, 50,000 permeabilized fibroblasts (65µg/million 
cells) were added to 250µl of buffer (150mM KCl, 25mM Tris, 2mM EDTA, 0.1% 
bovine serum albumin, 10mM KH2PO4, 0.1mM MgCl2; pH7.4) containing 1mM ADP 
and 500µM P1, P5-Di(adenosine-5’) pentaphosphate, which is routinely introduced to 
inhibit adenylate kinase (Kurebayashi et al., 1980) or together with 5mM each of 
glutamate, pyruvate and malate or 10mM succinate. The assay mixture was incubated at 
37°C for 5 min. The assay incubates were boiled to inactivate cellular ATPases, and the 
amount of ATP generated was determined by the chemiluminescence generated by the 
luciferin-luciferase reaction which was read in a luminometer (PerkinElmer Life and 
Analytical Sciences, Turku, Finland; Victor3).  
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9.2.5.2  Inhibitors of glycolysis or OXPHOS  
Each of the following chemicals was pre-incubated with fibroblasts for 5 min before the 
mixture was added to the assay incubate described above for ATP biosynthesis: 10mM 
each of sodium iodoacetate or oxamic acid, or 250µM TTFA, 10µM carbonyl cyanide p-
trifluoro-methoxyphenylhydrazone (FCCP) or 10µg oligomycin per ml.  
9.2.6  MEASUREMENT OF INTRACELLULAR ATP 
The amount of ATP present intracellularly was determined in lysates prepared from five 
different batches of confluent KF and NF that were prepared following the assay protocol 
reported in (Jeong et al., 2004).  
To determine the effect of 3-BP, 3x104 fibroblasts were plated per well in a 24-well plate 
and left to adhere overnight in 5% CO2. Following exposure of fibroblasts to 30-100µM 
3-BP for 2 h, intracellular ATP was determined by the luciferin-luciferase reaction as 
described in the previous section 9.2.5.1.  
To test the effect of 3-BP in KF grown in different media, cells plated were grown 
overnight in 5mM pyruvate without glucose or in 5mM glucose as control. The protein 
content in each well was determined (Bradford, 1976). 
9.2.7  MEASUREMENT OF RATE OF GLUCOSE UTILIZATION 
The rate of glucose utilization was determined by the production of 3H2O from D-[2-3H] 
glucose as described in (McKay et al., 1983). Normal and keloid fibroblasts were plated 
in six-well plates at 105 cells per well in glucose-free DMEM supplemented with 10% 
fetal bovine serum. The cells were used the next day when they were approximately 60-
70% confluent as recommended. The reaction was started by adding 0.25mM unlabeled 
glucose and 93.75nM D-[2-3H] glucose (containing 2.25µCi). At hourly intervals up to 4 
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hours, 100µl aliquots were removed to assay for 3H2O. To analyze the effect of 3-BP on 
rate of glucose utilization, cells were pre-treated for 2h with 30 and 50µM 3-BP after 
which glucose utilization was measured.  
The separation of 3H2O from the radiolabeled glucose was carried out by column 
chromatography using Dowex-1-borate and eluting with 0.9ml deionized water 
(Hammerstedt, 1973). The radioactivity in the eluate was measured by liquid scintillation 
counting. At the end of the experiment, the cells were lysed with a buffer containing 7M 
urea, 2M thiourea, 4% 3-[3-cholamidopropyl) dimethylammonio]- 1-propanesulfonic 
acid (CHAPS), and 10mM Tris. The protein content in each well was determined by the 
Bradford assay (Bradford, 1976).  
9.2.8  MEASUREMENT OF ENZYMES ACTIVITES 
9.2.8.1  Glycolytic enzymes acitivites 
The activities of hexokinase, glyceraldehyde 3- dehydrogenase, lactate dehydrogenase 
and pyrvate kinase were measured in extracts (containing 30µg protein) of normal and 
keloid fibroblasts by the methods described, respectively, in (Bustamante and Pedersen, 
1977; Krebs, 1955; Clark and Lai, 1989; Bucher and Pfleiderer, 1955) . The fluorescence 
of NADH and NADPH was monitored at Ex/Em of 352/464nm in a luminescence 
spectrophotometer (Perkin-Elmer LS55) and the activities were expressed as an increase 
in fluorescence of NADH or NADPH/minute/mg protein. 
9.2.8.1.1  Hexokinase 
Hexokinase activity was measured by coupling glucose phosphorylation to NADH 
formation by glucose-6-phosphate dehydrogenase (G6PDH). 2ml of assay buffer (32mM 
Hepes and 12mM MgCl2; pH 7.6) containing 6.5mM ATP, 0.9mM NADP+, 1U G6PDH    
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and extracts (30µg) were incubated at 37°C for 5 min following which 0.5mM glucose 
was added to start the reaction. For measurement of hexokinase activity in mitochondrial 
and cytosolic fractions, 30µg protein from each fraction was used. 
9.2.8.1.2  Glyceraldehyde-3-phosphate dehydrogenase 
2ml of 0.015M sodium pyrophosphate (pH 8.5) containing 0.5mM DL-glyceraldehyde-3-
phosphate, 3.33mM dithiotreitol and 0.25mM NAD+, 30µg extracts were added and the 
rate of formation of NADH was measured for 5min. 
9.2.8.1.3  Lactate dehydrogenase 
Briefly, cell extracts were added to 2ml of assay medium (0.4M hydrazine, 0.5M glycine; 
pH 9.0) containing 0.15mM NAD+ and 1mM lactate at 37°C. Activity was measured for 5 
min using a luminescence spectrophotometer. 
9.2.8.1.4  Pyruvate kinase (PK) activity 
PK activity was evaluated by measuring the rate of NADH oxidation at 340nm for 10 
min. Extracts were added to 200µl buffer containing 10mM phosphoenolpyruvate, 2mM 
ADP, and 140 units LDH following 5 min incubation at 37ºC. 0.15mM NADH was 
added to start the reaction and the decrease in absorbance resulting from NADH 
oxidation was monitored at 340nm using a microplate reader SpectraMax 190 (Molecular 
Devices, Sunnyvale, CA). PK activity was expressed as µmol NADH oxidized/min/mg. 
9.2.8.1.5  Glucose-6-phosphate dehydrogenase (G6PDH) activity 
G6PDH activity was assayed by measuring the rate of reduction of NADP+ for 10 min at 
340 nm at 37ºC following the procedure reported in (Deutsch, 1983). 2µl of the 
mitochondrial and 10µl of the cytosolic fraction (each containing 30µg protein) were 
used for measurement of G6PDH activity. 
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9.2.8.2  Mitochondrial enzymes activities  
9.2.8.2.1  Pyruvate dehydrogenase activity 
Cells were homogenized with 10 up-and-down strokes in a glass homogenizer and 
aliquots of the homogenate, containing 20µg protein were used to determine the “active” 
and “total” PDH activity as described in (Baudry et al., 1982). The assay mixture 
contained 0.05mM potassium phosphate, 2.5mM NAD+, 0.2mM thiamine pyrophosphate, 
0.1mM coenzyme A, 1mM MgCl2, 0.6mM p-iodonitrotetrazolium violet (INT) and 
6.5µM phenazine methosulfate. The reaction was started by adding 5mM sodium 
pyruvate and followed for 10min at 500nm in a microplate reader (SpectraMax 190, 
Molecular Devices, Sunnyvale, CA). 
9.2.8.3  SDH or Complex II (Succinate-Ubiquinone oxidoreductase) activity 
SDH activity was determined as the reduction of 2,6-dichloro-phenolindophenol (DCPIP) 
by the transfer of electrons from succinate in the presence of rotenone, antimycin A and 
KCN (Trounce et al., 1996). Briefly, the reaction buffer containing 35mM KH2PO4, 
2mM sodium azide, 5mM MgCl2, 1µM rotenone, 2µg/ml antimycin A, 0.06mM DCPIP 
and 0.06mM decylubiquinone was pre-incubated at 37°C for 5min. Similarly, cytosolic 
and mitochondrial extracts were pre-incubated with 10mM succinate in separate wells. 
The reaction was started by adding the reaction buffer to the extracts and the rate of 
reaction was followed for 5 min at 37ºC using an absorbance microplate reader at 600nm.  
9.2.8.4  Complex V (FoF1ATPase) activity 
ATPase activity was measured by the coupled assay using lactate dehydrogenase and 
pyruvate kinase as the coupling enzyme by following the decrease in absorbance at 
340nm resulting from NADH oxidation. Reaction mixture contained 50mM Tris pH 8.0, 
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5mg/ml BSA, 20mM MgCl2, 50mM KCl, 10mM Phosphoenolpruvate, 2.5mM ATP, 4 
units LDH, 4 units PK, 1mM NADH. Reaction medium was added to start the reaction 
after both extracts and buffer were incubated at 37ºC for 5min separately.  
9.2.9  DETERMINATION OF GLUCOSE AND LACTATE IN CELL CULTURE 
MEDIUM 
4 x 104 fibroblasts were plated in each well of a six-well plate containing 3ml culture 
medium of DMEM supplemented with 5mM glucose, 10% fetal bovine serum, and 
100U/ml of penicillin-streptomycin mixture. The concentrations of glucose and lactate in 
the culture medium were measured as follows: 
9.2.9.1  Glucose determination 
20µl of the culture medium in triplicate wells were added to 2ml of buffer (adjusted to 
pH 7.4) containing 145mM KCl, 30mM HEPES, 5mM KH2PO4, 3mM MgCl2, 0.1mM 
EGTA, 0.2mM homovanillic acid, 1U/ml horseradish peroxidase, and 20mU/ml glucose 
oxidase. Hydrogen peroxide produced from the oxidation of glucose was coupled to the 
reaction between horseradish peroxidase and homovanillic acid to produce a fluorescent 
dimmer (Barja, 2002), which was measured at Ex/Em 312/429 nm. The concentration of 
glucose was extrapolated from a standard of 0.1–5mM glucose oxidized by glucose 
oxidase under identical conditions. 
9.2.9.2  Lactate determination 
20µl aliquots of the culture medium from triplicate wells were added to 2ml of buffer 
containing 0.4 M hydrazine and 0.5 M glycine adjusted to pH 9.0, 0.15mM NADP+ and 
26U LDH (Clark and Lai, 1989). The increase in fluorescence corresponding to the rate 
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of formation of NADPH was measured at Ex/Em 352nm/464nm using a luminescence 
spectrometer.  
9.2.10  MEASUREMENT OF OXYGEN CONSUMPTION 
5 x 105 cells each from 3 different batches of normal and keloid fibroblasts were 
resuspended in 200µl medium A (20mM Hepes, 250mM sucrose and 10mM MgCl2; pH 
7.1) supplemented with 12.5mM KH2PO4. The cells were added into the BDTM oxygen 
biosensor system (BD Biosciences, Bedford, MA) and fluorescence was read at hourly 
intervals for 5 hours in a fluorescence microplate reader (Gemini XS, Molecular Devices 
Corporation, Sunnyvale, CA) at Ex/Em 485nm/600nm. This assay is based on kinetic 
monitoring of dissolved oxygen. A schematic representation of this assay system is 
shown below. Briefly, as oxygen becomes depleted, the biosensor fluoresces, providing a 
linear signal that can be directly correlated to oxygen consumption by the cell. 
 
Figure 9.1  Schematic of BDTM Oxygen Biosensor signal generation  
9.2.11  REACTIVE OXYGEN SPECIES (ROS) PRODUCTION 
ROS production was measured by the procedure based on the oxidation of 2’, 7’-
dichlorofluorescein (Wang and Joseph, 1999). The generation of hydrogen peroxide was 
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determined by the Amplex® Red hydrogen peroxide/peroxidase assay following the 
protocol provided by the supplier (Molecular Probes Inc, Eugene, OR).  
9.2.11.1  Oxidation of 2’, 7’-dichlorofluorescein (DCF) 
3 x 104 cells were added to each well of a 96-well plate and grown overnight in 5% CO2. 
The action of 50 µM each of Trolox and ascorbate on the production of ROS was also 
examined. The rate of DCF oxidation was measured for 30 min at Ex/Em 485/526nm in a 
fluorescence plate-reader (Gemini XS from Molecular Devices Corporation, Sunnyvale, 
CA). Cells were lysed at the end of the experiment with 20% Triton-X and the protein 
content in each well was measured (Bradford, 1976)  
9.2.11.2  Amplex RedTM hydrogen peroxide/peroxidase assay 
In the presence of peroxidase, the Amplex Red reagent reacts with hydrogen peroxide 
(H2O2 ) at 1:1 stoichiometry to produce the red-fluorescent oxidation product, resorufin, 
that has absorption and emission maxima of 571nm and 585nm, respectively (Molecular 
Probes Inc, Eugene, OR). 50µM Amplex red reagent and 0.1U/ml horseradish peroxidase 
were added into Krebs-Ringer phosphate (145mM NaCl, 5.7mM Na3PO4, 4.86mM KCl, 
0.54mM CaCl2, 1.22mM MgSO4, 5.5mM glucose; pH 7.35) to make up the reaction 
mixture. 100µl of reaction mixture was added per well, to which 5 x 105 cells were added 
to start the reaction. The action of 50 µM Trolox on the production of H2O2 was also 
examined. Fluorescence was monitored for 30min at Ex/Em 563nm/587nm at 37°C. The 
amount of   H2O2 was extrapolated from a standard curve of 0-10µM H2O2.     
9.2.12  MEASUREMENT OF ANTIOXIDANT LEVELS  
Intracellular antioxidants work to scavenge reactive oxygen species produced by cellular 
processes. Different types of antioxidants, such as glutathione, can be found within the 
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cells. Glutathione levels and total antioxidant power within the cells were determined as 
follows: 
9.2.12.1  Intracellular glutathione (GSH) levels 
Fibroblasts were suspended in medium A (20mM Hepes, 250mM sucrose and 10mM 
MgCl2; pH 7.1) at a concentration of 1.5x106 cells per 500µl and freeze-thawed. The 
lysed cells were then centrifuged at 15,000 g, in a microfuge (Microfuge®R, Beckman 
Coulter, Inc., Fullerton, CA) at 4ºC for 10min and the supernatant was used for 
determination of GSH. 100µl of the cell lysate was added to 0.2U GST and 0.5mM 
monochlorobimane. This reaction mixture was incubated for 30min at 37ºC and the 
fluorescence of monochlorobimane-S-glutathione congujate was read at Ex/Em 
380nm/460nmm using the Gemini XS fluorescence microplate reader (Molecular 
Devices Cooperation, Sunnyvale, CA). GSH concentrations were extrapolated from a 
standard curve of GSH ranging from 10µM-1mM and normalized with protein content 
determined by the Bradford assay. 
9.2.12.2  Total antioxidant power 
This assay is based on the ability of antioxidants to reduce copper (II) ions (Cu2+)   to 
copper (I) ions (Cu+). Cu+ forms a complex with a chromogenic reagent, bathocuproine 
disulfonate. This complex absorbs at 490nm. The assay was done following the protocol 
from (de Martino et al., 2001) with some modifications. Essentially, samples were diluted 
1:4 with a dilution buffer (3.6mM bathocuproine disulfonate in 1M Tris-HCl; pH 7.4). 
Absorbance of 200µl of diluted samples were read at 490nm using a plate reader 
(SpectraMax 190 from Molecular Devices Corporation, Sunnyvale, California, USA) for 
reference measurement. 50µl of 1.6mM CuSO4.5H2O was added to each well (final 
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concentration 0.26mM) and samples were incubated at room temperature for 3min 
following which 50µl of stop solution (0.5M EDTA) was added. Absorbance readings 
were taken again at 490nm. OD value for each sample was taken as A = A2nd reading – 
Areference reading. Total antioxidant power of samples was expressed in terms of µM uric acid 
equivalents, which were determined using uric acid standards of concentrations 62.5µM 
to 500µM.  
9.2.13  PREPARATION OF NUCLEAR EXTRACTS FOR WESTERN BLOT 
ANALYSIS 
The nuclear extracts were used in the Western blot analysis. Preparation of nuclear 
extracts from KF and NF was according to the procedure from (Huang et al., 2004). 
Briefly, cells grown in a T25 flask were scraped and washed twice with cold PBS. The 
pellet was re-suspended in 100µl Buffer A (10mM Hepes, pH 7.9, 1.5mM MgCl2, 10mM 
KCl, 0.5mM DTT, 0.5mM PMSF) supplemented with a protease inhibitor cocktail 
(Sigma) and kept on ice for 15min. 5µl of 10% Nonidet P-40 was then added to the cell 
suspension and mixed gently. Cells were centrifuged at 2,000g for 10min at 4°C. The 
pellet was resuspended in 40µl of buffer B (20mM Hepes, pH7.9, 1.5mM MgCl2, 
450mM NaCl, 25% glycerol, 0.2mM EDTA, 0.5mM DTT, 0.5mM PMSF) supplemented 
with a protease inhibitor cocktail and incubated on ice for 30min with gentle mixing once 
every 5min. The pellet was centrifuged at 20,000g for 15min. The supernatant 
representing the nuclear extract was used for the western blot of HIF-1α.  Protein content 
was determined using the Bio-Rad Protein Assay Dye Reagent Concentrate (Hercules, 
CA, USA).  
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9.2.14  PREPARATION OF WHOLE CELL LYSATES FOR WESTERN BLOT   
ANALYSIS 
Cell lysates were prepared by exposing fibroblasts for 5 min to 1x lysis buffer 
supplemented with protease inhibitor cocktail (Sigma) after which the cells were scraped 
and sheared by passing through a syringe with a 26.5 gauge needle 10 times. Following 
centrifugation at 14,000 g for 15 min at 4oC, the protein content of the supernatant was 
determined using a BCA® protein assay reagent (Pierce, Rockford, IL).  
9.2.15  WESTERN BLOT ANALYSIS 
9.2.15.1  PCNA, Hypoxia inducible factor 1-α, lactate dehydrogenase type A, 
voltage dependent anion channel (VDAC or porin-1), pyruvate 
dehydrogenase E1-α subunit, pyruvate dehyrogenase kinase 1, 
hexokinase type II, ATP synthase β subunit, phosphorylated GSK-3β, 
VEGF and V5-tag 
Aliquots of the nuclear lysates (20µg) for HIF1-α and whole cell lysates (50µg) for all 
other proteins were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred to nitrocellulose membrane (HybondTM-
ECLTM, Amersham Biosciences). After blocking with 10% non-fat milk in TBS with 
0.1% Tween-20 (TBS-T), the membranes were probed for 1h at room temperature with  
mouse anti-human HIF1-α at 1: 2000. Mouse anti-human cyclin A at 1:1000 was used as 
loading control for nuclear extracts; for the remaining proteins the following antibody 
dilutions were used with β-tubulin as loading control: goat PDK-1 polyclonal antibody at 
1:2000 dilution, mouse PCNA at 1:1000, mouse LDH-A at 1: 2000, mouse Porin-1 at 
1:2000, mouse PDH E1α at 1:1500, goat HKII polyclonal antibody at 1:1000, mouse β-
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tubulin at 1: 3750 dilution, mouse V5 monoclonal antibody at 1:3000. The membranes 
were washed and incubated with the respective secondary antibodies (Santa Cruz 
Biotechnology, Santa Cruz, CA; 1:15000) in 5% non-fat milk in TBS-T for 1h. For GSK-
3β analysis, the blocking solution used was 5% BSA and membrane was probed with 
rabbit anti-GSK-3β in 5% BSA at 1:1000 dilutions. Rabbit HRP-conjugated antibody at 
1:10000 in 5% BSA was used as secondary antibody. Detection was performed with a 
SuperSignal West Femto Maximum sensitivity substrate (Pierce, Rockford, IL). 
Densitometric measurements of the bands in western blot analysis were performed using 
the scientific software program Image J.  
9.2.15.2  HKII expression in the mitochondrial fractions 
Mitochondrial fractions (20µg) from four different keloid and normal fibroblasts were 
prepared as described in section 9.2.17 and immediately subjected to 10% SDS-PAGE 
and electroblotted onto a nitrocellulose membrane (HybondTM-ECLTM, Amersham 
Biosciences) overnight. After blocking with 10% non-fat milk in TBS-T, the membranes 
were incubated with goat HKII polyclonal antibody at 1:500 dilution or as loading 
control with mouse monoclonal anti-complex I antibody at 1:1000 for mitochondrial 
fractions for 1h at room temperature. The membrane was washed and incubated with 
horseradish peroxidase-conjugated rabbit anti-goat secondary antibody or goat anti-
mouse secondary antibody at 1:15000 for 1 h at room temperature (26ºC) in 5% non-fat 
milk in TBS-T. Detections were performed with a SuperSignal West Femto Maximum 
sensitivity substrate (Pierce, Rockford, IL). Densitometric measurements of the bands in 
western blot analysis were performed using scientific software program Image J.  
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9.2.16  MEASUREMENT OF CELL VIABILITY 
1 x 104 NF and KF per well were plated on a 96-well plate and grown overnight in 5% 
CO2. They were exposed to 30 to 100µM 3-BP for 2 h. The cells were then washed twice 
with PBS and incubated with 200µl of 0.5mg/ml MTT in cell culture medium for 2 h. 
The solution of MTT was removed and 100µl DMSO was added to each well followed 
by a 15-min agitation of the plate to dissolve the formazan produced by viable cells. The 
resultant absorbance was read at 550nm on a plate reader (Spectramax 190, Molecular 
Devices Corporation, Sunnyvale, California, USA).  
To analyze the effect of 3-BP on KF grown in different media, cells plated were grown 
overnight in medium without glucose but containing 5mM pyruvate, 10% FBS and 
100U/ml penicillin-streptomycin mixture (pyruvate medium) or in a medium with 5mM 
glucose as control. The cells were exposed on the following day to 30-100µM 3-BP for 2 
h prepared in the same medium after which cell viability was determined.  
9.2.17  PREPARATION OF MITOCHONDRIAL AND SOLUBLE FRACTIONS 
OF FIBROBLASTS 
Mitochondrial and cytosolic fractions were prepared from NF and KF by differential 
centrifugation at 600 g and 15,000 g for 10 min each time following the procedure 
described in (Birch-Machin and Turnbull, 2001). Marker enzymes for the mitochondrial 
and cytocolic fractions, namely succinate dehydrogenase (SDH) and glucose-6-phosphate 
dehydrogenase (G6PDH), were also assayed to assess the purity of the two fractions. 
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9.2.18  QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION 
(PCR) 
Total RNA from six samples each of normal and keloid fibroblasts was isolated using 
TRIzol reagent (Invitrogen, Carlsbad, CA). The integrity of the RNA samples was 
validated by denaturing agarose gel electrophoresis. 1µg of total RNA was reverse 
transcribed using 400U of Improm II and 0.5µg random hexamer (Promega, Madison, 
WI, USA) for 60 min at 42°C according to the manufacturer’s instructions. The reaction 
was terminated by heating at 70°C for 10 min and was used directly for quantitative real 
time PCR which was performed on the iCycler iQ (Bio-Rad, Hercules, USA) using Sybr 
Green I. The threshold cycles (Ct) were calculated automatically using the Optical 
interface v3.0B. Real time PCR was performed after an initial denaturation for 3 min at 
95°C followed by 40 to 50 cycles of 30 s denaturation at 95°C, 30 s annealing at 60°C 
and 30 s extension at 72°C. Detection of fluorescence was carried out at the annealing 
phase. The reaction was carried out in a total volume of 50µl in 1x XtensaMix-SGTM 
(BioWORKS), containing 2.5 mM MgCl2, 10 pmol of primers (shown in Table 1) and 1 
U Dynazyme II (Finnzymes, Finland). Melt curve analyses and agarose gel 
electrophoresis were carried out at the end of PCR to verify the identity of the products. 
The fold changes of the target genes in keloid cells, normalized to 18S rRNA and relative 
to the expression in normal cells, was calculated using the equation 2-∆∆Ct, where ∆∆Ct = 
(CtTarget gene – Ct18SrRNA)Keloid - (CtTarget gene – Ct18SrRNA)Normal. 
Gene Forward primer  Reverse primer  
18S Rrna 5’CGTCTGCCCTATCAACTTTCG3’ 5’GCCTGCTGCCTTCCTTGG3’ 




Primers used for quantitation of relative expression of HKII 
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9.2.19  IMMUNOFLUORESCENCE ANALYSIS OF HEXOKINASE TYPE II 
LOCALIZATION IN KELOID FIBROBLASTS 
KF (1x105 per well) were plated in 6-well plates containing three round coverslips (15-
mm diameter) per well. They were allowed to adhere overnight. On the day of the 
experiment, the culture medium was removed and cells were fixed in 3.7% 
paraformaldehyde (prepared in PBS pH 7.4) for 15 minutes at room temperature. The 
cells were then washed twice with ice-cold PBS and incubated for 2 minutes with 0.25% 
Triton X-100 (prepared in PBS pH 7.4). The cells were washed with PBS thrice, at 5 min 
per wash. Cells were blocked in blocking solution (1% BSA in TBS with 0.1% Tween-
20) for 30 min following which they were incubated in a mixture of primary antibodies 
(porin-1 and HKII) in blocking solution for 1h at room temperature. The cells were 
washed thrice with PBS, at 5 min per wash and incubated with a mixture of 
fluorochrome-tagged secondary antibodies (Alexa Fluor® 488 rabbit anti-goat for HKII 
and Alexa® 594 goat anti-mouse for porin-1, Molecular Probes, Invitrogen Cooperation, 
Carlsbad, CA). The samples were washed thrice in PBS, at 5 min per wash in the dark. 
Cells on the coverslips were observed by confocal microscopy using FITC and Texas 
Red filters (IX81; Olympus, Center Valley, PA, USA). 60xNA 1.4 oil lens is from 
Optivar. Filter sets were purchased from Omega and Semrock and images were captured 
using a CCD camera (CoolSnap HQ; Photometrics). Image acquisition was controlled by 
Metamorph Software from Molecular Devices.  
 9.2.20  CALCEIN-AM AND ETHIDIUM HOMODIMER STAINING 
Cell death induced by 3-BP on KF was determined by staining the cells with a 
combination of 2µM calcein-AM and 4µM ethidium homodimer 1 (EH-1) prepared in 
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1xPBS. NF and KF were grown on coverslips to sufficient cell density. Cells were 
washed with PBS and incubated with 3-BP for 2h, following which they were washed 
again with PBS and exposed to calcien-AM and EH-1 for 30min. Cells were then 
examined with a confocal microscope Zeiss LSM 510 (Carl Zeiss Vision GmbH, 
Műchen-Hallbergmoos, Germany) simultaneously for membrane integrity (calcien 
retention and EH-1 exclusion). As a positive control, cells were treated for 30s with 
0.05% Triton X-100.  
9.2.21  WOUND HEALING ASSAY 
Prior to the assay, KF were cultured to near confluence (>90%) in 6 well plates. Cells 
were then rinsed with PBS and starved in low serum media overnight (0.5% FBS). 
On the day of the assay, a line is drawn with a marker on the bottom of the dish. Using a 
200µl sterile pipet tip, three separate wounds are scratched through the cells moving 
perpendicular to the line drawn. The cells are then rinsed with PBS and replaced with 
media with 3-BP at concentrations of 10, 30, 50µM for 2h, after which normal growth 
media was added. Pictures were taken at 0, 8h, 16h and 24h after initial wounding. The 
three wounding sites were analyzed under a light microscope (Axio Vision 2.05, Carl 
Zeiss Vision GmbH, Műchen-Hallbergmoos, Germany) and images were captured by a 
camera (Coolpix, Nikon).  
9.2.22  CELL MIGRATION 
 Migration assay was performed using the Transwell 8.0µM pore size Fluorescence 
Blocking PET track-etched membrane (BD & Co., Franklin Lakes, NJ, USA). Equal cell 
numbers of KF were grown until 90% confluency in T25 flasks. Cells were then exposed 
to 30-50µM 3-BP for 2h, after which cells were harvested by trypsinization. Cell pellets 
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were resuspended in 200µl of low serum medium (0.5% FBS) and were seeded at the top 
of the insert, with 0.5ml 10% FBS/DMEM in the bottom chamber as a chemoattractant. 
For HIF-1αDN experiments, 5 x 104 cells resuspended in low serum medium were 
seeded. After 48h, inserts and media were removed and the wells were washed with PBS. 
Cells were stained with 0.2% crystal violet (in 2% ethanol) for 10min after which the 
plate was rinsed with tap water. Crystal violet from the stained cells were extracted using 
0.5% SDS (in 50% ethanol) for 1h at 37°C and quantified spectrophotometrically at 
600nm to determine relative migration rates. 
9.2.23  EXTRACELLULAR MATRIX SECRETION 
Equal cell numbers of KF were grown in T25 flasks until 80% confluent. Cells were 
treated with 0, 30 and 50µM 3-BP (in DMEM) for 2h, after which DMEM alone was 
added. For HIF-1αDN experiments, 4 x 104 cells were grown in 24-well plate overnight 
in full medium following which DMEM alone was added. Fibroblasts were grown for 1 
week and 1ml aliquots of cell medium were removed. The aliquots were freeze dried 
(VIRTIS, Freeze Mobile 25EL, Gardiner, NY, USA) and resuspended in 100µl deionised 
water. 20µl of sample subjected to electrophoresis on 8% SDS-polyacrylamide gels and 
electrophoretically transferred to a nitrocellulose membrane (HybondTM-ECLTM, 
Amersham Biosciences). Blotted nitrocellulose was washed twice with deionized water 
and then blocked in freshly prepared Tris-buffered saline (TBS) containing 0.1% Tween 
20 (TBS-T) and 7% skim milk for 2 h at room temperature. The nitrocellulose membrane 
was then incubated with mouse monoclonal antibodies against collagen I, II and III 
(Monosan, Sanbio, The Netherlands) or against fibronectin (BD Transduction 
laboratories (San Jose, CA, USA) overnight at 4°C. The membranes were then washed 
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six times with TBS-T and incubated for 1h with horseradish peroxidase-conjugated anti-
mouse secondary antibody at 1:2500 dilution. The western blot was washed once for 
15min and twice for 10min with TBS-T before detection was performed via SuperSignal 
West Femto Maximum sensitivity substrate (Pierce, Rockford, IL). 
9.2.24  KELOID FIBROBLASTS TRANSDUCTION 
 
Dr Thilo Hagen (National University of Singapore, Singapore) generously provided the 
lentivectors: PuroMarx-green fluorescent protein (GFP)-V5 and PuroMarx-HIF-1α (30-
389)-V5, used for transduction. Lentiviral particles were produced by transient 
transfection of 293GP cells using GeneJuice® (Novagen, Merck KGaA, Darmstadt, 
Germany) reagent. Determination of the titer of each viral supernatant was performed by 
assessing enhanced green fluorescent protein expression.  
For transduction, keloid fibroblasts (KF25) were plated in a 24-well plate (3 x 104 
cells/well) and incubated for 24h in complete medium. Medium was removed and cells 
were incubated with viral supernatants for 36h at 37ºC in the presence of 8µg/ml 
polybrene. Transduction efficiency was assessed by testing VEGF protein expression and 
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Fibroblasts M/F Race Age of 
“Donor”, years 
Origin Age of 
Scar 
NORMAL      
NF124 F Chinese 35 years old Upper eye lid - 
NF103 M Chinese 8 months old Hand - 
NF101 F Chinese 46 years old Breast  
NF102 M Indian 20 years old Abdominal - 
NF110 F Chinese 23 years old Eyelid - 
NF112 F Indian 32 years old Breast - 
NF113 M Indian 23 years old Right wrist - 
NF116 F Indian 31 years old Earring clefts - 
NF119 M Caucasian 37 years old Right back - 
NF154 F Caucasian 46 years old Earlobe - 
NF159 F Chinese 22 years old Alar skin - 
NF108 M Chinese 39 years old Hand dorsum - 
NF2 M Indian 38 Abdominal - 
NF8 F Indian 38 Abdominal - 
NF6 F Chinese 18 Eyelid - 
NF7 M Caucasian 30 Groin - 
NF125 F Chinese  31 Breast - 
NF4 M Chinese 3 Earlobe - 
NF3 F Chinese 54 Breast - 
      
KELOID      
KF22 F Malay 21 years old Earlobe 1 year 
KF23 F Chinese 18 years old Earlobe 1 year 
KF24 F Chinese 23 years old Earlobe 1.5 years  
KF25 M Chinese 34 years old Elbow 0.5 year 
KF26 M Chinese 36 years old Forearm 1 year 
KF27 M Indian 25 years old Chest 0.5 year 
KF111 F Chinese 21 years old Right back 1 year 
KF116R F Indian 47 years old Right earlobe 1 year 
KF48 F Indian 23  Earlobe 1.5 years 
KF3 F Malay 20  Earlobe 1.5 years 
KF6 F Chinese 16  Earlobe 1 year 
KF29 F Chinese 22  Earlobe 1 year 
KF46 M Chinese 36 Forearm 1 year 
KF16 F Chinese 19 Earlobe 1.5 years 
KF38 F Chinese 25 Earlobe 1.5 years 
KF44 F Chinese 50 Forearm 3 years 
KF8 F Chinese 19 Earlobe 1.5 years 
KF49 F Malay 28 Earlobe 1 year 
 
Table 9.1 Clinical data on specimens of fibroblasts used in this study 
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Human Skin Keloid Fibroblasts Display Bioenergetics
of Cancer Cells
Annette S. Vincent1, Than T. Phan2, Anandaroop Mukhopadhyay2, Hwee Y. Lim1, Barry Halliwell1 and
Kim P. Wong1
Cultured human skin keloid fibroblasts (KFs) showed bioenergetics similar to cancer cells in generating ATP
mainly from glycolysis as demonstrated by increased lactate production. Activities of hexokinase,
glyceraldehyde-3-phosphate dehydrogenase, and lactate dehydrogenase were also significantly higher
compared with normal fibroblasts (NFs). Inhibitors of glycolysis decreased the rate of ATP biosynthesis more
significantly in KFs suggesting their reliance on glycolysis. In contrast, ATP generation in NFs was derived mainly
from oxidative phosphorylation (OXPHOS), which was more compromised by mitochondrial/respiratory
inhibitors. However, when fortified with excess exogenous respiratory substrates, ATP production was
increased to a similar maximal level in both types of fibroblasts. In spite of this seemingly equal total capacity,
ATP biosynthesis and intracellular ATP concentration were significantly higher in KFs, which further increased
their ATP production when exposed to hypoxia and hypoxia-mimetics: desferrioxamine and cobalt chloride.
This upregulation was again significantly compromised by glycolytic inhibitors. The rate of generation of
reactive oxygen species was lower in KFs possibly due to their switch to aerobic glycolysis from mitochondrial
OXPHOS. Thus, cultured skin KFs could provide a human cell model to study the de-regulation of bioenergetics
of proliferative cells and their response to the HIF (hypoxia-inducible factor) signaling.
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INTRODUCTION
Keloid scars are found only in humans and presently there is
no cure for this condition because the underlying biochemi-
cal mechanisms of pathogenesis remain unknown (Haverstock,
2001). Keloids are characterized by the excessive deposition
of extracellular collagens by abnormal fibroblasts in response
to cutaneous injury. It is known that Type I and III collagens
and their respective mRNAs are upregulated in these highly
proliferative cells (Naitoh et al., 2001), which suggest an
overactive system. As most of the energy in the cell is
produced in the mitochondrion, this organelle is implicated in
keloid pathophysiology. Interestingly, ATP levels remain high
in the keloid scar tissue 10 years after the initial injury (Ueda
et al., 2004). In this study, we examined the mechanism by
which keloid fibroblasts (KFs) sustain a high ATP level.
Histological examination of keloid demonstrates a normal
skin periphery, an inflammatory border, and a stable portion,
which is hypo-vascular and hypoxic (Berry et al., 1985).
Human hypertrophic burn scars were shown to be sites of
relative hypoxia (Sloan et al., 1978) and the oxygen tension in
a wound is low days after the injury (Ninikoski and Hunt,
1972; Haroon et al., 2000). The presence of hypoxia could
possibly explain the induction of the expression of hypoxia-
inducible factor 1a (HIF-1a) mRNA and of HIF-1a protein in
wound cells hours and days later (Albina et al., 2001). HIF-1
is a heterodimer consisting of two subunits: 1a and 1b. The
regulation by oxygen is through its 1a subunit, which is
rapidly destroyed by proteasomal degradation under normal
oxygenation (Beck et al., 1993; Maxwell et al., 1993; Wang
and Semenza, 1993). Hypoxia results in decreased ubiquiti-
nation and accumulation of HIF-1a (Sutter et al., 2000).
Keloid has been shown to express constitutively a higher
level of HIF-1a protein compared with the adjacent skin
(Zhang et al., 2003; Wu et al., 2004). The similarity in
the hypoxic microenvironment in solid tumors and keloids
led us to examine the response of KF to hypoxia and
hypoxia-mimetic agents, such as desferrioxamine and cobalt
chloride.
RESULTS
Titration of digitonin permeabilization of fibroblasts
Both KFs and normal fibroblasts (NFs) were optimally
permeabilized with 65 mg digitonin per 106 cells as shown
by the maximal increase in the fluorescence of the
J-aggregates following the entry of glutamate/malate and
succinate. The energization of the mitochondrial membrane
potential by these respiratory substrates (as previously shown
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in our publication, Ng et al., 2006) was apparent and the
increase in mitochondrial membrane potential was inhibited
by rotenone and malonate, respectively (data not shown).
ATP biosynthesis and intracellular ATP
From the five batches of KF and NF, the former were shown
to biosynthesize ATP from exogenous ADP (1mM) more
rapidly than NF; their respective specific activities, expressed
in nmol ATP per minute per 106 cells were 11.973.7 and
3.270.8, giving a ratio of 3.7. Likewise, intracellular ATP
was higher in KF with respective values, expressed in nmol
ATP per 106 cells of 8.971.2 and 4.670.9. Both sets of data
showed significant difference between NF and KF with
Po0.01.
Action of respiratory substrates, inhibitors, uncoupler, or
oligomycin on ATP generation
The biosynthesis of ATP in KF was inhibited to a higher
degree by 3-bromopyruvate, iodoacetate and oxamate,
inhibitors of hexokinase, glyceraldehyde-3-phosphate dehy-
drogenase, and lactate dehydrogenase (LDH), respectively,
compared with NF, which implied that their ATP production
relied more on the glycolytic pathway (Table 1). On the other
hand, the degree of inhibition by thenoyltrifluoroacetate, an
inhibitor of respiratory complex II; carbonyl cyanide p-
trifluoro-methoxyphenylhydrazone, an uncoupler; and oligo-
mycin, an inhibitor of FoF1 ATPase was more pronounced in
NF, suggesting that they depend more on oxidative phos-
phorylation (OXPHOS) for their ATP production. In view of
this finding, OXPHOS was studied by measuring the amount
of ATP produced from the oxidation of respiratory substrates
such as pyruvate/malate, glutamate/malate, and succinate in
digitonin-permeabilized cells. Consistent with the data on
ATP biosynthesis above, KF again showed inherently higher
capacity of about 3.6 times compared with NF measured in
the absence of exogenous substrates (Table 2). Addition of
respiratory substrates increased significantly the rate of ATP
production in both NF and KF to a similar maximum value.
The increase represents the amount of ATP derived from their
oxidation via OXPHOS. The magnitude of increase was
greater in NF compared with KF supporting the earlier
conclusion that contribution by OXPHOS was greater in NF
when thenoyltrifluoroacetate, carbonyl cyanide p-trifluoro-
methoxyphenylhydrazone, or oligomycin was added (Table 1).
Glucose consumption and lactate production
The uptake of glucose from the culture medium was not
different in KF and NF for the first 2 days of culture when the
cells were o50% confluent. For the subsequent 3 days, KF
consumed more glucose as reflected by a greater decrease of
glucose in the medium (Figure 1); this was accompanied by a
higher accumulation of lactate compared with NF. The cell
number and protein contents per well were essentially similar
in NF compared with KF during the 5 days of culture.
Activity of glycolytic enzymes
The specific activities of hexokinase, glyceraldehyde-3-
phosphate dehydrogenase, and LDH, expressed as nmol
reduced nicotinamide adenine dinucleotide or reduced
nicotinamide adenine dinucleotide phosphate per minute
per mg protein were 1.8.70.51, 343.1728.3, and
554.3712.1, respectively, for five samples of NF. The
corresponding values for KF, which were significantly
different (with Po0.05) were 130, 63, and 35% higher.
Glucose utilization
When cells metabolize D-[2-3H]glucose, the tritium label is
lost as 3H2O at the phosphoglucose isomerase reaction (Rose
and O’Connell, 1961). The rate of glucose utilization
measured by the amount of tritiated water formed from
D-[2-3H]glucose was linear for the first 3 hours and was
significantly higher in the KF compared with NF (Figure 2).
Effects of hypoxia, desferrioxamine, and cobalt chloride on ATP
biosynthesis in KF
The rate of production of ATP was significantly higher in KF
exposed to hypoxia, desferrioxamine, or cobalt chloride
compared with values obtained under normoxic condition
(Table 3). Under these conditions, the cell viability of the
fibroblasts measured by the 3-(4,5,dimethylthiazolyl-2)-2,
5-diphenyltetrazolium bromide assay was not compromised
(data not shown). The increase was significantly reduced by
inhibitors of glycolysis, namely 3-bromopyruvate, iodoace-
tate and oxamate under both normoxic and hypoxic
conditions.
Production of reactive oxygen species and hydrogen peroxide
Total reactive oxygen species (ROS) production measured by
the 20,70-dichlorofluorescein-diacetate assay was significantly
Table 1. Action of inhibitors of glycolysis and
OXPHOS on ATP biosynthesis in NF and KF1
NF KF
Inhibitor Inhibition of % Inhibition % Inhibition
3-Bromopyruvate
(10mM)
















FCCP, carbonyl cyanide p-trifluoro-methoxyphenylhydrazone; G3PDH,
glyceraldehyde-3-phosphate dehydrogenase; HK, hexokinase; KF, keloid
fibroblast; LDH, lactate dehydrogenase; NF, normal fibroblast; OXPHOS,
oxidative phosphorylation; TTFA, thenoyltrifluoroacetate.
1Normal and keloid fibroblasts were pre-incubated with the various
inhibitors for 5min and the data were expressed as mean % inhibi-
tion7SD for n=3, as compared to controls.
2*Po0.05, **Po0.01, #Po0.005 were obtained by comparing values
between NF and KF.
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higher in three batches of NF compared with KF (Figure 3a).
Known antioxidants, ascorbate, and Trolox (a vitamin E
analog) were able to reduce the ROS production. The
generation of H2O2 was higher in NF and the antioxidant
effect of Trolox was also apparent (Figure 3b).
DISCUSSION
Keloid scars are characterized by excessive collagen deposi-
tion during the wound healing process. ATP is required for
this uncontrolled production of extracellular matrix. Although
cellular ATP is normally synthesized in the mitochondria by
OXPHOS, the increased lactate in keloid tissue (Hoopes
et al., 1971) suggests that glycolysis may provide the main
energy source. To examine the separate contribution of
mitochondrial and extra-mitochondrial compartments to the
biosynthesis of ATP, it is necessary to examine OXPHOS
activity in mitochondria to delineate any cytoplasmic
contribution from glycolysis. Isolation of mitochondria from
fibroblasts is a technical challenge because of the scarcity of
this organelle, which represents only 2.4% of the volume of
human skin fibroblasts compared with 28% of the cell
volume in hepatocytes (Mourant et al., 1998). On the other
hand, to measure ATP synthesis by mitochondria in whole
cells, it is necessary to permeabilize the plasma membrane to
facilitate the entry of respiratory substrates without compro-
mising the integrity of the mitochondrial membranes.
Digitonin permeabilization has previously been monitored
by ATP synthesis (Ouhabi et al., 1998; Manfredi et al., 2002)
or by oxygen uptake (Kunz et al., 1995; Villani et al., 1998).
Our method of measuring the mitochondrial membrane
potential with 5,50,6,60-tetrachloro 1,1, 3,30tetraethyl-
benzimidazolcarbocyanine iodide (JC-1) to monitor digitonin
titration is rapid and sensitive and the assay also provides an
assessment of the activity (or lack of activity) of the
mitochondrial respiratory complexes. Using this procedure,
complex I and II activities in both NF and KF were observed
when their respective substrates were introduced (data not
shown).
Under normal basal conditions, KF appeared to preferen-
tially use the alternative pathway of glycolysis instead of
OXPHOS for their ATP biosynthesis (see Figure 4). This
conclusion was supported by the observation of increased
accumulation of lactate in the culture medium. The higher
activities of glycolytic enzymes (hexokinase, glyceraldehyde-
3-phosphate dehydrogenase, and LDH) contributed to the
greater rate of glucose utilization by KF compared with NF.
Biochemical data on ATP biosynthesis using specific inhibi-
tors of glycolysis and OXPHOS have alluded to glycolysis as
Table 2. Biosynthesis of ATP in digitonin-permeabilized fibroblasts from respiratory substrates1
NF KF
ATP (nmol per min
per 106 cells) Fold increase
ATP (nmol per min
per 106 cells) Fold increase
Control 3.770.3 13.470.5*2 3.62
Pyr/Mal 33.871.5**2 9.19 32.872.3# 3 2.44
Glu/Mal 35.672.3** 9.67 30.373.0# 2.26
Succinate 22.471.5** 6.09 24.571.0# 1.83
KF, keloid fibroblast; NF, normal fibroblast.
1Rate of ATP biosynthesis (expressed in nmol per min per 106 cells for n=3) from 1mM ADP was measured in NF and KF permeabilized with 65 mg digitonin
per 106 cells in the absence or presence of 5mM each of exogenous respiratory substrates: pyruvate/malate, glutamate/malate, and succinate.
2* and **Po0.005 compared with NF control.




































Figure 1. Glucose uptake and lactate accumulation. Glucose and lactate in
the culture medium were measured by the glucose oxidase and LDH assays,
respectively. From day 3 to 5 when the cells became confluent, KF consumed
significantly more glucose compared with NF, concomitant with a greater
production of lactate by KF. *Po0.01 for glucose values; #Po0.05,






























Figure 2. Rate of glucose utilization in keloid and normal fibroblasts.
Tritiated water formed from radiolabeled glucose was separated by Dowex-1-
borate column chromatography and measured by liquid scintillation
counting. The rate of glucose utilization was significantly higher in KF
compared with NF as shown by two representative plots.
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the preferred pathway in KFs, because ATP generation was
inhibited to a greater extent by 3-bromopyruvate, iodoacetate,
and oxamate. In contrast, inhibition by thenoyltrifluoroacetate
(a respiratory inhibitor), carbonyl cyanide p-trifluoro-methoxy-
phenylhydrazone (an uncoupler), and oligomycin (an inhibitor
of FoF1 ATP synthase) was more pronounced in NF.
Proliferative cells preferentially use aerobic glycolytic
rather than oxidative metabolism to generate ATP (Brand and
Hermfisse, 1997), a phenomenon proposed as the primary
defect in cancer (Warburg, 1956). Clinically, keloids are
benign tumors as they continue to grow beyond the periphery
of the original wound margins. Although our data showed
that KF appeared to rely mainly on glycolysis for their energy
supply under basal conditions, these cells are also capable of
generating ATP from added respiratory substrates via
OXPHOS. It is tempting to propose that this dual capability
with a greater reliance on glycolysis confers on KF the
capacity to proliferate and survive in spite of (or because of)
its hypoxic environment. This advantage was translated into a
higher rate of biosynthesis of ATP with its accumulation in the
cell. In addition, a switch to glycolysis may enable the KF to
minimize their production of ROS, which are generated
normally from mitochondrial oxidation. Although mitochon-
dria isolated from human skin fibroblasts have been shown to
produce ROS, including superoxide and nitric oxide (Chen
et al., 1996; Cobbold, 2001), we found that the rate of ROS
production was lower in KF compared with NF.
The aerobic glycolysis described above in KF is a common
feature of many cancer cells and this Warburg effect has been
linked to the HIF-1, which affects angiogenesis, glucose
transporter, and glucose metabolism (Semenza, 1999). The
HIF-1a subunit has been reported in healing wounds (Albina
et al., 2001) and demonstrated to be expressed at higher
levels in keloid tissues compared with the adjacent skins
(Zhang et al., 2003; Wu et al., 2004). Our measurement of
the HIF-1a protein in KF and NF (data not shown)
corroborated these findings. The enhanced ATP biosynthesis
in KF was further increased on exposure to hypoxia possibly
the result of an upregulation of the HIF-1a protein (Zhang
et al., 2006). Desferrioxamine and cobalt chloride, known to
mimic intracellular hypoxia (Gleadle et al., 1995) exhibited
similar effects. HIF-1a has been shown to activate the
transcriptional regulation of genes encoding glycolytic
enzymes (Semenza et al., 1994). The co-ordinated upregula-
tion of all glycolytic enzymes on exposure to hypoxia has
previously been demonstrated, whereas the activity of non-
glycolytic enzymes remained unchanged (Robin et al., 1984).
These observations were consistent with the conclusion
that the rate of glycolysis was positively controlled by
the glycolytic enzymes (Ainscow and Brand, 1999), a
Table 3. Effect of inhibitors of glycolysis on ATP biosynthesis in KFs under normoxic and hypoxic conditions1
ATP (nmol per min per 106 cells)
Normoxic Hypoxic2
0.5% O2 Desferrioxamine CoCl2
ADP 1.1770.04 3.5770.15*3 2.46709* 2.4370.06*
+ADP 3.2870.09 6.0370.08**4 9.3370.6** 10.9970.8**
+ADP+3-bromopyruvate 1.0870.03# 5 3.9670.12# 5.9570.5# 5.6270.7#
+ADP +iodoacetate 1.5270.14# 3.8470.09# 5.9170.2# 7.0270.5#
+ADP+oxamate 1.9770.1# 3.4670.04# 5.2570.37# 6.2170.4#
1ATP biosynthesis from 1mM ADP following exposure of intact KF to 10mM each of 3-bromopyruvate, iodoacetate, or oxamate for 5min.
2KF were exposured to 0.5% oxygen for 16 h or to 130mM desferrioxamine or 70 mM cobalt chloride for 24 h.
3*Po0.005 as compared to normoxic value without ADP.
4**Po0.005 as compared to normoxic value with ADP.

























































Figure 3. Production of ROS and H2O2 in NF and KF. The rates of production
of (a) ROS and (b) H2O2 were significantly higher in NF compared with KF.
The antioxidants, Trolox and/or ascorbate, at final concentration of 50 mM
reduced the production of ROS and H2O2. Values are means7SD for n¼ 3;
**Po0.01 when compared with basal ROS generation and #Po0.005 for
comparison of basal H2O2 production between NF and KF. RFU, relative
fluorescence unit.
www.jidonline.org 705
AS Vincent et al.
Bioenergetics in Keloid Fibroblasts
relationship that was also apparent in our study of a higher
rate of glycolysis with higher activities of hexokinase,
glyceraldehyde-3-phosphate dehydrogenase, and LDH in KF.
In conclusion, KF under basal conditions are characterized
by a higher rate of ATP biosynthesis, with glycolysis as their
primary energy source. This enhanced glycolytic flux
provides a mechanistic basis to treat keloid scar formation
with glycolytic inhibitors of which 3-bromopyruvate has been
noted to be highly efficacious against liver cancers in
experimental animal models (Ko et al., 2004; Vali et al.,
2007). The KF appear to retain their keloid characteristics
during culture by their ability to synthesize collagens in vitro
(Diegelmann et al., 1979) and to respond to hypoxia and
hypoxia mimetics with further increase in ATP biosynthesis
(this study). It is tempting to relate the latter changes to the
presence of a functional HIF-signaling pathway. Thus, KF in
culture could provide a human cell model to study the effects
of drug candidates on their bioenergetics including their
response to hypoxia, conceivably via the activation of the HIF
pathway. Enhanced glycolysis and attenuated OXPHOS as
observed in KF seem to be a salient feature of many cancer
cells (Moreno-Sanchez et al., 2007) and the dependency on
glycolysis appeared to more pronounced with the progression
of tumorigenesis (Ramanathan et al., 2005).
MATERIALS AND METHODS
Materials – 5,50,6,60-tetrachloro 1,1, 3,30tetraethylbenzimidazol-
carbocyanine iodide and the Amplexs Red hydrogen peroxide/
peroxidase assay kit were from Molecular Probes Inc. (Eugene,
OR). P1,P5-Di(adenosine-50) pentaphosphate pentalithium salt and
glucose-6-phosphate dehydrogenase (204Uml1) were obtained
from Fluka Chemie (Buchs, Switzerland). The following were
purchased from Sigma Aldrich Co. Ltd (St Louis, MO): ADP,
ATP, 3-bromopyruvate, 20,70-dichlorofluorescein diacetate; carbonyl
cyanide p-trifluoro-methoxyphenylhydrazone; glucose oxidase
(151 kUmg1), L-glutamic acid, homovanillic acid, horseradish
peroxidase, (298Umg1), iodoacetate, LDH (5.3 kUml1),
L-malic acid, NADþ , NADPþ , oligomycin (containing 59, 18, and
14% of oligomycin A, B, and C), oxamate, pyruvate, rotenone,
succinate, thenoyltrifluoroacetate, 6-hydroxy-2,5,7,8-tetramethyl
chromane-2-carboxylic acid (Trolox), FL-ASC Bioluminescent cell
assay kit. D-[2-3H]glucose (16Cimmol1) was purchased from GE
Healthcare UK Limited (Buckinghamshire, UK).
Collection and processing of skin specimens
Excised normal skin and keloid skin specimens were collected from
plastic surgical procedures (Table 4) as reported in Mukhopadhyay
et al. (2006) under the guidelines approved by the National
University Institutional Review Board. Signed informed consent
had been obtained before operative excision. For babies, informed
consent was obtained from the parents. All clinical investigations
were conducted according to the Declaration of Helsinki Principles.
A portion of the excised specimen was sent for histological
confirmation of keloid identity and other portions were used for
primary cell culture to isolate fibroblasts.
Primary fibroblast cell culture
Remnant dermis was minced and incubated in a solution of
collagenase type-I (0.5mgml1) and trypsin (0.2mgml1) for
6 hours at 371C. Cells were cultured in DMEM medium supple-
mented with 10% fetal bovine serum and 100Uml1 of penicillin-
streptomycin mixture at 371C in 5% CO2.
Permeabilization of fibroblasts with digitonin
Digitonin permeabilization was carried out on skin fibroblasts from
passages 3 to 7 by the method described in our publication (Ng
et al., 2006). The titration of digitonin was monitored by measuring
the mitochondrial membrane potential using 5,50,6,60-tetrachloro
1,1, 3,30tetraethylbenzimidazolcarbocyanine iodide. The rate of
formation of the J-aggregates was measured upon sequential addition
of 5mM each of glutamate/malate and 5mM succinate. Specific
inhibitors of respiratory complexes I and II, namely rotenone and
malonate, were used to validate that the oxidation of these substrates
occurred via the mitochondrial electron transport system. This assay
also provides a means of assessing the activity (or lack of activity) of
these respiratory complexes.
Measurement of ATP production
(a) Assay conditions. ATP generation from the oxidation of


















Figure 4. An overview of glycolysis and OXPHOS showing sites of action of respiratory substrates and inhibitors (in parentheses) used in this study.
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been measured in isolated mitochondria (Vincent et al., 2004; Zhang
et al., 2004) and was extended in this study to digitonin-
permeabilized skin fibroblasts. The chemiluminescence generated
by the luciferin-luciferase reaction was read in a luminometer
(PerkinElmer Life and Analytical Sciences, Turku, Finland; Victor3) as
described in our report (Ng et al., 2006).
(b) In the presence of inhibitors of glycolysis or OXPHOS.
In addition to 500lM P1,P5-Di(adenosine-50) pentaphosphate,
which was routinely introduced to inhibit adenylate kinase
(Kurebayashi et al., 1980), each of the following chemicals
was pre-incubated with fibroblasts for 5minutes before the
mixture was added to the assay incubate described above for
ATP biosynthesis: 10mM each of 3-bromopyruvate, iodoacetate
or oxamate, or 250lM thenoyltrifluoroacetate, 10lM carbonyl cyanide
p-trifluoro-methoxyphenylhydrazone or 10lg oligomycin per ml.
(c) Under normoxic and hypoxic conditions. KF were incubated
under normoxic condition or in a hypoxic chamber (Billups-
Rothenberg Inc, Del Mar, CA) containing 0.5% oxygen, 94.5% N2
and 5% CO2 for 16 hours followed by measurement of ATP
biosynthesis. In another set of experiments, KFs were exposed to
130lM desferrioxamine or 70 lM cobalt chloride for 24 hours.
Intracellular ATP
The amount of ATP present intracellularly was determined in five
different batches of confluent KF and NF, following the assay
protocol reported in Jeong et al. (2004).
Glycolysis and glycolytic enzymes
(a) Glycolysis – The rate of glucose utilization was determined by
the production of 3H2O from D-[2-
3H] glucose as described in
McKay et al. (1983). NF and KF were plated in six-well plates at 105
cells per well in glucose-free DMEM supplemented with 10% fetal
bovine serum. The cells were used the next day when they were
approximately 60–70% confluent as recommended. The reaction
was started by adding 0.25mM unlabeled glucose and 93.75 nM
D-[2-3H]glucose (containing 2.25 mCi). At hourly intervals up to
4 hours, 100 ml aliquots were removed to assay for 3H2O.
The separation of 3H2O from the radiolabeled glucose was carried
out by column chromatography using Dowex-1-borate and eluting
with 0.9ml deionized water (Hammerstedt, 1973). The radioactivity
in the eluate was measured by liquid scintillation counting. At the
end of the experiment, the cells were lysed with a buffer containing
7M urea, 2 M thiourea, 4% 3-[3-cholamidopropyl) dimethylammo-
nio]-1-propanesulfonic acid (CHAPS), and 10mM Tris. The protein
content in each well was determined (Bradford, 1976).
(b) The activities of hexokinase, glyceraldehyde 3-p dehydro-
genase, and LDH were measured in extracts (containing 0.03mg
protein) of NF and KF by the methods described in Krebs (1955),
Clark and Lai (1989) and Jenkins and Thompson (1989). The
fluorescence of NADH and NADPH was monitored at Ex/Em of 352/
464 nm in a luminescence spectrophotometer (Perkin-Elmer LS55)
and the activities were expressed as an increase in fluorescence of
NADH or NADPH per minute per mg protein.
Determination of glucose and lactate in cell culture medium
A total of 40,000 fibroblasts were plated in each well of a six-well
plate containing 3ml culture medium of DMEM supplemented with
5mM glucose, 10% fetal bovine serum, and 100Uml1 of penicillin-
streptomycin mixture. The concentrations of glucose and lactate in
the culture medium were measured as follows:
(a) Glucose oxidase assay – 20 ml of the culture medium in
triplicate wells were added to 2ml of buffer (adjusted to pH 7.4)
containing 145mM KCl, 30mM HEPES, 5mM KH2PO4, 3mM MgCl2
0.1mM EGTA, 0.2mM homovanillic acid, 1Uml1 horseradish
peroxidase, and 20mUml1 glucose oxidase. Hydrogen peroxide
produced from the oxidation of glucose was coupled to the reaction
between horseradish peroxidase and homovanillic acid to produce a
fluorescent dimer (Barja, 2002), which was measured at Ex/Em 312/
429 nm. The concentration of glucose was extrapolated from a
standard of 0.1–5mM glucose oxidized by glucose oxidase under
identical conditions.
(b) LDH assay – Likewise, 20 ml aliquots of the culture medium
from triplicate wells were added to 2ml of buffer containing 0.4 M
hydrazine and 0.5M glycine adjusted to pH 9.0, 0.15mM NADþ and
26U LDH (Clark and Lai, 1989).
ROS production
ROS production was measured by the procedure based on the
oxidation of 20,70-dichlorofluorescein (Wang and Joseph, 1999)
using 30,000 cells per well of a 96-well plate and grown overnight in
5% CO2. The action of 50 mM each of Trolox and ascorbate on the
production of ROS was also examined. The rate of 20,70-dichloro-
fluorescein oxidation was measured for 30minutes at Ex/Em 485/
526 nm in a fluorescence plate-reader (Gemini XS from Molecular
Table 4. Profiles of Normal Skin and Keloid Scar







NF 2 M Indian 38 Abdominal —
NF 8 F Indian 38 Abdominal —
NF 6 F Chinese 18 Eyelid —
NF 7 M Caucasian 30 Groin —
NF103 M Chinese 8 months Hand —
NF 4 M Chinese 3 Earlobe —
NF 3 F Chinese 54 Breast —
NF125 F Chinese 36 Breast —
Keloid
KF 6 F Chinese 16 Earlobe 1
KF 46 M Chinese 36 Forearm 1
KF 3 F Malay 20 Earlobe 1.5
KF 48 F Indian 23 Earlobe 1.5
KF 16 F Chinese 19 Earlobe 1.5
KF 38 F Chinese 25 Earlobe 1.5
KF 44 F Chinese 50 Forearm 3
KF 24 F Chinese 23 Earlobe 1.5
KF 8 F Chinese 19 Earlobe 1.5
KF29 F Chinese 22 Earlobe 1
KF49 F Malay 28 Earlobe 1
F, female; KF, keloid fibroblast; M, male; NF, normal fibroblast.
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Devices Corporation, Sunnyvale, CA). Cells were lysed at the end of
the experiment with 20% Triton-X and the protein content in each
well was measured (Bradford, 1976). The generation of H2O2 was
determined by the Amplex Red hydrogen peroxide/peroxidase assay
following the protocol provided by the supplier (Molecular Probes).
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